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Abstract
WILLIAM GENE ROBICHAUX III. Regulation of the Gαi – G-protein Regulatory 
(GPR) Module and the Biological Function of GPR-containing Proteins in 
Chemokine Signal Processing of Primary Leukocytes. (Under the direction of Joe 
B. Blumer) 
Activators of G-protein Signaling (AGS) proteins modulate G-protein signaling in 
diverse and unexpected ways and have functional roles in numerous 
physiological systems. The functions of AGS proteins in the immune system, 
where Gαi-coupled chemokine receptors are predominantly involved in dynamic 
signaling events, are poorly understood.  The Group II AGS proteins AGS3 and 
AGS4 express multiple G-protein regulatory (GPR) motifs, each of which dock 
GDP-bound Gαi/o/t subunits and effectively compete with Gβγ for binding. This 
unique ability positions these proteins to modulate downstream signaling of Gαi 
and Gβγ, thus promoting signal diversity from seven-transmembrane receptors 
(7TMR). However, regulatory mechanisms and functional roles for the Gαi2–GPR 
module in leukocytes are poorly understood. Using a bioluminescence resonance 
energy transfer (BRET) platform, we demonstrated chemokine regulation of 
Gαi2–GPR modules that were receptor-proximal. Generation of fusion proteins 
with Gαi physically tethered to the 7TMR revealed that regulation of Gαi2–GPR 
was independent of endogenous G-protein cycling subsequent to receptor 
activation, suggesting that Gαi-GPR couples to 7TMRs analogous to Gαβγ 
heterotrimer. Additional modes of regulation for AGS4 were also investigated 
including identification of alternative binding proteins ARID1b and eEF1d, 
suggesting potential modulatory functions for AGS4 in transcription and protein 
translation, and phosphorylation of AGS4-Y108 by JAK2 and Src, which 
regulates the Gαi-AGS4 interaction. Furthermore, regulation of Gαi2–GPR by 
chemokine receptors and expression of AGS3 and AGS4 in immune cells and 
tissues suggested functional roles of these proteins in the immune system. 
Investigating chemoattractant signal processing in primary leukocytes from wild-
type, AGS3-null and AGS4-null mice demonstrated 25-40% decreased migration 
with corresponding reduction in ERK1/2 activation of null-animals. The 
importance of the Gαi–GPR interaction in chemokine signaling provides a novel 
platform for development of pathway targeted small molecules, identified in 
preliminary screening for modulators of the Gαi–GPR interaction. These studies 
have broad implications for G-protein signal processing and Gαi-GPR complexes 
in immune function. 
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Introduction to Canonical G-protein Signal Transduction 
Signaling through G-proteins is a fundamental transduction pathway for 
cells. G-protein coupled receptors (GPCRs) are the most commonly used 
mechanism for cells to process extracellular stimuli into appropriate signal output. 
Signifying the importance and diversity of G-protein signaling, 3-4% of the entire 
human genome is dedicated to the genes of GPCRs, thus representing the single 
largest gene superfamily (Katritch et al 2013). Such a variety of receptors allows 
for G-proteins to be integrated into signaling pathways from countless stimuli, 
and as a consequence, perturbations to this core signaling system are linked to 
the development of cardiovascular, metabolic, neurodegenerative, cancer and 
immunological diseases. The practically universal use of G-proteins by cells has 
made the development of therapeutics to this pathway quite attractive, leading to 
greater than 30% of known pharmaceuticals targeting GPCRs or downstream 
effectors of these signaling pathways (Overington et al 2006, Rask-Andersen et 
al 2011). However, although this pathway is well exploited for drug development, 
the manner in which cells are able to achieve appropriate signal specificity, 
efficiency, and strength and maintain flexibility and adaptability in the face of 
dynamic alterations of external stimuli is still largely unknown.  
 Although involved in a vast array of signaling pathways, receptors from the 
GPCR superfamily all contain general structural similarities including an 
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extracellular amino-terminus, seven transmembrane-spanning (7TM) alpha 
helical domains, and an intracellular carboxy-terminus forming three extracellular 
and three intracellular loops as seen in solved crystal structures of rhodopsin, M2 
muscarinic acetylcholine, β2 adrenergic, and CXCR4 receptors. (Haga et al 
2012, Palczewski et al 2000, Pierce et al 2002, Rasmussen et al 2007, Wu et al 
2010). Even with these common structural features, the superfamily is further 
categorized into five subclasses: rhodopsin and adrenergic receptors, secretin 
receptors, glutamate receptors, adhesion receptors and frizzled/taste receptors 
(Fredriksson et al 2003). The primary conduit of signal transduction for this 
receptor superfamily are heterotrimeric G-proteins, although G-protein 
independent mechanisms are also reported, including β-arrestin-mediated 
signaling cascades and Janus kinase 2 (JAK2) activation of Stat1 and Stat3 (Azzi 
et al 2003, Godeny et al 2007, Lefkowitz & Shenoy 2005, Luttrell & Lefkowitz 
2002).  
Initially, GPCRs were viewed as simple “on-off” switches for activation of 
G-protein heterotrimers; however, recent studies demonstrate the dynamic 
conformations these receptors can adopt. In the most basic context, extracellular 
ligand binding triggers conformational changes in the transmembrane domains 
and intracellular loops, thus stabilizing active, thermodynamically-favorable 
conformations which have increased affinity for heterotrimeric G-protein coupling 
and subsequent activation (Azzi et al 2003, Bockenhauer et al 2011, Kahsai et al 
2011, Malik et al 2013, Park 2012, Vilardaga et al 2005, Yao et al 2009). Of the 
conformational changes occurring in the receptor, three notable clusters of 
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highly-conserved residues in the transmembrane domains (TM), termed micro-
switches, are hypothesized to be of utmost importance for complete receptor 
activation (Katritch et al 2013, Nygaard et al 2009). These residues are pivotal 
points in the receptor that adopt completely altered conformations after receptor 
activation thus mediating larger conformational changes throughout the 
remaining receptor complex, especially TMVI and TMVII. Although these are not 
the sole residues that undergo conformational changes, these three micro-switch 
motifs are commonly thought to contribute to complete receptor activation 
(Katritch et al 2013, Nygaard et al 2009). 
One highly conserved motif throughout GPCRs is the CWxP motif. This 
motif is strategically located near the ligand binding pocket in TMVI and is in 
close proximity to the proline kink found in TMVI (Crocker et al 2006, Ruprecht et 
al 2004, Schwartz et al 2006, Shi et al 2002). Activation of the receptor results in 
a conformational change in position of the Trp residue of the CWxP motif 
resulting in a rotation of the Trp side chain toward TMV where the residue can 
partake in aromatic interactions with a highly conserved Phe/Tyr residue thus 
stabilizing the active conformation (Shi et al 2002). This rotation is suggested to 
result in an outward bending of the TMVI domain of the receptor allowing G-
proteins to access the cytoplasmic binding pocket (Crocker et al 2006, Ruprecht 
et al 2004, Schwartz et al 2006, Shi et al 2002). Conformational rotation of the 
Trp in the CWxP motif has not been as dramatic as predicted in crystal structures 
recently published, while the subsequent two micro-switches conformational 
changes were readily visualized in X-ray crystal structures of GPCRs 
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(Rasmussen et al 2011, Scheerer et al 2008). The NPxxY motif is the second of 
these highly conserved motifs suggested to be intricately involved in receptor 
activation. Located in TMVII, the Asn residue of this motif has been observed to 
interact with TMVI either through additional polar residues in TMVI or through a 
hydrogen binding network involving a water molecule in receptor inactive state(s) 
(Govaerts et al 2001, Okada et al 2002). Additionally, in rhodopsin the Tyr 
residue of this motif associates with helix VIII (typically Phe) through aromatic 
interactions, while this residue exists in a upward tilted conformation in other 
GPCRs where it is involved in a hydrogen bonding network with water (Barak et 
al 1995, He et al 2001, Li et al 2004). Activation of the receptor results in bending 
of the TMVII causing a shift in the Asn residue of the NPxxY motif to face the 
middle of TMII, thus alleviating the hydrogen bond lockdown of TMVI, allowing 
TMVI to swing open (Barak et al 1995, Govaerts et al 2001, Nygaard et al 2009). 
In addition, the bending of TMVII also orients the Tyr residue of the NPxxY motif 
to obstruct TMVI from withdrawing from the outward movement and thereby 
leaving the cytoplasmic pocket open for G-protein binding (Barak et al 1995, 
Govaerts et al 2001, Nygaard et al 2009, Park et al 2008a). A third highly 
conserved micro-switch region located in the cytoplasmic end of TMIII of most 
GPCRs is known as the DRY motif (Asp/Glu-Arg-Tyr residues). Association of 
the Arg/Glu of the DRY motif with TM-VI results in what has been deemed an 
“ionic lock” resulting in TM-VI occupying the cytoplasmic pocket and sterically 
hindering G-protein coupling (Rasmussen et al 1999, Xie & Chowdhury 2013, 
Yao et al 2006b). The importance of the Arg/Glu residue of the DRY micro-switch 
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was demonstrated through site-directed mutagenesis studies resulting in 
increased constitutive activity which suggested this residue assisted in stabilizing 
inactive conformations of the receptor (Alewijnse et al 2000, Arnis et al 1994, 
Ballesteros et al 2001, Malik et al 2013, Rasmussen et al 1999, Zhu et al 1994). 
Although constitutive activity of the receptor is the most common observation 
obtained when mutating this residue, there are reports of no change to receptor 
activity, but rather to receptor folding (Chung et al 2002, Lu et al 1997). Overall, 
the conformational changes induced by these micro-switches in receptor tertiary 
structures are required to transfer external signals to the intracellular 
environment for further signal processing. Determination of the crystal structures 
of Gα and Gβγ subunits assisted in the development of hypotheses on the ability 
of GPCRs to propagate cellular signals through the G-protein heterotrimer.    
Initial crystals for Gα subunits were obtained in the 90’s and revealed 
structural characteristics that lead to hypotheses of how the Gα subunit 
functioned and coupled to GPCRs. Crystallography revealed that Gα subunits 
primarily consist of two α-helical domains that bind nucleotide and one of which 
harbors an intrinsic GTPase domain (Ras-like domain) illustrated in previous 
biochemical studies (Lambright et al 1994, Lambright et al 1996, Mixon et al 
1995, Sunahara et al 1997). The nucleotide binding “pocket” is positioned 
between the Ras-like domain and helical domain and is bordered by flexible 
regions known as switch domains. Aside from hydrolyzing guanosine 
nucleotides, the Ras-like domain is also a suitable binding surface for interacting-
proteins such as GPCRs, Gβγ dimer, effectors, and other signal modulators such 
6 
 
as regulators of G-protein signaling (RGS) proteins (Tesmer et al 1997a, Tesmer 
et al 1997b). Post-translational lipid modifications of the amino terminus of Gα 
subunits by myristolylation and palmitoylation also suggest the amino terminus to 
be important for anchoring the Gα subunit to the plasma membrane for signaling 
(Degtyarev et al 1994, Preininger et al 2003). Coupling of Gα subunits with 
GPCRs is thought to depend on the associations of the C-terminus, α4 – β6 loop, 
and N-terminus of the Gα subunits with the cytoplasmic “pocket” of a GPCR in an 
active conformation (Bae et al 1999, Cai et al 2001, Hamm et al 1988, Ho & 
Wong 2000). The Gα C-terminus was found to contact TM6 or intracellular loop 3 
(ICL3) in the cytoplasmic “pocket” of the GPCR, where it can be modulated by 
the receptor upon activation (Cai et al 2001, Hu et al 2010, Rasmussen et al 
2011, Scheerer et al 2008). The solved structure for the β2 adrenergic receptor 
(AR) – GαsGβγ complex in an active receptor conformation and nucleotide-free, 
intermediate Gα bound state supported many interactions and crystal structures 
previously determined for active GPCRs mentioned previously (Rasmussen et al 
2011). Of note, the α3 – β5 loop of Gα subunits previously postulated to interact 
with receptors was not observed in the solved β2AR – GαsGβγ complex; 
however, this may imply different conformational states of the receptor which 
may bind Gα subunits in altered orientations or different Gα subunits 
preferentially (Grishina & Berlot 2000). 
There are sixteen Gα subunit isoforms in mammals (Downes & Gautam 
1999, Wettschureck & Offermanns 2005). These Gα subunits are typically 
grouped into four distinctive classes based on effector regulation: Gαs, Gαi/o, 
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Gαq/11 and Gα12/13 (Downes & Gautam 1999, Wettschureck & Offermanns 
2005). Activation of adenylyl cyclase by the Gαs subunit is known to catalyze the 
conversion of adenosine triphosphate (ATP) to cyclic adenosine monophosphate 
(cAMP). On the other hand, Gαi subunits confer an inhibitory effect on adenylyl 
cyclases, suppressing cAMP production. Therefore, Gαs and Gαi/o regulation of 
adenylyl cyclase enzymes acts to counter one another’s effects on cAMP levels 
within the cell (Chen-Goodspeed et al 2005, Chen et al 1997, Dessauer et al 
1998, Taussig et al 1994). Active GαGTP subunits have also been implicated in 
the activation of tyrosine kinase signaling cascades through direct association 
with the catalytic domain of c-Src resulting in increased activity of this kinase 
(Corre et al 1999, Ma et al 2000). Further support of crosstalk between Gα 
subunits and receptor tyrosine kinase downstream signaling was illustrated in 
mice expressing constitutively active Gαi2, where this mutation results in 
activation of c-Src, MAPKs, and STATs (Edamatsu et al 1998, Ram et al 2000). 
Interestingly, the GαGDP subunit is also a substrate for phosphorylation by c-Src 
which is able to modulate coupling of the Gα subunit to 7TMRs (Hausdorff et al 
1992). Gαq/11 subunits increase intracellular calcium through activation of 
phospholipase Cβ (PLCβ) (Blank et al 1991). The final Gα group, Gα12/13, 
activates Rho-GTPases mediating actin cytoskeletal remodeling and subsequent 
cellular migration (Sugimoto et al 2003). Of the four groups of Gα subunits, the 
Gαi/o class is the most highly expressed, thus one working hypothesis is that the 
relative pool of Gβγ released subsequent to GαiGβγ heterotrimer activation is 
higher than for  other Gα classes, which would explain why many of the 
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responses from Gαi-coupled GPCRs are predominantly mediated by Gβγ 
(Blumer & Tall 2012). 
In comparison to Gα subunits, there are five Gβ subtypes and twelve Gγ 
subtypes (Downes & Gautam 1999, Wettschureck & Offermanns 2005). The Gβ 
subunit adopts a structure resembling a seven-bladed propeller consisting of 
WD40 repeats and interestingly contains no catalytic domain (Sondek et al 1996, 
Wall et al 1995). Gγ subunits are relatively small proteins (~8-10 kDa) consisting 
of two alpha helices joined by a single loop (Sondek et al 1996, Wall et al 1995). 
Gβ and Gγ subunits are bound through interaction of the Gγ N-terminal helix with 
the N-terminal alpha helical domain of the Gβ subunits, while the C-terminal helix 
of Gγ subunit is found to associate with propellers five and six of the Gβ subunit 
(Sondek et al 1996, Wall et al 1995). The Gβγ dimer is quite stable once 
assembled; however, proper folding and assembly of this complex requires the 
chaperone function of chaperonin containing TCP-1 (CCT) to assist with Gβ 
subunit folding with subsequent release of the properly folded subunit by the co-
chaperone phosphoducin-like protein (PhLP) to allow association with the Gγ 
subunit  (Lukov et al 2006, Lukov et al 2005, McLaughlin et al 2002, Wells et al 
2006). Further post-translational lipid modifications of the Gγ subunits C-terminus 
by farnesyl or geranylgeranyl group addition illustrates the importance of Gγ 
subunits in membrane targeting of Gβγ dimers (Takida & Wedegaertner 2003). 
One exception to the rule of Gβγ dimer formation involves Gβ5 subunits, which 
shares the least homology amongst the Gβ isoforms and interacts with and is 
stabilized by RGS proteins containing a Gγ-like (GLL) domain in the absence of 
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Gγ to prevent the degradation of GLL containing proteins (Chen et al 2003, Snow 
et al 1998, Witherow et al 2000).  
The absence of a catalytic domain illustrated that Gβγ subunits mediate 
effects by protein-protein interactions on surface domains often referred to as 
Gβγ “hot spots” (Lin & Smrcka 2011, Lodowski et al 2003, Panchenko et al 1998, 
Scott et al 2001). Although each effector binds Gβ using unique residues, the 
general area in which many of these effectors associate with the Gβ subunit is 
directly associated with the Gα subunit in the inactive heterotrimer complex thus 
preventing Gβγ effector activation until the heterotrimer dissociates/rearranges 
upon activation (Davis et al 2005). Perhaps contrary to expectations, 
crystallography of the β2 adrenergic receptor (AR) – GαsGβγ complex in the 
nucleotide-free transition state demonstrated no direct associations of the Gβγ 
dimer with the GPCR suggesting that the GPCR does not act on the Gβγ directly 
in this conformation; however, these results do not exclude the potential 
importance of Gβγ subunits to initial coupling of heterotrimeric G-proteins to the 
7TMR (Rasmussen et al 2011, Wu et al 2000). 
 G-protein heterotrimers are the major conduit for signal transfer from 
receptor to effector. Upon ligand binding the GPCR undergoes conformational 
changes as described previously, resulting guanosine nucleotide exchange factor 
(GEF) activity of the receptor, which induces the exchange of guanosine 
diphosphate (GDP) for guanosine triphosphate (GTP) bound to the Gα subunit 
(Figure 1.1 [1]), (Chung et al 2011, Malik et al 2013, Rasenick et al 1994, 
Rasmussen et al 2011).  Agonist-bound receptor-mediated rearrangement of the 
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Gα subunit results in a large conformational shift of the helical domain that 
dramatically opens the nucleotide binding pocket to allow GDP release and 
exchange for GTP as had long been hypothesized (Chung et al 2011, Noel et al 
1993, Rasmussen et al 2011, Van Eps et al 2011, Westfield et al 2011, Yao & 
Grant 2013). Changes in switch regions of the Gα subunit result in dissociation or 
rearrangement of the GαGTP subunit and Gβγ dimer of the G-protein heterotrimer 
exposing the effector binding surface on Gβγ, allowing the two G-protein entities 
to interact with and regulate distinct downstream signaling pathways (Chung et al 
2011, Davis et al 2005, Van Eps et al 2011). Intrinsic GTPase activity of the Gα 
subunit induces hydrolysis of the terminal phosphate of the GTP molecule 
serving as a time dependent ‘off’ switch for Gα subunits and its effectors (Figure 
1.1 [2]), (Graziano et al 1989, Kleuss et al 1994, Linder et al 1990). This process 
is relatively slow, but is accelerated by association with accessory proteins 
known as regulators of G-protein signaling (RGS) proteins (Berman et al 1996b, 
Doupnik et al 1997, Watson et al 1996). Conversion of GαGTP to GαGDP 
terminates the effector signaling of the Gα subunit. Furthermore, with the Gα 
subunit returning to a basal inactive state, the Gα subunit is free to re-associate 
with the Gβγ dimer and effectively terminate the Gβγ effectors as well (Figure 1.1 
[3]). The intact G-protein heterotrimer is then able to couple once again with the 


















Figure 1.1. The G-protein activation-deactivation cycle  
(1) After engaging the receptor, G-proteins are activated in response to agonist 
stimulation and subsequent conformational changes that occur within the 
receptor to catalyze nucleotide exchange of the Gαi subunit. This promotes 
subunit dissociation to reveal effector binding motifs for activation of independent 
downstream signaling cascades for Gαi and Gβγ. Activation has also been 
demonstrated by guanine nucleotide exchange factors (GEF) proteins in the 
absence of receptor activation. 
(2) Intrinsic GTPase activity of the Gαi subunit hydrolyzes GTP back to GDP to 
turn off Gαi signaling. This process is relatively slow, but is often catalyzed by 
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GTPase accelerating (GAP) proteins such as regulators of G-protein signaling 
(RGS) proteins. 
(3) The resulting GDP-bound Gαi subunit is free to reassociate with Gβγ to 
effectively inhibit further Gβγ effector signaling and then return to the receptor for 
further signal transmission. The inactive Gαi is also a target of guanine 
nucleotide dissociation inhibitors (GDI) proteins that bind to the Gαi and can 
exclude Gβγ from reassociating.  














 Physiological responses initiated by G-protein signaling are determined by 
a diverse group of proteins that act as secondary messengers or have a direct 
action on cellular responses through interactions with Gα or Gβγ (Kristiansen 
2004). This diverse group includes enzymes such as adenylyl cyclases and 
phospholipases, ion channels, adhesion proteins, tubulin, as well as a large 
number of novel G-protein effectors (Hewavitharana & Wedegaertner 2012, 
Woehler & Ponimaskin 2009). Gα subunits are commonly associated with 
activation/inhibition of adenylyl cyclase enzymes. Generation of elevated cAMP 
levels by Gαs sequentially activates second messengers such as protein kinase 
A (PKA), while Gαi balances this activation by demonstrating an opposing effect 
on adenylyl cyclase to inhibit the signaling (Wan & Huang 1998). A second major 
signaling pathway of G-protein activation involves the release of intracellular 
calcium resulting from activation of phospholipase-Cβ (PLCβ) isoforms by Gβγ 
and also Gαq/11 (Blank et al 1991, Boyer et al 1992, Park et al 1993, Smrcka & 
Sternweis 1993). Upon activation, PLCβ hydrolyzes phosphatidylinositol 4,5-
bisphosphate (PIP2) cleaving the phospholipid into diacylglycerol (DAG) and 
inositol 1,4,5-triphosphate (IP3) (Park et al 1993, Smrcka & Sternweis 1993). 
DAG further propagates signaling via activation of protein kinase C (PKC), while 
IP3 travels to the endoplasmic reticulum where it engages IP3 receptors and 
stimulates release of intracellular calcium stores (Berridge 1989, Bishop & Bell 
1988). Gβγ also activates multiple other signaling cascades including but not 
limited to phosphoinositide 3 kinase (PI3K), G-protein coupled inwardly-rectifying 
14 
 
potassium channels (GIRK channels), specific adenylyl cyclase isoforms and 
MAPK cascades (Lin & Smrcka 2011). 
Termination of signal processing at the receptor has also been observed 
to be an important aspect of G-protein signaling. Following receptor activation, 
GPCRs undergo an endocytosis process to sequester and desensitize the 
receptor signaling by removing receptor from the cell surface and consequently, 
the agonist. Activated protein kinases such as protein kinases A and C as well as 
G-protein regulatory kinases (GRKs) phosphorylate the carboxyl terminus and 
three intercellular loops of the GPCRs (Benovic et al 1989, Nobles et al 2011). 
Additionally, phosphorylation of the receptor enhances the recruitment of 
arrestins from the cytoplasm to the receptor’s intracellular domain (Lohse et al 
1992). The recruitment of arrestin is essential to serves as an adaptor protein 
between the receptor and clathrin protein heavy chain (Goodman et al 1996). 
Arrestins are also responsible for binding to β2 adaptin subunits, resulting in the 
organization of the AP-2 complex and targeting of the complex to clathrin coated 
pits (Laporte et al 2000, Laporte et al 1999). The receptor-arrestin-AP2 complex 
then undergoes clathrin-mediated endocytosis where the clathrin coat 
disassembles leaving an endosome containing the GPCR for receptor 
resensitization (Pippig et al 1995).   
 Although classical G-protein signaling is well documented in numerous 
biochemical studies, the malleability of G-protein signaling to variations in 
signaling inputs still remains elusive to investigators. One possible explanation 
for this flexibility is the presence of proteins that are secondary to the core 
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signaling unit, which could potentially modulate the signal transfer from receptor 

























Modulation of Canonical Signal Transduction by Accessory Proteins 
 In light of the common features of activation shared by nearly all GPCR 
receptor and heterotrimers, one of the key questions in biology is the nature of 
GPCR signal diversity. One possible explanation is the existence of additional 
proteins outside of the core signaling triad (receptor, G-protein, effector) that are 
able to act on and modify signal transfer from receptor to G-protein or G-protein 
to effector resulting in signal diversity from a commonly shared mechanism.  
 Looking simplistically at the G-protein activation cycle, there are three 
critical points that are prime targets for potential regulation (Figure 1.1). The first 
is transfer of signal from an agonist-bound receptor or other protein with guanine 
nucleotide exchange factor (GEF) activity, to stimulate nucleotide exchange on 
Gα. Subsequently, Gα and Gβγ subunits dissociate/rearrange to activate 
effectors, thus propagating the signal. Secondly, intrinsic GTPase activity of Gα 
results in hydrolysis of the gamma phosphate of GTP that returns the Gα subunit 
to the inactive state.   Finally, GαGDP and Gβγ reassociate to reform an intact 
heterotrimer, which is available to couple to the receptor in order to reinitiate the 
cycle.  
 Accessory proteins, which are proteins distinct from the core signaling 
triad of receptor, G-protein and effector, modulate signal transfer at each of these 
three points to regulate signal strength, efficiency, duration, location and 
providing mechanisms for signal flexibility to adapt to a changing environment. 
One such scenario is interference of receptor – G-protein coupling or proteins 
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possessing GEF activity in lieu of the receptor (Ahn et al 2003, Attramadal et al 
1992, Chan et al 2011, Cismowski et al 2000, Cismowski et al 1999, Collins et al 
1990, Ferguson et al 1996, Garcia-Marcos et al 2009, Klattenhoff et al 2003, 
Lohse et al 1992, Tall et al 2003, Wilden et al 1986). A second instance of 
modulation involves accelerating the intrinsic GTPase activity of the Gα subunit, 
resulting in enhanced signal termination, increasing the turnover rate of Gα and 
reassociation with Gβγ (Berman et al 1996b, Hunt et al 1996). Lastly, accessory 
proteins could bind Gα subunits subsequent to GTP hydrolysis to decrease the 
rate of heterotrimer reassociation (Blumer & Lanier 2003, Cismowski et al 1999, 
De Vries et al 2000, Natochin et al 2000, Takesono et al 1999). Taken together, 
one can begin to envision how accessory proteins may influence signal 
adaptation of a commonly shared GPCR activation mechanism, thus providing 
additional texture and functional diversity to G-protein signaling systems. 
Furthermore, disruption or alteration of either the core signaling triad or the 
accessory proteins that modulate it may underlie pathophysiological or disease 
states.  An additional line of thought suggests that aside from acting as 
modulators of the canonical heterotrimeric signaling event, accessory proteins 
may also serve as independent signaling modules separate and distinct from 
GPCRs (Oner et al 2010a, Oner et al 2010b). 
 A well-studied regulatory mechanism used by accessory proteins to 
modulate transfer of signal from receptor to G-protein is by effectively uncoupling 
the G-protein from the receptor. A family of serine/threonine kinases referred to 
as G-protein regulatory kinases (GRKs) are responsible for many 
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phosphorylation events on receptors subsequent to agonist-mediated activation 
and contribute to receptor desensitization (Benovic et al 1989, Premont et al 
1996, Rockman et al 1996). Of the seven GRKs expressed in mammalian 
tissues, GRK2, 3, 5, and 6 are ubiquitously expressed and employed by cells for 
receptor desensitization. The other GRK variants have more restricted 
expression profiles in visual tissues and testes (Premont et al 1996). 
Phosphorylation of the receptor in turn enhances the recruitment of arrestins, 
most commonly arrestin 2 (β-arrestin 1) or arrestin 3 (β-arrestin 2), to the 
receptor (Lohse et al 1992). At the receptor, arrestin proteins unfold to reveal a 
polar core that interacts with the phosphorylated C-terminus residues of the 
receptor (Shilton et al 2002). This displaces the C-terminus of the arrestin 
protein, which then adopts an active conformation that is accessible for N- and C-
terminal interactions with intracellular loops of the receptor (Shilton et al 2002). 
Arrestin association with the receptor intercellular loops sterically precludes G-
proteins from coupling to the receptor and targets the receptor for internalization 
(Ahn et al 2003, Attramadal et al 1992, Ferguson et al 1996). In the past, 
investigators predicted that this event would mark the ending of G-protein 
signaling until the receptor was able to return to the surface to signal further; 
however, recent studies have suggested that although G-protein coupled 
receptors are trafficked from the membrane and away from ligands, the receptors 
actually continue signaling and contributing to overall cAMP levels through 
coupling G-protein heterotrimers while present on the endosome membrane 
(Calebiro et al 2009, Ferrandon et al 2009, Irannejad et al 2013). Additionally, 
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arrestin proteins in complex with 7TMRs can act as an alternative signaling 
complex for activation of ERK1/2 through G-protein independent, arrestin-
mediated mechanism (Gesty-Palmer et al 2006).  
 Another mechanism utilized by accessory proteins to regulate receptor to 
G-protein signal processing is by exhibiting GEF activity in the absence of 
receptor thereby presenting as non-receptor GEFs. One example of an 
accessory protein that expresses this ability, although not the sole function, is the 
resistance to inhibitors of cholinesterase 8 (Ric8) proteins (Chan et al 2011, 
Miller et al 2000, Tall & Gilman 2004, Tall et al 2003). Ric8 was initially found in 
C. elegans and demonstrated positive regulation of neurotransmitter release 
through Gα signaling events (Miller et al 2000, Reynolds et al 2005, Schade et al 
2005). Two variants of Ric8 were found in mammals and demonstrated divergent 
binding of Gα subunits (Klattenhoff et al 2003, Tall et al 2003). Ric8a was found 
to bind to GDP-bound Gαi/o, Gα12/13, and Gαq/11 subunits, while Ric-8B 
demonstrated binding to Gαs/olf subunits in the absence of Gβγ (Chan et al 
2011, Klattenhoff et al 2003, Tall et al 2003, Von Dannecker et al 2005). In vitro, 
Ric8A and Ric8B both demonstrate stabilization of a nucleotide free transition 
state, via the switch II and C-terminus contact sites of Gαs/i, to catalyze 
nucleotide exchange, similar to that seen by activated GPCR on heterotrimeric 
G-proteins (Chan et al 2011, Kataria et al 2013, Nagai et al 2010, Rasmussen et 
al 2011, Tall et al 2003, Thomas et al 2008). Upon Gα subunit nucleotide 
exchange, GTP-bound Gα no longer acts as a substrate for Ric8 and the 
complex dissociates (Chan et al 2011, Tall et al 2003).  A multifunctional role for 
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Ric8A emerged through studies involving pertussis toxin treatment to block the 
GEF activity, which incidentally revealed a secondary chaperone-like function of 
Ric8 where in the presence of Ric8A, Gα subunit expression was markedly 
increased (Oner et al 2013b). This report along with other supportive studies 
suggests a multifunctional role for Ric8 through regulation of Gα subunit folding 
during biosynthesis (Chan et al 2013, Gabay et al 2011, Oner et al 2013b). Ric8 
proteins are functionally characterized to regulate positioning of the mitotic 
spindle, asymmetric division, and acting as molecular chaperones for Gα 
subunits (Afshar et al 2004, Chan et al 2011, David et al 2005, Gabay et al 2011, 
Oner et al 2013b, Wang et al 2005, Woodard et al 2010). Thus, through direct 
regulation of receptor or activation of G-protein signaling in the absence of 
receptor, accessory proteins present many unexpected roles in influencing G-
protein signal processing.  
 The existence of proteins that modulate G-protein activation suggests the 
existence of proteins that may facilitate the opposing side of the G-protein cycle, 
i.e. signal termination. A large family of accessory proteins that fills this niche is 
known as the regulators of G-protein signaling (RGS) protein family. Initially 
found in S. cerevisiae, this family of proteins is comprised of more than thirty 
human members containing RGS domains   (Berman et al 1996b, Chan & Otte 
1982, De Vries et al 1995, Siderovski et al 1996). RGS proteins increase speed 
of Gα subunit deactivation by accelerating the GTPase activity of these proteins, 
classifying them as GTPase-accelerating proteins (GAPs) (Berman et al 1996b, 
Faurobert & Hurley 1997, Hunt et al 1996). Investigation of the crystal structure 
21 
 
for RGS4 bound to Gαi1GDP-AlF4- suggested that the mechanism of action for 
RGS proteins was to stabilize the switch domains of Gα subunits, rather than 
contributing additional residues to the active site on Gα subunits, (Berman et al 
1996a, Tesmer et al 1997a). These studies provide substantial evidence for roles 
of accessory proteins in the deactivation of the G-protein activation cycle.   
The initiation and deactivation of G-protein signaling are extensively 
studied and yet still present unexpected mechanisms of regulation that augment 
the canonical signaling paradigm as is the case for the final family of accessory 
proteins. Discovered over a decade ago using a yeast-based functional screen 
for activators of heterotrimeric G-proteins independent of cell surface receptors, 
the Activators of G-protein signaling (AGS) proteins remain an important focus of 
study in the investigation of G-protein signal modulation (Cao et al 2004, 
Cismowski et al 1999, Sato et al 2011b, Takesono et al 1999).The AGS proteins 
were further subdivided into four specific groups dependent on functional aspects 
of each protein and Gαi subunit binding (Blumer et al 2005, Blumer et al 2007, 
Sato et al 2006a, Sato et al 2011b).  
Group I AGS proteins are classified as non-receptor GEFs and include 
proteins such as AGS1, Ric8a, Ric8b  and Gα interacting vesicle-associating 
protein (GIV/Girdin) (although the latter three may be considered Group I AGS 
proteins, they were not actually identified in the original yeast-based functional 
screen as described previously),(Chan et al 2011, Cismowski et al 2000, 
Cismowski et al 1999, Garcia-Marcos et al 2009, Klattenhoff et al 2003, Tall et al 
2003). AGS1 is related to the Ras small-GTPase superfamily and was found to 
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interact with Gαi/o to facilitate nucleotide exchange to regulate ERK1/2 and 
adenylyl cyclase activation (Cismowski et al 2000, Cismowski et al 1999, 
Graham et al 2002, Graham et al 2004, Nguyen & Watts 2005, Takesono et al 
2002). Functionally, AGS1 is involved in regulation of hormone secretion, 
circadian rhythm, and is anti-proliferative (Cheng et al 2004, Lellis-Santos et al 
2012, McGrath et al 2012, Vaidyanathan et al 2004). GIV/Girdin is another Group 
I AGS protein determined to have GEF activity on Gα subunits (Garcia-Marcos et 
al 2009). Knockout of GIV/Girdin in a mouse model demonstrated defects in 
angiogenesis, neurogenesis, and cell migration (Enomoto et al 2005, Kitamura et 
al 2008, Wang et al 2011). This protein has also been implicated in cell 
autophagy where GIV acts on Gα subunits complexed with Group II AGS 
proteins at autophagic vesicles (Garcia-Marcos et al 2011, Garcia-Marcos et al 
2009). Overall, Group I AGS proteins have unveiled many unexpected inputs into 
G-protein signaling linked to numerous physiological responses.  
Group II AGS proteins are functionally classified as GDIs and have seven 
family members that all share a common ~20 amino acid motif, the G-protein 
regulatory (GPR) motif (Figure 1.2) (Takesono et al 1999). Four members 
express multiple (2-4) of these GPR motifs and include AGS3 (4 GPRs), LGN (4 
GPRs), AGS4 (3 GPRs), PCP2 (2 GPRs), while the other three members, 
RGS12, Rap1Gap, and RGS14, express a single GPR motif (Figure 1.2), (Cao et 
al 2004, Jordan et al 1999, Kimple et al 2001, Luo & Denker 1999, Mochizuki et 
al 1996, Takesono et al 1999). The GPR motif (also referred to as the GoLoco 
motif) binds and stabilizes inactive, GDP-bound Gαi/o/t subunits, inhibit GTPγS 
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binding to Gαi/o/t subunits, and competes with Gβγ subunits for binding Gαi/o 
subunits (Bernard et al 2001, Cao et al 2004, Kimple et al 2001, Natochin et al 
2001, Peterson et al 2000, Peterson et al 2002, Siderovski et al 1999, Takesono 
et al 1999). Interestingly, members of this family containing a single GPR motif 
also contain a secondary GAP domain to accelerate GTP hydrolysis of Gα 
subunits suggesting possible multifunctional roles of these proteins in Gα subunit 
cycling mechanisms yet to be identified (Brown et al 2015, Vellano et al 2013, 
Zhao et al 2013).  Additionally, the reported ability for GIV/Girdin and Ric8A to act 
on Gαi-GPR complexes provides an additional mode of signaling cross-talk 
between Group I and Group II proteins (Garcia-Marcos et al 2011, Oner et al 
2013b). Previous studies have linked GPR proteins to several disease 
pathologies including drug addiction and craving, learning and memory, ischemia 
reperfusion injury, polycystic kidney disease, blood pressure control, energy 
expenditure and metabolism, and rheumatoid arthritis and inflammatory 
pathways (Blumer et al 2008, Bowers et al 2004, Branham-O'Connor et al 2014, 
Conley & Watts 2013, Giguere et al 2013, Kwon et al 2012, Lee et al 2010, 
Nadella et al 2010, Regner et al 2011, Yao et al 2005). Group II AGS proteins, 












Figure 1.2. Group II AGS proteins 
Left, Depicted representations of Group II AGS proteins exhibiting more than one 
G-protein regulatory (GPR, red) motifs. Tetratricopeptide repeats (TPR, blue) 
domains are also labeled where applicable. Right, Representative domain 






Unlike the Group I and Group II AGS proteins, Group III AGS proteins 
demonstrate binding to Gβγ (Cismowski et al 1999, Sato et al 2006b, Sato et al 
2009, Yuan et al 2007). Overall, these proteins function to activate Gβγ signaling 
either by dissociation of the heterotrimeric complex through binding shared ‘hot 
spot’ domains with the Gα subunit or adopting an adaptor role between Gβγ, in 
associated heterotrimer with Gα subunit, and Gβγ effectors to promote effector 
activation without heterotrimer dissociation (Sato et al 2006b, Sato et al 2009, 
Yuan et al 2007). One member of the Group III AGS proteins, AGS8, is involved 
in hypoxia-induced apoptosis of cardiomyocytes and exhibited the ability to 
activate PLCβ2 in the absence of subunit dissociation (Sato et al 2006b, Sato et 
al 2014, Sato et al 2009, Yuan et al 2007). In addition, AGS2 (Tctex-1), which 
was initially described as a light chain component for dynein, demonstrated roles 
in neurogenesis and neurite outgrowth and recently phosphorylation of AGS2 
was linked to cilia resorption prior to cell cycle entry into S-phase (Gauthier-
Fisher et al 2009, King et al 1996, Li et al 2011, Sachdev et al 2007, Yeh et al 
2013). Subsequent investigation determined activation of the insulin-growth 
factor 1 receptor (IGF-1R) and stabilization of GDP-bound Gα subunits by AGS3 
induce activation of AGS2 by released Gβγ which is required for cilia resorption 
and progression of the cell cycle (Yeh et al 2013). This study provides yet 
another mode of connectivity between multiple AGS proteins working 
synergistically to modulate signal transduction in the cell. However, more studies 
of the Group III AGS proteins roles in G-protein signaling are needed to 
completely elucidate the function of this group. 
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Diverging from the other groups of AGS proteins, the more recently 
identified Group IV AGS proteins (AGS11-13) are transcription factors and 
revealed non-receptor mediated activation of G-protein signaling utilizing Gα16 
and, to a lesser extent, Gαs in yeast functional screens (Sato et al 2011b). 
Although functional roles of these proteins have yet to be identified, Group IV 
AGS proteins are expressed in the hypertrophic mouse heart, where nuclear 
localization of Gα16 was reported in the presence of AGS11 resulting in a 
substantial increase to claudin 14 mRNA expression (Sato et al 2011b). This 
unique group of AGS proteins is an interesting addition to the family of AGS 
proteins, but further structural and functional studies of these proteins are 
needed to determine if there exist additional roles for these proteins in tissues 
other than the heart. 
In summary, accessory proteins have demonstrated the ability to modulate 
signal transfer of the core signaling triad at every step of the G-protein 
activation/deactivation cycle. Interestingly, a family of proteins identified in a 
yeast based functional screen has revealed a functionally diverse group of 
proteins that effectively influence signal processing and integration in various 
ways. Further analysis of specific members of this group of proteins will reveal 






Roles of Group II AGS Proteins in G-protein Signal Processing 
As mentioned, the discovery of AGS proteins through yeast-based 
functional screens for proteins that activated G-protein signaling through Gαi, but 
not Gαs or Gα16 lead to the classification of seven mammalian Group II AGS 
proteins (Cao et al 2004, Cismowski et al 1999, Takesono et al 1999). These 
proteins were found to harbor at least one GPR motif that competes with Gβγ for 
binding Gαi/o/t subunits in the GDP-bound state, thus stabilizing the inactive 
conformation and resulting in the inhibition of nucleotide exchange (Bernard et al 
2001, Cao et al 2004, Kimple et al 2001, Natochin et al 2001, Peterson et al 
2000, Peterson et al 2002, Siderovski et al 1999, Takesono et al 1999). 
Interestingly, the number of GPR containing genes has expanded throughout 
evolution. There exists a single GPR protein in D. melanogaster that has been 
linked to cell polarity and asymmetric cell division known as Partner of 
Inscuteable (Pins), while C. elegans contains three GPR motif-containing 
proteins, GPR1/GPR2, which are 99% identical and functionally redundant and 
F32A6.4/AGS3, which plays a role in feeding behavior  (Bergstralh et al 2013, 
Colombo et al 2003, Gotta et al 2003, Hofler & Koelle 2011, Nipper et al 2007, 
Schaefer et al 2001, Schaefer et al 2000, Srinivasan et al 2003, Yu et al 2000). 
GPR1/2 are involved in asymmetric cell division, but were also observed to have 
a role in a Gαo food-seeking behavioral mechanism (Colombo et al 2003, Gotta 
et al 2003, Hofler & Koelle 2011, Srinivasan et al 2003). In mammals there are 
seven genes encoding proteins with GPR motifs suggesting the need for a larger 
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repertoire of these modulatory proteins as signaling events became more 
complex.  
Of particular interest, within Group II AGS proteins are members 
expressing more than one GPR motif, which confer the capability to bind an 
equivalent number of Gα subunits simultaneously (Figure 1.2), (Adhikari & 
Sprang 2003, Bernard et al 2001, Oner et al 2010a, Oner et al 2010b). Selectivity 
of GPR motifs for Gα subunits is typically observed as Gαi1-3 > Gαt > Gαo, but 
individual motifs of GPR containing proteins have demonstrated preferences for 
certain Gαi/o/t subunits (Cao et al 2004, McCudden et al 2005b, Mittal & Linder 
2004, Peterson et al 2000, Willard et al 2006). Thus, the Group II AGS proteins 
containing multiple GPR motifs may potentially “seed” multiple Gα subunits to 
7TM receptors and/or receptor-independent GEFs (Blumer & Lanier 2014, 
Blumer et al 2007, Sato et al 2006a). 
Of the four Group II AGS proteins with multiple GPR motifs, the most 
extensively studied is AGS3 (Takesono et al 1999). This protein expresses seven 
amino-terminal tetratricopeptide repeat (TPR) domains followed by four carboxy-
terminal GPR motifs (Figure 1.2), (Bernard et al 2001, De Vries et al 2000, 
Takesono et al 1999). These structural domains allow for the possibility of four 
Gαi/o subunits to be bound to AGS3 at any given time, while the TPR domains 
have demonstrated importance in mediating protein-protein interactions for 
subcellular targeting of AGS3 and function as intramolecular modulators for GPR 
binding of Gα subunits (Adhikari & Sprang 2003, An et al 2008, Bernard et al 
2001, Blumer et al 2003, Oner et al 2010a, Oner et al 2013c, Pan et al 2013, 
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Vural et al 2010). The enriched expression of AGS3 in the brain and heart 
(AGS3-short), as well as expression in smooth vascular tissue and leukocyte 
populations was valuable in the determination of function for AGS3 in tissues of 
the body (Blumer et al 2008, Branham-O'Connor et al 2014, Pizzinat et al 2001). 
Absence of AGS3 was found to further exacerbate dysregulation of 
spindle orientation as seen with disruption of Gβγ signaling during neurogenesis, 
thus implicating AGS3 in asymmetric cell division similar to its ortholog Pins 
(Sanada & Tsai 2005). To further support a role for AGS3 in asymmetric cell 
division, the TPR domain of AGS3  interacts with liver kinase B1 (LKB1), an 
ortholog of PAR-4 protein in C. elegans, which is also  involved in asymmetric 
cell division (Blumer et al 2003, Watts et al 2000). LKB1 phosphorylated the GPR 
domains of AGS3 as demonstrated by substitution of a phospho-mimetic aspartic 
acid residue within the GPR motif to impede association with Gα subunits 
(Blumer et al 2003). Further investigation into the role of AGS3 in the central 
nervous system revealed a functional role for AGS3 in drug-seeking behavior 
(Bowers et al 2008, Bowers et al 2004, Fan et al 2009, Yao et al 2005, Yao et al 
2006a). AGS3 is upregulated in the prefrontal cortex of mice after withdrawal 
from repeated cocaine administration, and silencing of AGS3 expression by 
antisense oligonucleotides injected into the nucleus accumbens effectively 
prevented drug-seeking behavior in mice withdrawn from heroin, ethanol, and 
cocaine (Bowers et al 2008, Bowers et al 2004, Yao et al 2005). The role of 
AGS3 in kidney disease has also recently been of keen interest to the field. 
Under normal conditions, AGS3 levels in the kidney are quite low, but upon 
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injury, the expression of AGS3 in this tissue drastically increases (Kwon et al 
2012, Nadella et al 2010, Regner et al 2011). Impaired renal tubule recovery 
from ischemia reperfusion injury and increased rate of cyst progression in 
polycystic kidney disease models were observed upon loss of AGS3 expression, 
again mimicking the loss of Gβγ signaling in these same models (Kwon et al 
2012, Nadella et al 2010, Regner et al 2011).  
An additional binding partner of the TPR domain of AGS3, mammalian 
Inscuteable (mInsc), has demonstrated multifaceted functions when bound to 
AGS3 proteins that further expand the roles of AGS3 in mammalian cells 
(Kamakura et al 2013, Vural et al 2010). Ectopic and endogenous AGS3 
associates with pre-aggresomal structures in the cytoplasm that can be readily 
diffused by increasing levels of Gα subunits, but binding of mInsc reverts  AGS3 
back into the punctate structures (Vural et al 2010). Recently,  binding of AGS3 
to mInsc at the leading edge of neutrophils also targeted of the Par3-Par6-
atypical protein kinase C (aPKC) complex to induce directional migration in these 
cells (Kamakura et al 2013). Another ortholog of Pins and member of Group II 
AGS proteins, LGN, which is over 60% identical to AGS3, has a similar domain 
organization to AGS3 and has important regulatory roles in asymmetric cell 
division, cytokinesis, and cell polarity (Blumer et al 2002, Blumer et al 2006, Du & 
Macara 2004, Du et al 2001, Du et al 2002, Fuja et al 2004, Fukukawa et al 
2010, Kaushik et al 2003, Lechler & Fuchs 2005, Zheng et al 2013). LGN-Gαi 
complexes are known to localize to spindle poles, centrosomes and the midbody 
during cell division through association of the LGN-TPR domain with the nuclear 
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mitotic protein NuMA  (Blumer et al 2002, Blumer et al 2006, Du & Macara 2004, 
Du et al 2001, Du et al 2002, Fuja et al 2004, Kaushik et al 2003). The binding of 
microtubules by NuMA is disrupted upon association with LGN-Gαi complexes 
(Du et al 2002). However, the Gαi-LGN complex bound to NuMA was observed 
to also be substrate for the non-receptor GEF Ric8a, resulting in nucleotide 
exchange of the Gαi subunit (Tall & Gilman 2005). Upon Gαi activation, NuMA is 
released from LGN allowing NuMA to return to modulating microtubule dynamics 
(Tall & Gilman 2005). Silencing expression of NuMA was also shown to disrupt 
LGN localization to spindle poles and improper segregation of chromosomes (Du 
& Macara 2004). Additionally, LGN interacts with mInsc and aPKC-Par6 
complexes further implicating this protein in mitotic spindle orientation and 
polarity in cells (Izaki et al 2006, Lechler & Fuchs 2005, Yasumi et al 2005). 
Further studies demonstrate the involvement of LGN in regulation of the basal 
activity of G-protein regulated ion channels such as the Gβγ-dependent GIRK 
channel (Wiser et al 2006). 
Taken together, these studies indicate a diverse array of functions for 
AGS3 and the related protein LGN and have demonstrated roles for AGS3 in 
many pathologies such as drug addiction and neuronal plasticity, ischemia 
reperfusion injury and polycystic kidney disease, blood pressure control, energy 
expenditure and metabolism, autophagy, membrane protein trafficking, and 
directional migratory response (Blumer et al 2008, Bowers et al 2004, Conley & 
Watts 2013, Garcia-Marcos et al 2011, Kamakura et al 2013, Kwon et al 2012, 
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Nadella et al 2010, Pattingre et al 2003, Regner et al 2011, Vural et al 2010, Yao 
et al 2005).  
One of the less investigated member of the Group II AGS proteins, AGS4, 
harbors three separate GPR motifs for binding GαiGDP (Cao et al 2004). Unlike 
the previously described multi-GPR proteins AGS3 and LGN, AGS4 is absent of 
any obvious regulatory domains (Figure 1.2). Rather, the amino terminus of 
AGS4 contains a 56 amino acid proline-rich domain, which is reported to have 
potential guanine nucleotide exchange properties (Zhao et al 2010). In one report 
the amino terminus of AGS4 was also found to interact with Gβ subunits, 
although this is in direct contrast to previous biochemical studies demonstrating 
that AGS4 does not associate with Gβγ subunits (Cao et al 2004, Giguere et al 
2012c). Another key feature of AGS4 is restricted expression to cells of 
hematopoietic lineage, and thus a role for AGS4 in the immune system is of 
expanding interest to the field (Cao et al 2004, Giguere et al 2013, Giguere et al 
2014, Zhao et al 2010). Investigations into the role of AGS4 in a model of acute 
inflammatory arthritis demonstrated that AGS4 expression was required for the 
increase in number of pro-inflammatory monocytes, and loss of AGS4 reduces 
the onset of inflammation-mediated arthritis (Giguere et al 2013).  
The final member of Group II AGS proteins with multiple GPR motifs is 
PCP2. Somewhat similar to AGS4, PCP2 expresses two GPR motifs with no 
defined regulatory protein domains (Zhang et al 2002). PCP2 demonstrates 
restricted expression in the cerebellum and retinal bipolar neurons where it 
interacts with Gαi/o subunits through the two GPR motifs (Dhingra et al 2008, 
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Redd et al 2002). Early investigations into PCP2 deficient mice illustrated no 
altered behavior or cerebellar anatomy (Mohn et al 1997, Vassileva et al 1997); 
however, a recent study investigating mice with inactivated PCP2 has reported 
sex-dependent differences in anxiety and fear conditioning suggesting an active 
role for PCP2 in the cerebellum responses (Walton et al 2012).  
The ability of the Group II AGS proteins to stabilize the inactive Gαi 
subunit suggests possible mechanisms by which multiple GPR motif-containing 
proteins may modulate G-protein signaling. One possible scenario is that GPR 
proteins compete for binding Gα subunits in complex with Gβγ to initiate subunit 
dissociation of the heterotrimer in the absence of receptor or presence of 
unknown signal to prompt this competition, thus promoting or prolonging Gβγ 
signaling and inhibiting Gα signaling (Figure 1.3A), (Bernard et al 2001, Ghosh et 
al 2003, Schaefer et al 2001). One could also envision a scenario where GPR 
motif-containing proteins bind Gα subunits subsequent to hydrolysis of GTP 
preventing reassociation with Gβγ subunits, either during basal G-protein cycling 
events or post receptor-mediated activation of the G-protein heterotrimer (Figure 
1.3B),  (Blumer et al 2005, Blumer & Lanier 2003, Blumer & Lanier 2014, Blumer 
et al 2012, Blumer et al 2007, Cismowski et al 1999, Kinoshita-Kawada et al 
2004, Sato et al 2006a, Takesono et al 1999, Webb et al 2005, Yao et al 2005, 
Yao et al 2006a). Again, the end result of the second scenario would be 
enhanced or prolonged Gβγ-regulated effector signaling while inhibiting signaling 
though Gα subunits. These two situations would implicate AGS3/LGN/AGS4 in 
the regulation of subunit interactions to decrease receptor – G-protein coupling in 
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a manner to suppress signaling through Gα effectors while facilitating Gβγ 
signaling.  
A third scenario also suggests that Gαi – GPR complexes form novel 
signaling modules distinct from the canonical Gαβγ heterotrimer (Figure 1.3C). In 
this scenario, GPR proteins could act in a manner analogous to Gβγ by serving 
as substrates for receptor or non-receptor GEFs, resulting in nucleotide 
exchange and subsequent dissociation of the GαGTP from the GPR protein. In 
support of such a scenario, GIV/Girdin and Ric8A have demonstrated GEF 
activity on Gαi-GPR complexes (Garcia-Marcos et al 2011, Oner et al 2013b, Tall 
et al 2003, Thomas et al 2008, Vellano et al 2011a, Vellano et al 2011b, 
Woodard et al 2010).  Additionally, experiments investigating regulation of the 
Gαi-GPR complex have demonstrated close proximity of the GPCRs to 
AGS3/AGS4 proteins bound to Gαi1, which is regulated by agonist activation of 
the GPCRs in live cells (Oner et al 2010a, Oner et al 2010b). The Gαi-GPR 
complex may also act as a noncanonical signaling entity as was recently 
described by the formation of the Gαi-GPR complex acting as a scaffold for 
recruitment of mInsc-Par3-Par6-aPKC polarity complex required for chemokine-
directed migration of neutrophils (Kamakura et al 2013). It is also interesting to 
envision AGS3/LGN/AGS4 forming scaffolds of multiple Gα subunits 
simultaneously to generate larger signaling complexes to increase signal 
efficiency whether through noncanonical signaling pathways or by cycling Gα 
subunits back to the receptor (Adhikari & Sprang 2003, Bernard et al 2001, 
Blumer & Lanier 2014).   
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The discovery of Group II AGS proteins with multiple GPR domains has 
revealed many unexpected regulatory mechanisms for G-protein signaling 
systems. Further investigation of the Group II AGS proteins have unveiled a 
surprisingly large number of roles these proteins participate in, both in canonical 
G-protein signaling through GPCRs as well as new and exciting alternative 
signaling mechanisms. While the interactions of the GPR motif with the Gαi 
subunit have been extensively studied biochemically, the cellular regulation of 
these proteins in the aspect of G-protein signaling require further exploration 
(Adhikari & Sprang 2003, Bernard et al 2001, Peterson et al 2000, Peterson et al 
2002). Although beginning to surface, in order to fully appreciate the roles of 
these multi-GPR proteins in the immune system further investigations are 














































Figure 1.3. Working hypotheses for the action of GPR motif-containing 
proteins in modulation of Gαi signal processing 
(A) Scenario depicting competitive binding of GPR-proteins and Gβγ for inactive 
Gαi resulting in subsequent heterotrimer dissociation and promoting Gβγ 
activation in the absence of receptor or presence of an unknown signal mediator. 
(B) Scenario illustrating receptor activation of Gαiβγ, followed by sequestration of 
Gαi by GPR-containing proteins subsequent to GTP hydrolysis, but prior to 
reassociation of Gαiβγ heterotrimer, thus prolonging Gβγ effector signaling. 
(C) Scenario displaying the coupling of novel signaling complexes, Gαi–GPR, to 
a 7TMR to initiate nucleotide exchange independent of Gαiβγ heterotrimer. In 
this scenario, the Gαi–GPR would signal analogous to the Gαiβγ heterotrimer, 
being substrate for 7TMRs as well as non-receptor GEFs as depicted in the 
illustration. Upon nucleotide exchange the Gαi–GPR would dissociate and 
following GTP hydrolysis the Gαi subunit would be available for reassociation 








Chemokine-Stimulated Activation of G-proteins and Potential Role for GPR-
containing proteins in Signal Processing 
Cells of the immune system have to adapt to a complex array of signals to 
coordinate the movement and redistribution of leukocytes to maintain proper host 
immunosurveillance. To accomplish this, the immune system employs 
chemokine receptors in the targeting of leukocytes to secondary sites of 
development or inflammation (Beider et al 2003, Forster et al 1999, Henderson et 
al 2003, Lu et al 1998, Wright et al 2002). Directed leukocyte migration either to 
secondary lymphoid organs or to sites of inflammation is accomplished through a 
series of events leading to the extravasation of the leukocyte into the tissue as 
first observed by electron microscopy nearly forty years ago (Anderson & 
Anderson 1976). Infiltration of pathogens into host tissue results in activation of 
sentinel resident leukocytes that secrete pro-inflammatory cytokines, which 
facilitate endothelial cells to increase surface expression of adhesion molecules 
including E-selection and P-selectin to recruit circulating lymphocytes (Alon et al 
1994, Bosse & Vestweber 1994, Jung & Ley 1999, Jutila et al 1994, Labow et al 
1994, Mayadas et al 1993). Parallel expression of adhesion molecules such as L-
selectin and P-selectin glycoprotein ligand 1 (PSGL-1) on the surface of 
circulating leukocytes mediates transient interactions of the adhesion molecules 
resulting in a characteristic, tethered “rolling” and decreased velocity of 
circulating leukocytes (Bosse & Vestweber 1994, Ley et al 1993, Xia et al 2002, 
Yang et al 1999). The slowing of leukocytes allows for increased exposure to 
chemokines presented on the luminal surface by the endothelial cells, thus 
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activating leukocyte integrins lymphocyte function –associated antigen 1 (LFA-1) 
and very late antigen 4 (VLA-4) to engage stronger adhesion forces with 
immunoglobulin family members intracellular adhesion molecule 1 (ICAM1) and 
vascular cell-adhesion molecule 1 (VCAM1), respectively, and promoting cell 
immobilization (Alon et al 1995, DiVietro et al 2007, Dustin et al 1986, Makgoba 
et al 1988, Rothlein et al 1986, Yang et al 2005). Once the mobility of the cell is 
arrested, extravasation of the cell through the endothelium can occur. This 
activity requires the use of a variety of cell-adhesion molecules, including platelet 
endothelial cell-adhesion molecule (PECAM) and junctional adhesion molecule-A 
(JAM-A), inevitably transferring the leukocyte from the blood, through the 
endothelium, and into the inflamed tissue region (Corada et al 2005, Khandoga 
et al 2005, Schenkel et al 2004a, Schenkel et al 2004b, Thompson et al 2001). 
Following proper extravasation into the inflamed tissue, leukocytes will continue 
following the chemotactic gradient to infiltrate the primary site of inflammation. 
The highly orchestrated transendothelial cell migration is required for efficient 
immune system development and function through redistribution of leukocytes, 
while perturbations of chemokine signaling in this process lead to immunological 
pathologies (Hornquist et al 1997, Jin et al 2008, Moreno et al 2015, Ohman et al 
2002, Rudolph et al 1995).  
Chemokine receptors are Gαi-coupled GPCRs and divided into four 
groups dependent on the chemokine ligand to which the receptor binds including 
CCRs, CXCRs, CX3CRs, XCRs (Arai & Charo 1996, Haribabu et al 1997, 
Murphy et al 2000, Polakis et al 1988). Although the primary role of this receptor 
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family is to regulate directed cell movement, functional overlap with the 
processes of cytokine and superoxide production are also documented after 
chemokine treatment (Hirsch et al 2000, Li et al 2000, Sasaki et al 2000). 
Chemokine-induced receptor activation leads to nucleotide exchange of GDP for 
GTP on the Gαi subunit leading to dissociation of the heterotrimer. Gβγ is then 
free to associate and activate downstream effectors essential for cell migration, 
PI3Kγ and PLCβ2/3 (Arai et al 1997, Bach et al 2007, Goldman et al 1985, 
Hannigan et al 2002, Hirsch et al 2000, Li et al 2000, Neptune & Bourne 1997, 
Neptune et al 1999, Rickert et al 2000, Sotsios et al 1999). PI3Kγ activation 
results in the generation of PIP3 and occurs largely at the leading edge of 
migrating leukocytes where it is involved in the maintenance of polarity and 
migratory signaling in these cells (Hannigan et al 2002, Rickert et al 2000, 
Servant et al 2000, Sotsios et al 1999, Wang et al 2014). Absence of PI3Kγ in 
leukocytes results in ineffective T-cell development and activation, as well as 
defects in migration and oxidative burst in neutrophils (Hirsch et al 2000, Li et al 
2000, Sasaki et al 2000). A second key Gβγ effector in leukocytes is PLCβ2/3, 
which hydrolyzes PIP2 into DAG and IP3 leading to the activation  PKC and 
release of calcium from intracellular stores, respectively  (Berridge 1989, Bishop 
& Bell 1988, Goldman et al 1985, Park et al 1993, Smrcka & Sternweis 1993). To 
further support a role for PLCβ2/3 in the immune system, PLCβ2/3-deficient 
neutrophils demonstrated defects in superoxide production and protein kinase 
regulation, but , interestingly, not chemotaxis (Li et al 2000). In contrast, T-cells 
deficient in PLCβ2/3 exhibited decreased chemotaxis, mirroring results obtained 
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with intracellular calcium chelating agents (Bach et al 2007). Additionally, a 
recent report that used a small molecule to trigger heterotrimer dissociation in the 
absence of nucleotide exchange indicated that Gβγ signaling was required for 
maximal chemotaxis in neutrophils; however, treatment with this small molecule 
combined with pertussis toxin demonstrated further decreases in chemotaxis, 
revealing  a lesser, but observable Gαi component to chemokine-induced 
migration of neutrophils (Surve et al 2014). Nevertheless, many of the 
downstream responses mediated by chemokine receptors have long been 
correlated to Gβγ effects from activation of G-protein heterotrimers (Arai et al 
1997, Goldman et al 1985, Neptune & Bourne 1997, Neptune et al 1999, 
Spangrude et al 1985).  
Numerous studies on the role of Gαi in lymphocyte biology, aided by the 
use of pertussis toxin to inhibit Gαi/o heterotrimer signaling and the development 
of Gαi2 and Gαi3 knockout mice, revealed that perturbations of G-protein 
signaling in lymphocytes negatively affect lymphocyte development and 
chemokine-induced signaling (Bargatze & Butcher 1993, Chaffin & Perlmutter 
1991, Cyster & Goodnow 1995, Dalwadi et al 2003, Han et al 2005, Huang et al 
2003, Hwang et al 2010, Hwang et al 2007, Jin et al 2008, Pero et al 2007, 
Rudolph et al 1995, Skokowa et al 2005, Spangrude et al 1985, Thompson et al 
2007, Warnock et al 1998, Wiege et al 2013, Wiege et al 2012, Zarbock et al 
2007). Initially demonstrating the importance of Gαi-dependent signaling in 
migration and homing to secondary lymphoid organs, lymphocytes treated with 
pertussis toxin to inhibit Gαiβγ signaling events revealed substantial defects in 
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lymphocyte and neutrophil migration, improper egress of mature T cells from the 
thymus, as well as defective homing and chemokine-induced arrest prior to 
transmigration into peripheral lymphatics (Chaffin & Perlmutter 1991, Cyster & 
Goodnow 1995, Spangrude et al 1985, Warnock et al 1998, Zarbock et al 2007). 
In addition to impaired chemokine-directed migration, Gαi2 null lymphocytes also 
exhibited reduced migration velocity compared to wild-type lymphocytes (Han et 
al 2005, Hwang et al 2007).  
In the intact animal, Gαi2 deficiency was linked to enhanced expression of 
IFN-γ, IL-1, IL-6, and TNF-α accumulating into a pro-inflammatory Th1 CD4+ 
response with development of severe immunological pathologies such as fatal 
cases of ulcerative colitis and adenocarcinoma (Gotlind et al 2011, He et al 2000, 
Hornquist et al 1997, Ohman et al 2002, Pena et al 2009, Rudolph et al 1995). 
The induction of cytokine expression in Gαi2-null macrophages, splenocytes, and 
lymphoid dendritic cell populations was also observed (He et al 2000, Huang et 
al 2003, Pena et al 2009). Interestingly in the absence of Gαi2, the proliferative 
response of T effector lymphocytes was demonstrated to be less susceptible to 
suppression by regulatory T lymphocytes resulting from increased secretion of 
pro-inflammatory cytokines including IL-6, which is known to be antagonistic to 
regulatory T lymphocyte activity (Gotlind et al 2011). The potential functional 
redundancy of Gαi2 versus Gαi3, in chemokine signaling events is of 
considerable interest and addressed with the use of knockout models for each of 
the Gαi genes. Gαi2 is required for T-cell migration via activation of CXCR3, 
while loss of Gαi3  resulted in increased migration via the CXCR3 receptor 
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suggesting a competitive or exclusionary nature between the two Gαi subunits 
(Thompson et al 2007). In B-cells, similar defects in chemotaxis to CXCL12, 
CXCL13, and CCL19 were indeed observed in Gαi2 null cells, while, again, the 
removal of Gαi3 appeared to amplify B-cell migration to these chemotaxis-
inducing molecules (Hwang et al 2010). Splenic architecture and B-cell 
development were also impacted by the absence of Gαi2 (Dalwadi et al 2003, 
Hwang et al 2010). The absence of Gαi2 was also protective against graft-
versus-host disease (Jin et al 2008). In contrast, Gαi3-deficient T-cells adoptively 
transferred exacerbated the disease compared with wild-type counterparts (Jin et 
al 2008). Corroborating these results, Gαi2 null mice also have decreased 
chemotaxis to CXCL10 and CXCL11, while Gαi3 null mice demonstrated higher 
levels of response to the same chemokines (Jin et al 2008). Additional support of 
the notion that Gαi2 is responsible for proper migration and trafficking of immune 
cells was reported for CCL2 and C5a-induced macrophage stimulation, while 
Gαi2 in endothelial cells also was shown to be required for proper transmigration 
of neutrophils (Pero et al 2007, Wiege et al 2013, Wiege et al 2012). Although 
not used predominantly in cell migration, Gαi3 is capable of substituting for Gαi2 
during C5a-induced activation of macrophages and bacterial-induced cytokine 
production (Fan et al 2007, Wiege et al 2013). Functional defects in cytokine 
production, migration, and trafficking revealed by the loss of Gαi offers insight 
into the contribution of G-protein signaling in the autoimmune pathologies caused 
by the absence of the Gαi proteins.  
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The ability of leukocytes to process, prioritize and respond appropriately to 
multiple signals remains a key question in immunology. The modulation of G-
protein signaling by accessory proteins in chemokine directed migration is of 
particular interest. As mentioned above, depletion of Gαi2 resulted in decreased 
migration of leukocytes to chemotactic stimuli (Hwang et al 2010, Hwang et al 
2007, Jin et al 2008, Pero et al 2007, Thompson et al 2007, Wiege et al 2013, 
Wiege et al 2012). The modulation of Gαi signaling by RGS1 was initially 
described in B-cells where loss of RGS1 resulted in impaired desensitization of 
chemokine signaling leading to increased migration and abnormal lymphocyte 
trafficking deficiency (Han et al 2005, Hwang et al 2010, Moratz et al 2004b). 
Subsequent studies using an RGS-insensitive Gαi2 knock-in mouse model 
reported impaired migration of neutrophils from bone marrow and impaired 
pathogen clearance linked to defective desensitization and unregulated 
chemokine signaling, as well as enhanced basal calcium levels and irregular B-
cell distribution and migration (Cho et al 2012, Hwang et al 2015). Additionally, 
roles for AGS3 and AGS4 in cell chemotaxis were recently described (Branham-
O'Connor et al 2014, Giguere et al 2013, Kamakura et al 2013). AGS3 
demonstrated upregulated expression upon leukocyte activation, whose 
importance was illustrated by depletion of AGS3 in dendritic cells, T lymphocytes 
and B lymphocytes exhibiting defective chemokine-mediated chemotaxis, 
calcium mobilization, and phosphorylation of Erk and Akt (Branham-O'Connor et 
al 2014). The loss of AGS4 also demonstrated decreased chemotaxis and 
instilled a protective phenotype from arthritis in these mice (Giguere et al 2013). 
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Interestingly, AGS3 was found to form a complex with Gαi and mInsc to target 
the Par3-Par6-aPKC complex to the leading edge, divulging an unexpected 
mechanism for AGS3 induced polarity and migration in neutrophils (Kamakura et 
al 2013). Migration of macrophages and tumor cells was also determined to 
require the GEF activity of GIV/Girdin on Gαi3 to induce maximal chemotaxis 
(Ghosh et al 2008). These studies suggest the importance of accessory proteins 
in modulation of the activation state of the G-protein alpha subunit, and thus 
possible promotion of prolonged Gβγ signaling, in chemokine receptor signaling 
in immune cells. 
The roles of Gαi subunits in cell migration continue to be debated in the 
literature (Kamakura et al 2013, Lehmann et al 2008, Neptune & Bourne 1997, 
Neptune et al 1999, Rudolph et al 1995, Surve et al 2014). Migration is generally 
considered a Gβγ-driven process, relying on the activation of numerous second 
messengers that contribute to cellular movement as mentioned above. The 
molecular function of the active GαiGTP released upon chemokine receptor 
activation of the heterotrimer is less understood. Although not completely 
defined, elevated levels of cAMP are implicated in inhibition of neutrophil 
chemotaxis supporting the action of active Gαi subunits to potentiate migration by 
inhibiting adenylyl cyclase in immune cells (Harvath et al 1991). More recent 
reports further demonstrate chemotaxis requires Gαi coupled receptors and even 
non-canonical Gαi signaling complexes for proper migration of cells (Kamakura 
et al 2013, Neptune et al 1999). Moreover, there is growing evidence for roles of 
accessory proteins that associate with Gαi in having modulatory functions in the 
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migratory response of immune cells (Branham-O'Connor et al 2014, Cho et al 
2012, Giguere et al 2013, Han et al 2005, Hwang et al 2010, Hwang et al 2015, 
Kamakura et al 2013, Moratz et al 2004b). Investigations into the function of 
accessory proteins in the context of chemokine receptor signaling have only 
begun to scratch the surface in terms of the importance of these proteins in 




















Herein, we developed three specific aims to further the knowledge of the 
dynamic and regulated Gαi – GPR module in 7TMR signaling and the 
requirement of two representative Group II AGS proteins, AGS3 and AGS4, in 
maximal chemokine signal integration of primary leukocytes. Specific aims are as 
follows:  
1) Determine if the Gαi – GPR complex is regulated by 7TM receptors and in a 
manner analogous to canonical Gαβγ heterotrimer.  
2) Define alternative modes of regulation for the Gαi – AGS4 interaction through 
potential interacting proteins identification and phosphorylation of key residues 
that influence complex formation.  
3) Demonstrate that the Gαi – GPR module is required for maximal 7TM 
chemokine receptor signal processing.  
Rationale for specific aim one is based on previous studies that 
demonstrate 7TMRs regulating the association of Gαi – GPR module in a 
receptor proximal manner. To explore the possibility that 7TMR directly couple 
the Gαi – GPR complex, we generated a fusion protein containing a 7TMR 
tethered to Gαi for targeting the Gαi – GPR module to the receptor microdomain 
and to observe the effect of receptor activation on the interaction between Gαi 
and GPR proteins through bioluminescence resonance energy transfer (BRET) 
techniques. Use of pertussis toxin-insensitive fusion proteins and sequestration 
of endogenous G-proteins demonstrated that the observed regulation is not due 
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to endogenous G-protein subunit cycling after receptor activation of canonical 
Gαiβγ heterotrimer. Additionally, previous studies depicting the importance of 
Gαi2 subunits in leukocyte signaling and expression of GPR proteins in immune 
tissues prompted the hypothesis that chemokine receptors regulate the Gαi2 – 
GPR complex to modulate Gαi signaling. Thus, using the chemokine receptor 
CXCR4 labeled with a fluorescent acceptor protein, we were able to determine if 
chemokine receptors could elicit regulation of the Gαi2 – GPR module.  
For specific aim two, we initially hypothesized that AGS4, which lacks 
well-defined protein interaction motifs, binds alternative proteins to modulate its 
subcellular localization and/or biological function. As an initial approach to test 
our hypothesis we generated a cell line that expressed AGS4 fused to a tandem 
affinity purification tag to isolate interacting proteins followed with mass 
spectrometry identification. We then determined the consequence of AGS4 
phosphorylation on the interaction with Gαi and potential kinases responsible for 
this phosphorylation through an in vitro kinase assay and BRET techniques. An 
initial screen for small molecule modulators of the Gαi – GPR complex identified 
compounds that may serve as a platform for development of reagents and/or 
targeted therapeutics towards the Gαi – GPR module. 
 Aim three arose from the hypothesis that AGS3 and AGS4 are involved in 
chemokine signal integration of leukocytes. Defects in chemokine-induced signal 
processing (e.g. directed migration and activation of ERK1/2) observed in AGS3-
null and AGS4-null mice indicated functional roles for AGS3 and AGS4 in 
chemokine signal processing. Furthermore, an in vivo model of peritonitis 
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revealed a biological role of AGS4 in inflammation-induced neutrophil migration. 
Taken together, these aims are focused to demonstrate the Gαi – GPR 
interaction is a dynamic and regulated event in cells of the immune system where 


















There are growing reports implicating G-proteins as regulators of 
numerous physiological signaling cascades. The increasing for G-proteins in 
various systems continues to divulge unexplored regulatory mechanisms to 
encompass the vast signaling repertoire required for proper signal integration, 
while retaining flexibility to adapt to dynamic extracellular signals. The discovery 
and subsequent characterization of AGS proteins lead to a conceptual 
advancement in terms of G-protein signal adaptation. AGS proteins were found 
to fit into various biological niches of the G-protein activation cycle (GEFs, GDIs, 
and effectors), allowing for adaptation from classical heterotrimeric signaling. 
Thus, the regulation by such a diverse group of signal modulators is of high 
importance when one considers the immense number of signaling cascades that 
AGS proteins potentially affect and the pathologies that present through 
disruption of these regulatory systems only beginning to be described. 
Of particular interest are Group II AGS proteins that express multiple GPR 
motifs capable of binding 2-4 GDP-bound Gαi/o/t simultaneously that could 
assemble unique signaling modulators to alter G-protein activation. Two 
representative members of this group, AGS3 and AGS4, have been found in 
immunological tissues; however, the biological significance of their expression is 
not well elucidated. Interestingly, a major receptor class utilized by hematopoietic 
cells is the chemokine receptor class, which happens to be comprised of Gαi-
coupled 7TMRs. Aside from a prospective role of these proteins in inflammatory 
pathologies, signaling through chemokine receptors is also involved in the 
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migration of malignancies of hematopoietic origin that “hijack” this receptor 
signaling system to home to secondary sites of metastasis such as bone and 
lymph nodes (Cunningham et al 2010, Singh et al 2010). Thus, AGS3 and AGS4 
may potentially modulate chemokine signal processing in these pathologies. 
Moreover, considering that one major limitation to targeting G-proteins in cells 
has been their ubiquitous expression in all tissues contributing to side effects, the 
role of AGS3 and AGS4 in chemokine signaling may provide a novel platform for 
developing therapeutics by virtue of the tissue specific distribution of these 
proteins.  
Group II AGS proteins like AGS3 and AGS4 provide insight into novel 
modes of signal input and regulation of heterotrimeric G-protein signaling and 
provide a platform for discovering mechanisms underlying signal strength, 
specificity, and integration of G-protein mediated cellular responses.  
Furthermore, they provide unexpected targets for development of therapeutics 
for diseases which result from altered heterotrimeric G-protein signaling. This 
dissertation addresses key questions in the field with respect to G-protein signal 
processing and will advance novel concepts for the role of accessory proteins in 









Multifaceted Regulation of the Gαi – GPR complex through Coupling of a 

















*Note: This chapter contains a portion of the manuscript: 
Direct Coupling of a Seven Transmembrane Span Receptor to a Gαi – GPR 
Complex 
Robichaux III WG, Oner SS, Lanier SM, and Blumer JB 




The discovery of Activators of G-protein Signaling (AGS) proteins, 
originally identified in a yeast-based functional screen for mammalian cDNAs that 
activated G-protein signaling in the absence of a receptor, revealed both 
unexpected regulatory mechanisms for G-protein signaling systems and 
expanded functional roles for the G-protein subunits (Cao et al 2004, Cismowski 
et al 1999, Sato et al 2006b, Sato et al 2011b, Takesono et al 1999).  Group I 
AGS proteins encompass non-receptor guanine nucleotide exchange factors 
whereas Group II AGS proteins, all of which contain a G-protein regulatory 
(GPR) motif, engage Gαi/o/t as guanine nucleotide dissociation inhibitors.  Group 
III AGS proteins appear to engage Gβγ, whereas Group IV AGS proteins, which 
were just recently identified, interact with Gα16 (Sato et al 2011a).  
AGS3 and AGS4 are representative members of two distinct subgroups of 
AGS proteins. AGS3 has four GPR motifs downstream of a series of 
tetratricopeptide repeat domains (TPR) involved in protein interactions and 
intramolecular regulatory events, whereas AGS4 is a smaller protein with three 
GPR motifs without any clearly defined protein interaction domains upstream of 
the GPR motifs. As the GPR motif stabilizes the GDP-bound conformation of Gα 
free of Gβγ, regulation of this interaction could effectively alter G protein signal 
processing and may be subject to regulation by a multitude of signal modulators 
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including 7TMRs, alternative interacting proteins, or post-translational 
modifications.  
Interestingly, AGS3 expression is upregulated upon lymphocyte activation 
and AGS4 has a restricted expression profile to cells of hematopoietic origins 
(Chapter 3), (Branham-O'Connor et al 2014, Cao et al 2004, Giguere et al 2013, 
Zhao et al 2010). Additionally, migrating leukocytes, as well as malignant 
hematopoietic cells, signal through chemokine receptors primarily by coupling to 
Gαi2, the predominant isoform of Gαi in these tissues (Arai et al 1997, Neptune & 
Bourne 1997, Wright et al 2002). However, initial studies investigating the 
regulation of AGS3, AGS4, and RGS14 by 7TMRs were demonstrated for Gαi1 
by α2A/D-adrenergic receptor (α2A/D-AR) (Oner et al 2010a, Oner et al 2010b, 
Vellano et al 2013). Therefore, regulation of GPR protein complexes in the 
context of the immune system has not been investigated. As an approach to 
address this question, we utilized a BRET platform with GPR proteins AGS3 and 
AGS4 fused to Renilla luciferase and Gai2 fused to YFP between the aB-aC 
loops in the helical domain as previously described (Gales et al 2005, Gales et al 
2006, Gibson & Gilman 2006) together with the chemokine receptor CXCR4.   
We hypothesized that Gαi2 – GPR complexes are regulated by chemokine 
receptors to modulate G-protein signaling. Two initial questions about the 
regulation of the Gαi2 – GPR complex by G-protein coupled chemokine receptors 
then arise: (1) Is the Gαi – GPR complex modulated specifically by chemokine 
receptor activation and, if so, (2) is the Gαi – GPR complex situated in the 
adjacent proximity of the receptor to be directly regulated in a manner similar to 
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that observed with the G-protein Gαβγ heterotrimer (Lambright et al 1996, 
Rasmussen et al 2011, Wall et al 1995). Alternatively, the regulation of GαGPR 
may be secondary to canonical 7TM receptor coupling to Gαβγ subsequent to G-
protein subunit flux within the microenvironment of a signaling complex. It was 
also recently postulated that Groups I-III AGS proteins may actually represent a 
signaling triad that parallels that of the well characterized 7TM receptor – Gαβγ – 
effector system (Blumer & Lanier 2014).   
As part of a broader approach to explore these concepts, we examined 
the 7TM receptor -mediated regulation of the Gαi-GPR complex when Gαi was 
actually tethered to the 7TM receptor itself.  Thus the Gαi-GPR interaction would 
be highly localized and could also be monitored independent of endogenous 
Gαβγ as the tethered G-protein could be rendered pertussis toxin insensitive by a 
single point mutation. The results of these studies suggest direct coupling of a 
7TM receptor to the GαGPR complex, which has broad implications for G-protein 
signal processing.  
 In addition to potential direct coupling to the receptor, the Gα-GPR 
cassette may also be regulated by alternative binding partners. Such regulation 
is observed for some GPR proteins such as AGS3, LGN, and RGS14 by virtue of 
their interaction with alternative binding partners via defined protein-protein 
interaction motifs (An et al 2008, Blumer et al 2003, Blumer et al 2002, Du & 
Macara 2004, Du et al 2001, Pizzinat et al 2001, Shu et al 2007). Interestingly, 
AGS4, aside from its three GPR motifs, does not contain any obvious protein 
interaction domains; however, the amino-terminus of AGS4 contains a poly-
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proline rich region that may subserve a regulatory function for AGS4 (Cao et al 
2004, Takesono et al 1999). As an initial approach to examine these potential 
modes of regulation for AGS4, we utilized a tandem affinity purification system 
and subsequent mass spectrometry analysis to identify potential AGS4 binding 
partners.  
Furthermore, post-translational modifications within or proximal to GPR 
motifs may differentially regulate the Gαi-GPR interaction (Adhikari & Sprang 
2003, Blumer et al 2003, Hollinger et al 2003, Kimple et al 2004). 
Phosphorylation has been linked to regulation of subcellular localization and 
modulation of Gαi binding of AGS3 and LGN (Blumer et al 2003, Groves et al 
2010, Johnston et al 2009). In contrast, phosphorylation of RGS14 appeared to 
enhance GαiGDP interaction (Hollinger et al 2003). These studies suggest that 
phosphorylation may play a key modulatory role in regulating  GPR-containing 
proteins; however, the functional consequences of phosphorylation on another 
Group II AGS protein, AGS4, are incompletely characterized (Giguere et al 
2012b, Rush et al 2005, Zarling et al 2000, Zhong et al 2012). Additionally, the 
kinases responsible for the phosphorylation of AGS4 are unknown. AGS4 
contains only two tyrosine residues, Y85 and Y108; interestingly, in a recent 
study to identify the phosphoproteomic changes induced by the cytokine thymic 
stromal lymphopoietin (TSLP) in a lymphocyte cell line, AGS4 was identified as 
being phosphorylated on Y108 (Zhong et al 2012). TSLP plays critical roles in 
shaping and regulating immune responses and is a critical mediator of allergic 
inflammation and hypersensitivity disorders, in particular asthma and other atopic 
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diseases (He et al 2008, Liu et al 2007, Redhu et al 2013, Roan et al 2012, 
Wilson et al 2013, Ziegler 2012, Ziegler et al 2013). TSLP also promotes 
maturation of dendritic cells and the induction of inflammatory-driven, type 2 
helper T-cell (Th2)-mediated immune responses, which underlies its involvement 
in allergic and hypersensitivity reactions.  TSLP induces the phosphorylation and 
activation of several tyrosine kinases, including JAK2 and Src (Zhong et al 2012).  
Interestingly, AGS4-Y108 is a consensus phosphorylation residue for both JAK2 
and Src. Therefore, as an initial approach to determine the role of AGS4 
phosphorylation, we generated aspartic acid mutations to serine and tyrosine 
residues to investigate modulation of Gαi binding to these residues upon 
phosphorylation. Additionally, in vitro kinase assays were used to determine if 
JAK2 and Src are able to effectively phosphorylate AGS4. 
Potential regulation of AGS4 by TSLP signaling further suggests a role for 
Group II AGS proteins in immune cell signal processing. Indeed, loss of AGS4 
conferred decrease in proinflammatory signaling and disease progression in a 
model of rheumatoid arthritis (Giguere et al 2013). Additionally, AGS3 was 
identified in a complex with Gαi and mInsc targeting the Par3-Par6-aPKC polarity 
complex to the leading edge of neutrophils and was required for directed 
migration in these cells (Kamakura et al 2013). We also recently demonstrated 
that AGS3 is required for proper chemokine signal processing  and migration of B 
and T lymphocytes as well as bone marrow derived dendritic cells (Branham-
O'Connor et al 2014). These collective studies as well as those indicating a role 
for GPR proteins in drug addiction and neuronal plasticity, ischemia reperfusion 
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injury and polycystic kidney disease, blood pressure control, energy expenditure 
and metabolism, autophagy, membrane protein trafficking, and directional 
migratory response suggest that the Gαi – GPR complex may be a prime target 
for therapeutic intervention (Blumer et al 2008, Bowers et al 2008, Bowers et al 
2004, Branham-O'Connor et al 2014, Cao et al 2004, Giguere et al 2013, Kwon 
et al 2012, Nadella et al 2010, Regner et al 2011, Yao et al 2005, Yao et al 
2006a, Zhao et al 2010). Thus, using a BRET-based drug screening platform, we 
identified seven potential inhibitors of the Gαi – GPR interaction to be further 
developed as biochemical tools for further investigation of the Gαi – GPR 














Materials and reagents:   
Polyethylenimine (PEI) (25 kDa molecular mass, linear form), was obtained from 
Polysciences, Inc (Warrington, PA) and Lipofectamine 2000 used for stable 
transfections was purchased from Life Technologies (Grand Island, NY). Benzyl-
coelenterazine was obtained from NanoLight Technology (Pinetop, AZ). 
UK14304, rauwolscine HCl, AMD3100, pertussis toxin, and β-actin antiserum 
(A5441) were purchased from Sigma-Aldrich (St. Louis, MO) and recombinant 
human CXCL12/SDF-1α was purchased from BioAbChem (Laden, SC).  Gray 
96-well Optiplates were obtained from Perkin Elmer (Waltham, MA). GFP 
antiserum was obtained from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). 
Gαi1/2 and Gαi3 antiserum was kindly provided by Dr. Thomas Gettys 
(Pennington Biomedical Research Center, Baton Rouge, LA). AGS4 antibody 
(AP5725c) and GRK2 antibody (ab50633) were obtained from Abgent (San 
Diego, CA) and Abcam (Cambridge, MA), respectively. Protease inhibitor 
mixture tablets (Complete Mini) were obtained from Roche Applied Science 
(Indianapolis, IN). Strepavidin resin and gallein were purchased from G 
Biosciences (St. Louis, MO) and Tocris Biosciences (Minneapolis, MN), 
respectively. Small molecules used in the screening for potential inhibitors were 
obtained through the ChemBridge DIVERSet library of compounds housed at 





Plasmids:   
AGS3, AGS3-short (AGS3-sh), AGS4 and AGS4-short (AGS4-sh) fused at the 
carboxyl terminus to Renilla luciferase (Rluc) as well as mutations to each GPR 
motif in these constructs (AGS3-Q/A and AGS4-Q/A), and α2A/D-AR constructs 
were generated as previously described (Oner et al 2010a, Oner et al 2013a, 
Oner et al 2010b). Gαi1-yellow fluorescent protein (Gαi1YFP) and Gαi2-yellow 
fluorescent protein (Gαi2YFP) were generated by Dr. Scott Gibson (Gibson & 
Gilman 2006) and kindly provided by Dr. Greg Tall (University of Rochester, 
Rochester, NY) and Dr. Nathan Dascal (Tel Aviv University, Tel Aviv, Israel), 
respectively. YFP was inserted within the αB-αC loops in the helical domain of 
Gαi as described (Gibson & Gilman 2006, Oner et al 2010a, Oner et al 2010b).  
CXCR4 constructs were kindly provided by Dr. Michel Bouvier (Universite de 
Montreal) and pcDNA3::GRK2-CT, which encodes amino acids Tyr466 – Leu689 in 
the carboxyl terminus of GRK2, was kindly provided by Dr. Jeffrey Benovic 
(Thomas Jefferson University, Philadelphia, PA). All other reagents and 
materials were obtained as described elsewhere (Oner et al 2010a, Oner et al 
2013a, Oner et al 2010b). 
Site-directed Mutagenesis and fusion protein plasmid construction: 
The α2AAR – Gαi2YFP fusion protein was generated by polymerase chain 
reaction (PCR) using the rat α2A/DAR as template and primer sets containing 
specific sites for restriction enzyme digest as follows: XhoI, α2AAR forward primer 
5’-AAA CTC GAG GCC GCC ACC ATG GGC TCC CTG CAG CCG GAC-3’; 
EcoRI, α2AAR reverse primer 5’-CAT GAA TTC CTG CAA GCT TCC TCC TCC 
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TCC GGA CAC GAT CCG CTT-3’. The reverse primer also encodes a SGGGS 
linker between α2ADAR and Gαi2YFP. Digestion of pcDNA3::Gαi2YFP or 
pcDNA3::Gαi2YFPC352I constructs at upstream XhoI/EcoRI sites followed by 
ligation with the digested receptor-linker resulted in in-frame construction of the 
α2AAR – Gαi2YFP fusion proteins.  Cysteine 352 (C352) in Gαi2, which is the site 
of ADP-ribosylation by pertussis toxin (PTX), was converted to isoleucine to 
render the protein PTX insensitive by site-directed mutagenesis using the 
pcDNA3::Gαi2YFP construct with the following primer set: Gαi2YFPC352I forward 
primer 5’-AAC AAC CTG AAG GAC ATT GGC CTC TTC TGA-3’; 
Gαi2YFPC352Ireverse primer 5’-TCA GAA GAG GCC AAT GTC CTT CAG GTT 
GTT-3’.  
Cell Culture, Transfection, Immunoblotting, BRET, Plasmid expression:  
BRET measurements and immunoblotting were performed as previously 
described (Oner et al 2010a, Oner et al 2013a, Oner et al 2010b). Plasmid 
transfection of HEK293 cells with PEI was conducted as previously described 
(Oner et al 2010a, Oner et al 2013a, Oner et al 2010b, Oner et al 2013b). 
Experiments measuring BRET between AGS3-Rluc or AGS4-Rluc and Gαi2YFP 
and α2A/DAR or CXCR4 had HEK293 cells transfected with 10 ng 
phRLucN3::AGS3 or 2 ng phRLucN3::AGS4, respectively, 500 ng 
pcDNA3::Gαi2YFP, and 500 ng pcDNA3::RG20, or pcDNA3::CXCR4. In 
experiments measuring BRET between AGS3-Rluc or AGS4-Rluc and α2A/DAR-
Venus or CXCR4-Venus in the presence or absence of Gαi2, HEK293 cells were 
transfected with 10 ng phRLucN3::AGS3 or 2 ng phRLucN3::AGS4, respectively, 
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750 ng pcDNA3::α2A/DAR-Venus or pIRESpuro3::CXCR4, and 750 ng 
pcDNA3::Gαi2 where indicated, HEK293 cells were transfected with 10 ng 
phRLucN3::AGS3 or 2 ng phRLucN3::AGS4, respectively and 500 ng 
pcDNA3::α2A/DAR-Gαi2YFP or pcDNA3::α2A/DAR-Gαi2YFPC352I in experiments 
measuring BRET between AGS3-Rluc or AGS4-Rluc and α2A/DAR-Gαi2YFP  or 
α2A/DAR-Gαi2YFPC352I. Experiments to measure BRET between AGS3-sh-Rluc or 
AGS4-sh-Rluc and α2A/DAR-Gαi2YFP or Gαi2YFP were conducted in HEK293 
cells transfected with 2 ng phRLucN3::AGS3-sh or 2 ng phRLucN3::AGS4-sh, 
respectively and 750 ng pcDNA3::α2A/DAR-Gαi2YFP or Gαi2YFP. Based upon a 
series of preliminary experiments we optimized the system to generate levels of 
α2A/DAR-Gαi2YFP and α2A/DAR-Gαi2YFPC352I that bracketed the levels of 
endogenous Gαi2 as determined by immunoblotting.   For BRET saturation 
experiments, AGS3–Rluc and AGS4-Rluc were expressed as above with 
increasing amounts (0 – 1000 ng) of pcDNA3::α2A/DAR-Gαi2YFP or 
pcDNA3::α2A/DAR-Gαi2YFPC352I. Forty-eight hours after cell transfection, cells 
were dispensed in triplicate at 1 x 105 cells/well in gray 96-well Optiplates (Perkin 
Elmer (Waltham, MA). Fluorescence and luminescence signals were measured 
using a TriStar LB 941 plate reader (Berthold Technologies) with MikroWin 2000 
software.  Cells were incubated with the α2-AR agonist (UK14304 – 10 µM) or 
vehicle in Tyrode’s solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1 mM CaCl2, 
0.37 mM NaH2PO4, 24 mM NaHCO3, 10 mM (4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES), pH 7.4 and 0.1% glucose (w/v)) for 5 
minutes prior to addition of coelenterazine H. Coelenterazine H (Nanolight 
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Technology, 5 μM final concentration) was added to each well and luminescence 
measured after two minutes (donor: 480 + 20 nm; acceptor: 530 + 20 nm) with 
the TriStar LB 941 plate reader. Gαi2YFP or α2A/DAR-Gαi2YFP fusion protein 
expression was monitored by measuring YFP fluorescence (excitation 485 nm, 
emission 535 nm). AGS3- and AGS4-Rluc expression was monitored by 
measuring the intensity of the luminescence signal.  BRET signals were 
determined by calculating the ratio of the light intensity emitted by the YFP 
divided by the light intensity emitted by Rluc. Net BRET values were determined 
by first calculating the 530 ± 20:480 ± 20 nm ratio and then subtracting the 
background BRET signal determined from cells transfected with the donor 
plasmids phRLucN3::AGS3 or phRLucN3::AGS4 alone. Cell lysates and 
immunoblotting were performed as previously described using 10-13% sodium 
dodecyl sulfate polyacrylamide gel electrophoresis (Oner et al 2010a, Oner et al 
2010b).  Where indicated, cells were incubated with α2-AR agonist UK14304 
(10uM), α2-AR antagonist rauwolscine (100 µM), CXCR4 agonist CXCL12 (100 
ng/mL), CXCR4 antagonist AMD3100 (1 µg/mL) for the times indicated and/or 
pretreated with pertussis toxin (100 ng/ml) 18 hours prior to BRET 
measurements. 
Stable cell line generation: 
Both NTAP AGS4 and Gαi1YFP stably expressing cells were generated in 
HEK293 cells using Lipofectamine 2000 (Invitrogen). HEK293 cells were seeded 
at ~70% confluency for transfection in 6-well dishes. Lipofectamine 2000 working 
solution was made by adding Lipofectamine 2000 (10 µl) to 250 µl Dulbecco’s 
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Modified Eagles Medium (DMEM, HyClone™) supplemented with 5% fetal 
bovine serum (FBS). DNA working solutions were made by adding NTAP-
taggged protein, NTAP empty vector, or Gαi1YFP (4 µg total DNA) to 250 µl of 
DMEM + 5% FBS. The two working solutions were combined, vortexed for 3 sec 
and incubated at room temperature for 20 min, after which the DNA:lipid 
complexes were added to each well of HEK293 cells. After 24 hours, the 
transfection media was removed, cells were dispersed in a 10cm dish in 10 ml of 
DMEM + 5% FBS supplemented with 2 μg/ml puromycin or 800 µg/ml G418, to 
select for NTAP AGS4 and Gαi1YFP expressing cells, respectively. Forty-eight 
hours post-transfection, cells were transferred into 15cm dishes with 20 ml fresh 
media containing selection antibiotics. After 7-10 days, single colonies were 
selected and isolated using cloning cylinders and separated into 10cm dishes 
with appropriate selection media. Immunoblotting and fluorescence 
measurements validated expression of the appropriate plasmid. 
Tandem Affinity Purification (TAP):  
Purification of TAP-tagged AGS4 required 1x108 cells of NTAP AGS4 stably 
expressing HEKs (NTAP-only cells used as negative controls). Cells were 
harvested using serum free DMEM, centrifuged at 500 x g for 5 min, and 
resuspended in 300 µl streptavidin binding buffer (50mM TRIS-HCl pH 8,  
150mM NaCl, 10% glycerol (v/v), 1% NP-40 lysis buffer, phosphotase inhibitors) 
to be lysed for 20 min on ice. After this incubation the lysates were centrifuged at 
20,000 x g, 4°C to isolate the protein in each sample. During this time, 500 µl 
streptavidin resin per condition (GBiosciences) was equilibrated in streptavidin 
65 
 
binding buffer as a 50% slurry. After centrifugation, 30 µl (10%) of the protein 
lysates was taken as an input control. The remaining lysate was added to the 
equilibrated 500 µl streptavidin resin for at least 2 hours, 4°C with constant 
rotation. After incubation, a 25 µl aliquot was taken for later analysis and the 
resin was then pelleted by centrifugation on a picrofuge for 5-10 s. Cleared lysate 
was removed and stored for later analysis. Resin bound to the TAP proteins was 
washed three times with 500 µl streptavidin binding buffer followed by 
subsequent burst centrifugations 5-10 s to pellet the resin, while cleared washes 
were removed for later analysis. Samples were resuspended in 150 µl 
streptavidin binding buffer and TAP tagged proteins were then eluted by 100 µl 
5x Laemmli sample buffer, followed by boiling of the resin for five minutes. The 
supernatant ~250 µl was transferred to a fresh microcentrifuge tube, where 
samples were subjected to SDS-PAGE, and transferred to polyvinylidene 
difluoride (PVDF) membranes. Membranes were then blocked with 50% Odyssey 
Buffer [LI-COR Biosciences] and 50% Tris-buffered saline + 0.01% Tween 
(TBST) or 5% blotto for 30 min at room temperature, immunoblotted for AGS4 
(1:250 dilution) antibody, Gαi1/2 antiserum (1:10,000 dilution), or  Gαi3 antiserum 
(1:10,000 dilution), followed three 10 min washes in TBST. Membranes were 
then exposed to 1:5,000 or 1:20,000 dilutions of horseradish peroxidase-
conjugated goat anti-rabbit IgG, respectively, followed by three 30 min washes 
with TBST and subsequent exposure with ECL. Additionally, SDS-PAGE was run 
with subsequent Coomassie blue staining to visualize bands from the elution that 
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were excised and sent to the MUSC Mass Spectrometry/Proteomics Core facility 
for identification of additional purified proteins.  
Excised gel plugs were washed with 50 mM ammonium bicarbonate for 10 
minutes. Next, the plugs were de-stained using 25mM ammonium bicarbonate in 
50% acetonitrile for 15 minutes, repeated twice. The plugs were dehydrated with 
100% acetonitrile for 15 minutes, and then dried in a speedvac. Each gel plug 
was covered with Proteomics Grade Trypsin (Sigma) and incubated at 37C 
overnight. 
The supernatant was collected in a clean dry eppendorf tube.  Peptides 
were further extracted with 1 wash of 25mM ammonium bicarbonate for 20 
minutes and three washes of 5% formic acid, 50% acetonitrile for 20 minutes 
each. The supernatant was collected and pooled after each wash then dried 
down in a speedvac to ~2 uL. Prior to LC/MS analysis the samples were 
reconstituted with 10 ul of 2% acetonitrile and 0.2% formic acid.  
Enzymatically digested samples were analyzed via liquid chromatography 
(LC)-electrospray ionization (ESI) -tandem mass spectrometry (MS/MS) on a 
linear ion trap mass spectrometer (LTQ, Thermo Finnigan) coupled to a Dionex 
3000 nano LC system. A 25cm 75micron C-18 reversed phase LC column 
(packed in house, with Waters ODS C18) was utilized with a 120 minute gradient 
from 2% acetonitrile, 0.2% formic acid to 60% acetonitrile, 0.2% formic acid.   
Data Dependent Analysis was utilized on the LTQ to perform MS/MS on the 10 
most intense ions in each MS spectra with a minimum ion count of 1000.  
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Dynamic Exclusion was set to exclude ions from MSMS selection for 3 minutes 
after being selected 2 times in a 30 second window. 
The MS/MS data was searched against a human database using Sequest 
via Bioworks 3.0 SP1 (Thermo). Variable modifications of methionine oxidation 
were considered. Protein identifications must have an Xcorr vs charge state  > 
1.5, 2.0, 2.5 for +1, +2, and +3 ions, with at least 2 unique peptides matching the 
protein, and a good match for at least 4 consecutive y or b ion series from the 
MS/MS spectra.  
32P autorad in vitro kinase assay:  
Purified GST-AGS4-short (Leu57-Cys160) was generated as described previously 
(Cao et al 2004).  GST-AGS4-short-Y108F was generated by site-directed 
mutagenesis and purified according to Cao et al.  Five µg purified GST, GST-
AGS4-short and GST-AGS4-short-Y108F was incubated with 1 µg purified active 
JAK2 (Leu808-Gly1132) and Src kinases in kinase buffer (50 mM HEPES pH 7.5, 
10 mM MgCl2, 3 µM Na3VO4, 1 mM EGTA, 1 mM DTT, 10 uM ATP and 10 µCi γ-
32P-ATP) for 30min at 25C.  Samples were subjected to SDS-PAGE and 
autoradiography. 
Small Molecule Screening: 
Gαi1YFP stably expressing HEK293 cells were generated by Lipofectamine 2000 
(Invitrogen) transfection and G418 antibiotic selection as described in the above 
section Stable cell line generation. Expression levels of Gαi1-YFP were 
determined to be 291,729 + 77,278 RFU. The 50,080 compound DIVERSet 
library from ChemBridge, (MUSC Drug Discovery Core) was used. HEK293 cells 
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stably expressing Gαi1YFP were transfected with 2 ng phRlucN3::AGS4 using 
PEI for forty-eight hours prior to drug treatment. Cells were dispensed at 1 x 105 
cells/well in gray 96-well Optiplates (Perkin Elmer (Waltham, MA). Prior to 
reading fluorescence or luminescence, compounds were administered to each 
well (10 compounds per well or individual in secondary screen) at a final 
concentration of 1 μM for 1 hour at 37°C, 5% CO2. Total fluorescence (ex. 485 
nm; em. 535 nm) was measured to monitor Gαi1YFP expression using the 
TriStar LB 941 plate reader (Berthold Technologies). Coelenterazine H 
(Nanolight Technology, 5 μM final concentration) was added to each well and 
luminescence measured after two minutes (donor: 480 + 20 nm; acceptor: 530 + 
20 nm) with the TriStar LB 941 plate reader with MikroWin 2000 software. BRET 
signals were determined by calculating the ratio of the light intensity emitted by 
the YFP divided by the light intensity emitted by Rluc. Net BRET was calculated 
as previously described using individual wells transfected with AGS4-Rluc alone 
to subtract background signals for each set of compounds. 
Data Analysis: 
Statistical significance for differences involving a single intervention was 
determined by one-way analysis of variance (ANOVA) followed with a post hoc 
Tukey’s test using GraphPad Prism version 4.03 (GraphPad Software, San 






Results and Discussion 
Agonist-sensitive regulation of the Gαi2–GPR module by chemokine receptors  
Two Group II AGS proteins containing multiple GPR motifs, AGS3 and 
AGS4, were used as model proteins to identify regulatory mechanisms for Gα – 
GPR interactions. AGS3 and AGS4 differ in the number of GPR motifs expressed 
and the domain composition of the amino terminus of each protein. AGS3 
contains a series of TPR domains involved in protein interactions and 
intramolecular regulatory events, while AGS4 is absent in these protein binding 
domains and only expresses a short proline-rich segment upstream of the GPR 
motifs. Although initial observations depict regulation of Gαi1 with AGS3 and 
AGS4 by α2A/D-AR, the regulation of these proteins with Gαi2, the predominant 
isoform in the immune system has yet to be determined (Branham-O'Connor et al 
2014, Cao et al 2004, Giguere et al 2013, Oner et al 2010a, Oner et al 2010b). 
Thus, as an initial approach to address the hypothesis that Gαi2 – GPR complex 
is regulated by chemokine receptors, BRET measurements were taken from 
HEK293 cells expressing AGS3-Luc or AGS4-Luc, Gαi2-YFP and the chemokine 
receptor CXCR4 (Figure 2.1A). The previously investigated receptor, α2A/D-AR 
was used as a positive control (Figure 2.1A) (Oner et al 2010a, Oner et al 
2010b). Indeed, Gαi2 - GPR complexes were regulated by agonists for both 
CXCR4 and a2-AR, reflected as a decrease in BRET signal upon receptor 
activation, suggesting either dissociation or rearrangement of the Gαi2 – GPR 
signaling complex (Figure 2.1B and 2.1C). This decrease was effectively blocked 
by appropriate antagonist or pertussis toxin (PTX), which prevents Gαi coupling 
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to receptor by ADP ribosylating a cysteine residue four residues from the 
carboxyl terminus of Gαi/o subunits (Figure 2.1B and C). Additionally, mutation of 
a critical glutamine residue in each of the GPR motifs from glutamine to alanine 
(Q/A) completed blocked GPR association with Gαi2 subunits in the BRET 
system similar to results previously ascertained for Gαi1 (Figure 2.1B and C) 


































Figure 2.1. Regulation of Gαi2 – GPR interaction by Gαi-coupled receptor 
activation  
(A) Schematic of bioluminescence resonance energy transfer (BRET) system 
along with representation of hypothesized agonist-induced regulation of Gαi2YFP 
– GPR-Rluc BRET association by receptor activation.  
(B) Net BRET signals were obtained from HEK cells transfected with 10 ng 
phRLucN3::AGS3 or 10 ng phRLucN3::AGS3-Q/A-Rluc along with 500 ng 
pcDNA3::Gαi2-YFP. Cells were also transfected in the presence or absence of 
500 ng pcDNA3::α2A/D-AR (left panel) or pcDNA3::CXCR4 receptor (right panel). 
Vehicle (Tyrode’s solution), α2A/D-AR agonist UK14304 (10 µM), or CXCL12 
(100ng/mL) were added to cells as indicated followed by fluorescence and 
luminescence readings as described in “Experimental Procedures.” The α2A/D-AR 
antagonist rauwolscine (10 µM) and CXCR4 antagonist AMD3100 (1 µg/mL) 
were added 10 minutes prior to agonist stimulation as indicated. Cells were 
treated with pertussis toxin (PTX, 100 ng/mL) 18 hours prior to receptor 
stimulation where indicated.  
(C) Net BRET signals were obtained from HEK cells transfected with 2 ng 
phRLucN3::AGS4 or 2 ng phRLucN3::AGS4-Q/A-Rluc along with 500 ng 
pcDNA3::Gαi2-YFP. Cells were also transfected in the presence or absence of 
500 ng pcDNA3::α2A/D-AR (left panel) or pcDNA3::CXCR4 receptor (right panel). 
Vehicle (Tyrode’s solution), α2A/D-AR agonist UK14304 (10 µM), or CXCL12 
(100ng/mL) were added to cells as indicated followed by fluorescence and 
luminescence readings as described in “Experimental Procedures.” The α2A/D-AR 
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antagonist rauwolscine (10 µM) and CXCR4 antagonist AMD3100 (1 µg/mL) 
were added 10 minutes prior to agonist stimulation as indicated. Cells were 
treated with pertussis toxin (PTX, 100 ng/mL) 18 hours prior to receptor 
stimulation where indicated. 
All data are expressed as means ± SEM from at least 3 independent experiments 
with triplicate determinations (N=9). Notations of *** signify p-values < 0.0001 as 
compared with vehicle stimulated control group based on Tukey’s post hoc test 



















Association of chemokine receptor with GPR-containing proteins is Gαi 
dependent and disrupted subsequent to receptor activation 
As an initial approach to test the hypothesis that the Gαi2 – GPR complex 
was in close enough proximity to 7TMRs to facilitate the observed regulation 
(Figure 2.1B and C), the BRET system was adapted by converting the receptor 
to the acceptor (Venus) while the donor (Rluc) was retained on AGS3 or AGS4 to 
observe the consequence of receptor activation on the association between 
GPR-containing proteins and receptors (Figure 2.2A). The association was 
indeed a Gαi2-mediated event subject to regulation by receptor activation, similar 
to that observed previously for Gαi1 (Figure 2.2B and C) (Oner et al 2010a, Oner 
et al 2010b). Agonist regulation of the Gαi-GPR complex was blocked by 
treatment of the appropriate antagonist or PTX, and substitution of GPR-Q/A 
mutations completely eliminated BRET signals between the receptor and GPR 
proteins (Figure 2.2B and C). These results suggest the existence of a ternary 
complex of GPR-Gαi2-GPCR, which is regulated by agonist stimulation and 
analogous to canonical Gαβγ – GPCR coupling. Additionally, regulation of these 
complexes by receptor activation was observed to be PTX sensitive, whereas 
Gαi-GPR interaction in the absence of agonist is unaffected by PTX (Figure 2.1B 



















Figure 2.2. Regulation of Gαi2-dependent proximity of GPR protein to 
receptor by Gαi-coupled receptor activation  
(A) Schematic representing BRET system to measure effect of receptor 
activation on proximity of GPR-Rluc protein to the receptor-venus. 
(B) HEK cells were transfected with 10 ng phRLucN3::AGS3 or 10 ng 
phRLucN3::AGS3-Q/A along with 750 ng pcDNA3::a2A-AR-Venus or 
pIRESpuro3::CXCR4-Venus in the presence or absence of 750 ng 
pcDNA3::Gαi2 as indicated. Vehicle (Tyrode’s solution), α2A/D-AR agonist 
UK14304 (10 µM), or CXCL12 (100ng/mL) were added to cells as indicated 
followed by fluorescence and luminescence readings as described in 
“Experimental Procedures.” The α2A/D-AR antagonist rauwolscine (10 µM) and 
CXCR4 antagonist AMD3100 (1 µg/mL) were added 10 minutes prior to agonist 
stimulation as indicated. Cells were treated with pertussis toxin (PTX, 100 ng/mL) 
18 hours prior to receptor stimulation where indicated. 
(C) HEK cells were transfected with 2 ng phRLucN3::AGS4 or 2 ng 
phRLucN3::AGS4-Q/A along with 750 ng pcDNA3::a2A-AR-Venus or 
pIRESpuro3::CXCR4-Venus in the presence or absence of 750 ng 
pcDNA3::Gαi2 as indicated. Vehicle (Tyrode’s solution), α2A/D-AR agonist 
UK14304 (10 µM), or CXCL12 (100ng/mL) were added to cells as indicated 
followed by fluorescence and luminescence readings as described in 
“Experimental Procedures.” The α2A/D-AR antagonist rauwolscine (10 µM) and 
CXCR4 antagonist AMD3100 (1 µg/mL) were added 10 minutes prior to agonist 
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stimulation as indicated. Cells were treated with pertussis toxin (PTX, 100 ng/mL) 
18 hours prior to receptor stimulation where indicated. 
All data are expressed as means ± SEM from at least 3 independent experiments 
with triplicate determinations (N=9). Notations of *** signify p-values < 0.0001 as 
compared with vehicle stimulated control group based on Tukey’s post hoc test 





















Regulation of Gαi2 – GPR module by physical tethering and subsequent 
activation of 7TMRs 
Specific regulation of the Gαi2 – GPR complex and its proximity to the 
receptor suggests that the complex may directly couple to the 7TMR in a manner 
analogous to heterotrimeric G-proteins. As an initial approach to address the 
hypothesis regarding direct receptor coupling to Gαi2GPR, we generated a 
fusion protein in which Gαi2YFP was tethered to the carboxyl terminus of the 
α2A/DAR via a flexible glycine linker (Bahia et al 1998, Bertin et al 1994, Burt et al 
1998, Seifert et al 1999, Wise et al 1997)  Similar results were obtained for 
untethered Gαi2YFP and α2A/D-AR constructs. We also generated a variant of the 
α2A/DAR-Gαi2YFP fusion protein that was PTX-insensitive (α2A/DAR-
Gαi2YFPC352I). We then examined the ability of GPR proteins to interact with the 
tethered Gαi2.  Interestingly, both AGS3 and AGS4 interacted with the tethered 
WT and PTX-insensitive Gαi2 as indicated by the robust basal levels of BRET 
(Figure 2.3B and E). Expression and functionality of α2A/DAR-Gαi2YFP and 
α2A/DAR-Gαi2YFPC352I were confirmed by immunoblotting (Figure 2.3C) and 
agonist-induced phosphorylation of ERK1/2 (Figure 2.3D).  α2A/DAR-
Gαi2YFP:AGS3-Rluc BRET and α2A/DAR-Gαi2YFP:AGS4-Rluc BRET were not 
observed with the GPR-insensitive GαiN149I mutant or with AGS3 or AGS4 that 
were rendered incapable of binding Gαi by mutation of a conserved glutamate 
residue in each of the GPR motifs, thus demonstrating the specificity of the 
interaction (Figure 2.5A, B, and C) (Oner et al 2010a, Oner et al 2010b, Peterson 
et al 2002, Sato et al 2004, Willard et al 2008). 
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Incubation of cells with the α2A/DAR agonist UK14304 reduced the 
α2A/DAR-Gαi2YFP:AGS3-Rluc BRET by ~40% (Figure 2.3D, left panel). 
Significant agonist-induced reductions in α2A/DAR-Gαi2YFP:AGS4-Rluc BRET 
were also observed, although not to the same magnitude as that observed for 
AGS3-Rluc (Figure 2.3D, right panel). Both the basal α2A/DAR-Gαi2YFP:AGS3-
Rluc BRET and the magnitude of the agonist-induced decrease in BRET 
observed for AGS3-Rluc or AGS4-Rluc with tethered Gαi2YFP were similar to 
that observed with untethered Gαi2YFP. Similar results were obtained for 
untethered Gαi2YFP and α2A/D-AR constructs.  Thus, these data indicate that a 
7TM agonist is regulating a GαGPR complex that is directly anchored to the 
receptor.  
A similar distinction between AGS3 and AGS4 with respect to the 
magnitude of agonist-induced changes in BRET was also observed with 
untethered Gαi1YFP (Oner et al 2010a, Oner et al 2010b). It is not clear if the 
differences in the magnitude of the agonist-induced changes in GαiYFP:AGS3-
Rluc versus GαiYFP:AGS4-Rluc BRET reflect different coupling efficiencies, 
stoichiometric considerations and/or the relative spatial positioning of the 
acceptor and donor for AGS3 versus AGS4.  To investigate if the amino terminal 
domains of AGS3 or AGS4 were responsible for this inconsistency with agonist 
response, we used AGS3-short (lacking all TPR domains and one GPR domain) 
and AGS4-short (proline-rich amino terminal deleted) tagged with Rluc in the 
context of the α2A/D-AR fusion protein BRET platform. Truncation of the amino 
terminal domains of AGS3 or AGS4 did not alter the agonist-induced reduction in 
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BRET signal for either construct as compared to the full-length counterparts 
(Figure 2.5C). These data suggest the difference in agonist regulation of these 
proteins does not involve the amino terminal domains, but rather there lies an 
intrinsic difference between the GPR domains and/or residues between these 
domains of AGS3 and AGS4 (Figure 2.5C). These differences may be 
reminiscent of results depicting that the 3rd GPR domain of AGS3 requiring 
flanking residues to attain proper GDI activity (Adhikari & Sprang 2003). In 
addition, the receptor-mediated regulation of GαiAGS3 and GαiAGS4 also differ 
in that agonist-mediated regulation of the GαiAGS3 complex results in 












































Figure 2.3. Agonist-induced regulation of an α2A/DAR-Gαi2 fusion protein 
complexed with the GPR proteins, AGS3 and AGS4 
(A) Schematic representing approach taken to determine the influence of 
endogenous, untagged Gαi on GPR-Rluc –  α2A/D-AR-Gαi2YFP BRET. Mutation 
of Cys352 to Ile (C352I) renders Gαi2YFP insensitive to pertussis toxin and was 
used to prevent flux by endogenous Gαi subunits, which may be released from 
endogenous Gαβγ heterotrimer coupling to the α2A/D-AR-Gαi2YFP fusion protein. 
Agonist bound to the receptor is denoted by an asterisk (*).  
(B) HEK293 cells expressing a fixed amount of AGS3-Rluc (left) or AGS4-Rluc 
(right) and increasing amounts (0, 100, 200, 500, 750, and 1000ng) of α2A/DAR-
Gαi2YFP (squares) or α2A/DAR-Gαi2YFPC352I (triangles) were processed for 
BRET measurements as described in “Experimental Procedures.”   
(C) Lysates (50 µg) from control HEK293 cells or HEK293 cells expressing Gαi2, 
Gαi2YFP, α2A/DAR-Gαi2YFP or α2A/DAR-Gαi2YFPC352I (750 ng each plasmid) 
were subjected to sodium dodecyl sulfide – polyacrylamide gel electrophoresis 
(SDS-PAGE), transferred to a PVDF membrane and immunoblotted with GFP 
antiserum.  
(D) Lysates (50 µg) from HEK293 cells expressing untethered α2A/DAR (500 ng) 
and Gαi2YFP or  Gαi2YFPC352I (750 ng each plasmid) or fusion proteins α2A/DAR-
Gαi2YFP or α2A/DAR-Gαi2YFPC352I (750 ng each plasmid). These lysates were 
subjected to SDS-PAGE, transferred to PVDF membranes and immunoblotted 
with total ERK1/2 and phospho-ERK1/2 (Y402) antibodies as indicated. 
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(E) HEK293 cells expressing AGS3-Rluc (left panel) or AGS4-Rluc (right panel) 
and α2A/DAR-Gαi2YFP or α2A/DAR-Gαi2YFPC352I were incubated in the absence or 
presence of pertussis toxin (100 ng/mL) for 18 hours as described in 
“Experimental Procedures.” Cells were then washed and incubated with vehicle 
(Tyrode’s solution) or α2A/DAR agonist UK14304 (10 µM) for five minutes followed 
by fluorescence and luminescence readings to obtain net BRET signals as 
described in “Experimental Procedures.” (D, Left panel) AGS3-Rluc relative 
luminescence units (RLU): AGS3-Rluc + α2A/DAR-Gαi2YFP – 335,234 ± 9,929; 
AGS3-Rluc + α2A/DAR-Gαi2YFP + PTX – 327,626 ± 15,110; AGS3-Rluc + 
α2A/DAR-Gαi2YFPC352I – 385,996 ± 22,073; AGS3-Rluc + α2A/DAR-Gαi2YFPC352I + 
PTX – 373,388 ± 17,790.  Relative fluorescence units (RFU):  α2A/DAR-Gαi2YFP 
– 111,523 ± 3,246; α2A/DAR-Gαi2YFP + PTX – 112,991 ± 2,545; α2A/DAR-
Gαi2YFPC352I – 110,420 ±  2,416; α2A/DAR-Gαi2YFPC352I + PTX – 112,565 ± 
3,072. (B, right panel) AGS4-Rluc RLU: AGS4-Rluc + α2A/DAR-Gαi2YFP – 87,143 
± 6,516; AGS4-Rluc + α2A/DAR-Gαi2YFP + PTX – 71,193 ± 5,723; AGS4-Rluc + 
α2A/DAR-Gαi2YFPC352I – 148,939 ± 7,362; AGS4-Rluc + α2A/DAR-Gαi2YFPC352I + 
PTX – 133,482 ± 11,038.  RFU:  α2A/DAR-Gαi2YFP – 106,882 ± 5,325; α2A/DAR-
Gαi2YFP + PTX – 109,976 ± 5,497; α2A/DAR-Gαi2YFPC352I – 142,380 ±  2,980; 
α2A/DAR-Gαi2YFPC352I + PTX – 166,057 ± 8,005.   
All BRET data are expressed as means ± S.E. from at least 3 independent 
experiments with triplicate determinations (N=9) and immunoblots are 
representative of three independent experiments. *, p < 0.05 compared with 
vehicle treated control group based on Tukey’s post hoc test following ANOVA. 
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Direct 7TMR regulation of the Gαi2 – GPR module occur independent of 
endogenous G-protein cycling  
Regulation of the α2A/DAR-Gαi2YFP:GPR-Rluc complex by agonist may 
reflect the ability of the Gαi2GPR cassette to directly sense agonist-induced 
conformational changes in the receptor (Figure 2.3A) as is the case for 7TM 
receptor coupling to Gαβγ heterotrimer.  Alternatively, the agonist-induced 
reduction of α2A/DAR-Gαi2YFP:GPR-Rluc BRET may reflect displacement of 
AGS3- or AGS4-Rluc from the 7TM receptor-Gαi2YFP fusion protein by Gβγ or 
Gα subsequent to receptor coupling to either endogenous Gαβγ heterotrimer 
(Burt et al 1998) or the α2A/DAR-Gαi2YFP fusion protein where endogenous Gβγ 
is bound to the tethered Gαi2YFP.   
To address these questions, we conducted two sets of experiments.  First, 
we studied the effect of agonist on α2A/DAR-Gαi2YFP:GPR-Rluc BRET after 
rendering the tethered Gα subunit PTX insensitive by mutation of the cysteine 
that is actually ADP ribosylated by pertussis toxin (Figure 2.3A). Such an 
approach would allow us to eliminate receptor coupling to endogenous Gαβγ, but 
retain the coupling integrity of the α2A/DAR-Gαi2YFPC352I fusion protein (Bahia et 
al 1998). Thus, we have an experimental platform that provides a highly localized 
readout of receptor-mediated regulation of Gαi2GPR.   
The agonist-induced regulation of α2A/DAR-Gαi2YFP:AGS3-Rluc or 
α2A/DAR-Gαi2YFP:AGS4-Rluc BRET observed with untethered or tethered Gα 
was completely blocked by incubation of cells with PTX (Figure 2.3D).   However, 
the agonist-induced regulation of untethered or tethered GαiC352I was not altered 
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by PTX pretreatment, which blocked receptor coupling to endogenous Gαi/oβγ 
(Figure 2.3D).  These data indicate that the agonist-induced regulation of 
α2A/DAR-GαiYFP:AGS3-Rluc or α2A/DAR-GαiYFP:AGS4-Rluc BRET is spatially 
localized and not likely due to exchange of endogenous Gαi/o for GαYFP bound 
to the GPR protein or to the displacement of GαYFP bound to the GPR protein 
by Gβγ subsequent to receptor-mediated coupling to Gαβγ heterotrimer.   
In addition to interacting with the GPR proteins AGS3 and AGS4, the 
α2A/DAR-Gαi2YFP fusion protein may also interact with endogenous Gβγ.  
Agonist induced activation of the α2A/DAR-Gαi2YFP:Gβγ complex may “release” 
Gβγ, which could potentially displace AGS3 or AGS4 from the α2A/DAR-Gαi2YFP 
fusion protein reducing α2A/DAR-Gαi2YFP:GPR-Rluc BRET. To address this 
issue, we used the carboxyl terminus of G-protein coupled receptor kinase 2 
(GRK2-CT) to scavenge any Gβγ that may be “released” by agonist-induced 
activation of α2A/DAR-Gαi2YFP:Gβγ (Figure 2.4A). GRK-CT expression was 
confirmed by immunoblotting (Figure 2.4B and C lower panels).  Expression of 
GRK2-CT did not alter the agonist induced regulation of the BRET observed with 
AGS3-Rluc or AGS4-Rluc and the untethered2 or tethered Gαi2YFP (Figure 2.4B 
and C upper panels). Under similar experimental conditions with untethered 
Gαi2YFP, expression of Gβγ reduces basal Gαi2YFP:GPR-Rluc BRET (Oner et 
al 2010a, Oner et al 2010b)  and this effect of Gβγ was reversed by GRK2-CT 
providing an internal control that indicates effective Gβγ scavenging (Figure 2.4B 
and C lower panels). The lack of effect of GRK2-CT on agonist-induced 
regulation of the interaction of GPR proteins with the tethered GαiYFP is 
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consistent with previous observations using untethered GαiYFP (Oner et al 
2010a).   Furthermore, the Gβγ inhibitor gallein also did not alter the basal or 
agonist-regulated BRET between AGS3-Rluc or AGS4-Rluc and either Gαi2YFP 
or the α2A/DAR–Gαi2YFP fusion protein (Figure 2.4 D).   These data suggest that 
the agonist-induced regulation of the interaction of Gαi with GPR proteins does 
not involve subunit flux subsequent to receptor coupling to Gαβγ. 
The ability for AGS3 and AGS4 to bind multiple Gαi subunits 
simultaneously suggests the intriguing possibility for these proteins to assist in 
scaffolding of larger signaling complexes to further increase the efficiency of 
signal transduction (Blumer & Lanier 2014). To determine if multiple Gαi subunits 
tethered to the α2A/DAR were effectively bound by AGS3 and AGS4 we again 
utilized our BRET fusion protein platform. Using subsequent Q/A mutations in the 
GPR domains of AGS3 and AGS4 rendering the motifs unable to bind Gαi 
subunits, the level of basal BRET was reduced stepwise with each additional 
GPR mutation (Figure 2.5A and B). Furthermore, agonist induced reduction of 
the BRET signal was maintained even in the presence of a single functioning 
GPR motif (Figure 2.5A & B). These data suggest that all GPR motifs of AGS3 
and AGS4 are able to functionally bind tethered Gαi subunits and contribute to 
the overall BRET signal.  

































Figure 2.4. Influence of a Gβγ scavenger on the agonist-induced regulation 
of GαiGPR where Gαi is tethered to the receptor 
(A) Schematic representing approach taken to determine the effect of 
endogenous Gβγ subunits, which may engage the α2A/D-AR-Gαi2YFP fusion 
protein resulting in altered BRET signals. GRK2-CT was expressed as a “sink” 
for free Gβγ released subsequent to receptor activation. Agonist bound to the 
receptor is denoted by an asterisk (*).  
(B) Net BRET values obtained from HEK293 cells expressing AGS3-Rluc (left 
panel) or AGS4-Rluc (right panel) and α2A/DAR-Gαi2YFP as described in 
“Experimental Procedures.”  Where indicated, cells also expressed GRK2-CT.   
Cells were incubated with vehicle (Tyrode’s solution) or UK14304 (10 µM) for 5 
minutes.  For experiments involving PTX, cells were incubated with PTX (100 
ng/mL) for 18 hours prior to agonist exposure. (B, left panel): RLU:   AGS3-Rluc 
– 195,791 ± 15,175; AGS3-Rluc + PTX – 178,887 ± 24,596; AGS3-Rluc + GRK2-
CT – 218,392 ± 12,663; AGS3-Rluc + GRK2-CT + PTX – 220,238 ± 19,824. 
RFU: α2A/DAR-Gαi2YFP – 110,414 ± 2,294; α2A/DAR-Gαi2YFP + PTX – 104,532 ± 
2,263; α2A/DAR-Gαi2YFP + GRK2-CT -106,967 ± 2,562; α2A/DAR-Gαi2YFP + 
GRK2-CT + PTX – 116,045 ± 3,266.  (B, right panel) RLU: AGS4-Rluc – 147,140 
± 7,740; AGS4-Rluc + PTX – 150,290 ± 8,165; AGS4-Rluc + GRK2-CT – 
155,576 ± 8,972; AGS4-Rluc + GRK2-CT + PTX – 147,944 ± 10,565. RFU: 
α2A/DAR-Gαi2YFP – 109,090 ± 2,942; α2A/DAR-Gαi2YFP + PTX – 112,983 ± 
3,019; α2A/DAR-Gαi2YFP + GRK2-CT – 124,288 ± 2,273; α2A/DAR-Gαi2YFP + 
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GRK2-CT + PTX – 112,371 ± 2,189. *, p < 0.05 compared with vehicle treated 
control group.   
(C) Lysates (50 µg) from a representative experiment as described in B were 
subjected to SDS-PAGE and immunoblotting with GRK2 and β-actin antisera as 
indicated (far left panel).  HEK293 cells expressing AGS3-Rluc (10 ng plasmid) 
and α2A/DAR-Gαi2YFP (250 ng plasmid) in the absence and presence of Gβ1, Gγ2 
and/or GRK2-CT (500 ng each plasmid) as indicated were subjected to BRET 
measurements as described in “Experimental Procedures” (left panel). Lysates 
(50 µg) from a representative experiment as described in the upper panel of B 
were subjected to SDS-PAGE and immunoblotting with GRK2 and β-actin 
antisera as indicated (right panel). HEK293 cells expressing AGS4-Rluc (2 ng 
plasmid) and α2A/DAR-Gαi2YFP (250 ng plasmid) in the absence and  presence 
of Gβ1, Gγ2 and/or GRK2-CT (500 ng each plasmid) as indicated for 48h were 
subjected to BRET measurements as described in “Experimental Procedures” 
(far right panel).  
 (D) Net BRET signals were obtained from HEK cells transfected with AGS3-Rluc 
(10 ng plasmid) and α2A-AR-Gαi2YFP (750 ng plasmid). BRET signals were 
measured as described in “Experimental Procedures.” Cells were also 
transfected with GRK2-CT (500 ng plasmid) as indicated or incubated with a 
pharmacological Gβγ inhibitor, gallein (10µM), for 30 minutes prior to receptor 
stimulation, followed by two subsequent washes with Tyrode’s solution to remove 
any remaining fluorescent gallein from the solution. Vehicle (Tyrode’s solution) or 
α2A-AR agonist UK14304 (10 µM) were added to cells as indicated followed by 
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fluorescence and luminescence readings as described in “Experimental 
Procedures.”  
All BRET data are expressed as means ± S.E. from at least 3 independent 
experiments with triplicate determinations (N=9) and immunoblots are a 
representative image of three independent experiments. *, p < 0.001 compared 
with control group. †, p < 0.001 compared with Gβ1γ2-expressing group based on 











































Figure 2.5. Single mutations in the GPR motifs progressively reduce 
association of GPR proteins with Gαi, while the amino terminus of AGS3 
and AGS4 does not effect this regulation  
(A) Schematic representing the phRLucN3::AGS3 constructs used in the following 
experiment that contain Q/A point mutations in each subsequent or a 
combination of the four GPR motifs (AGS3-Q/A) inhibiting the binding of Gαi to 
the mutated domains (left panel). Net BRET measurements from HEKs 
transfected with 750 ng pcDNA3:: α2A-AR-Gαi1YFP and 10 ng phRLucN3::AGS3 
or 10 ng of phRLucN3::AGS3 constructs containing Q/A point mutations in each 
subsequent or a combination of the four GPR motifs (AGS3-Q/A). BRET signals 
were measured as described in “Experimental Procedures.” Vehicle (Tyrode’s 
solution) or α2A-AR agonist UK14304 (10 µM) were added to cells as indicated 
followed by fluorescence and luminescence readings as described in 
“Experimental Procedures” (right panel).  
(B) Schematic representing the phRLucN3::AGS4 constructs used in the following 
experiment that contain Q/A point mutations in each subsequent or a 
combination of the three GPR motifs (AGS4-Q/A) inhibiting the binding of Gαi to 
the mutated domains (left panel). Net BRET measurements from HEKs 
transfected with 750 ng pcDNA3:: α2A-AR-Gαi1YFP and 2 ng phRLucN3::AGS4 or 
2 ng of phRLucN3::AGS4 constructs containing Q/A point mutations in each 
subsequent or a combination of the three GPR motifs (AGS4-Q/A). BRET signals 
were measured as described in “Experimental Procedures.” Vehicle (Tyrode’s 
solution) or α2A-AR agonist UK14304 (10 µM) were added to cells as indicated 
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followed by fluorescence and luminescence readings as described in 
“Experimental Procedures” (right panel). 
(C) Net BRET measurements from HEKs transfected with untethered Gαi1YFP 
or Gαi1YFPN149I (750 ng each plasmid) and α2A-AR (500 ng) or fusion proteins 
α2A-AR-Gαi1YFP or α2A-AR-Gαi1YFPN149I (750 ng each plasmid) in the presence 
of AGS3-Rluc (10 ng, left panel) or AGS4-Rluc (2 ng, right panel). BRET signals 
were measured as described in “Experimental Procedures.” Vehicle (Tyrode’s 
solution) or α2A-AR agonist UK14304 (10 µM) were added to cells as indicated 
followed by fluorescence and luminescence readings as described in 
“Experimental Procedures.”  
(D) Net BRET measurements from HEKs transfected with 750 ng pcDNA3:: α2A-
AR-Gαi2YFP and 10 ng phRLucN3::AGS3, 2 ng phRLucN3::AGS3-short (AGS3-
sh) (left panel), 2ng phRLucN3::AGS4 or 2 ng phRLucN3::AGS4-short (AGS4-sh) 
(right panel). BRET signals were measured as described in “Experimental 
Procedures.” Vehicle (Tyrode’s solution) or α2A-AR agonist UK14304 (10 µM) 
were added to cells as indicated followed by fluorescence and luminescence 
readings as described in “Experimental Procedures” Cells were treated with 
pertussis toxin (PTX, 100 ng/mL) 18 hours  prior to receptor stimulation where 
indicated. 
All data are expressed as means ± SEM from at least 3 independent experiments 
with triplicate determinations (N=9). Notations of * signify p-values <0.001 
compared to vehicle stimulated controls, and # signifies p-value <0.01 compared 
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to vehicle treated wild-type AGS constructs, respectively, based on Tukey’s post 























Our data suggest that a 7TM receptor couples directly to a GαiGPR 
complex, ostensibly promoting exchange of GDP for GTP in a manner that may 
be similar to 7TM receptor engagement of Gαβγ heterotrimer. Agonist-mediated 
activation of a 7TM receptor coupled to GαiGPR apparently results in reversible 
dissociation of the GPR protein from Gαi (Oner et al 2010a, Oner et al 2010b).  
Upon termination of agonist-induced activation, the GPR protein then re-
associates with GαiGDP, representing a cycle that is conceptually analogous to 
the Gαβγ activation – deactivation cycle (Oner et al 2010a, Oner et al 2013a, 
Oner et al 2010b, Oner et al 2013c). There are several interesting conceptual 
thoughts that emanate from this work.  As the regulation of both the GαiGPR 
complex and the Gαiβγ heterotrimer is PTX sensitive (Figures 2.1, 2.2, 2.3) 
(Oner et al 2010a, Oner et al 2010b), this raises the intriguing possibility that 
functional effects associated with PTX may be mediated in part by 7TM 
regulation of Gαi-GPR complexes. Secondly, as Group II AGS proteins may 
complex with multiple Gα subunits simultaneously (Figure 2.5) (Adhikari & 
Sprang 2003, Bernard et al 2001, Jia et al 2012, Kimple et al 2004), AGS3 and 
AGS4 may scaffold receptors and Gα subunits within a larger signaling complex 
(Blumer & Lanier 2014, Jahangeer & Rodbell 1993). Finally, of particular interest, 
the coupling of a receptor to the GαGPR complex or the Gαβγ heterotrimer may 
represent differentially regulated pathways preferred by particular hormones, 





Identification of novel interacting proteins for AGS4 
 AGS4 was selected to define potential interacting partners due to the lack 
of distinct protein interaction domains preceding the three GPR motifs as are 
present in other Group II AGS proteins (Cao et al 2004, Takesono et al 1999). To 
address the hypothesis that AGS4 binding partners regulate its subcellular 
location or function, cells stably expressing an amino-terminal tandem affinity 
purification (NTAP) tag linked to AGS4 (NTAP AGS4) were generated and 
demonstrated effective pulldown of known binding partners of AGS4, Gαi1/2 and 
Gαi3, thus validating my approach (Figure 2.6A & B). Three bands that 
specifically bound to NTAP-AGS4 were observed subsequent to resolving the 
eluate by gel electrophoresis and staining with Coomassie blue (Figure 2.6C). 
Trypsin digestion and mass spectrometry analysis of these bands demonstrated 
the presence of three protein classes including eukaryotic elongation factor 1d 
(eEF1d), AT-rich interacting domain 1b (ARID1b), and 14-3-3 isoforms (Figure 
2.6C).  Subsequent to my obtaining these results, a report implicated AGS4 
binding to 14-3-3 isoforms that affected the subcellular localization of AGS4 
(Giguere et al 2012b). Additionally, previous yeast-two hybrid screens using 
AGS4 as bait  identified two proteins, eEF2 and ARID2 (mKIAA1557) (Cao 
2005). Interestingly, these two proteins are closely related to eEF1d and ARID1b, 
respectively, which were identified in my NTAP-AGS4/mass spectrometry 
approach (Figure 2.6). Using GST tagged eEF2 and GST tagged ARID2, AGS4 
was precipitated validating the association of AGS4 with these two binding 
partners (Cao 2005). An interesting study demonstrated that eEF2 kinase, one of 
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the kinase that phosphorylates eEF2 protein, binds directly and is activated by a 
GPCR (Park et al 2008b). Phosphorylation of eEF2 results in inhibition of protein 
synthesis, and it is interesting to speculate that this may be a form of regulation 
of protein synthesis by GPCRs. Although the site of interaction between AGS4 
and eEF2 does not  contain the residue that is phosphorylated by eEF2K or the 
nucleotide binding domain, the interaction site does coincide with the site on 
eEF2 known to be ADP-ribosylated and inactivated by diphtheria toxin (Cao 
2005, Van Ness et al 1980). Therefore, AGS4 may act as an inhibitory molecule 
to eEF2 protein and result in decreased protein synthesis. The binding of ARID 
family members with AGS4 was quite unexpected. The ARID proteins identified 
are rather large proteins involved in the SWI/SNF chromatin remodeling complex 
of cells (Mohrmann et al 2004, Wang et al 2004). One possibility is that AGS4 
binds ARID proteins in a manner to exclude them from the nucleus, resulting in 
altered transcription within the cell. These potential regulatory roles of AGS4 in 
protein synthesis and gene transcription were unanticipated, but require further 










































Figure 2.6. Identification of AGS4 interacting proteins by tandem affinity 
purification (TAP) 
(A) Depicted is a representative immunoblot of lysates (50 µg) from HEK cells 
stably expressing pglue NTAP::AGS4 or transiently transfected with 1.5 µg 
pcDNA3::AGS4 using AGS4-specific antisera as described in “Experimental 
Procedures.” 
(B) Depicted is a representative immunoblot of lysates from NTAP-AGS4 stably 
expressing HEK cells processed through the tandem affinity purification (TAP) 
system. Samples are loaded fractionally (Input 1/200th, Wash 1/40th, Eluate 
1/40th, Pose-Elution 1/20th) and control HEK cells transfected with 750 ng 
pcDNA3::Gαi2 or 750 ng pcDNA3::Gαi3 are loaded are loaded at 50 µg per lane. 
Immunobloting was conducted as described in “Experimental Procedures” with 
AGS4-specific antisera, Gαi1/2 antisera, and Gαi3 antisera.  
(C) TAP eluates were subjected to polyacrylamide gel electrophoresis followed 
by coomassie blue staining as described in “Experimental Procedures.” Bands 
were excised & sent to the MUSC mass spectrometry facility for protein 
identification. Illustrated is a tabular representation of the mass spectrometry 
results for each band. 





Decreased Gαi interaction with AGS4 upon phosphorylation of single tyrosine by 
JAK2 and Src kinases 
 Phosphorylation is another form of regulation seen in proteins containing 
GPR motifs (Blumer et al 2003, Groves et al 2010, Hollinger et al 2003, Johnston 
et al 2009). The importance of post-translational modification of the linker region 
between TPR and GPR motifs of Pins (ortholog of LGN and AGS3 in mammals) 
was illustrated through phosphorylation by Aurora kinase-A , which was required 
to assemble the Discs large (Dlg) / Khc-73 polarity complex to properly orient the 
mitotic spindle in Drosophila cells (Johnston et al 2009). Additionally, the 
phospho-mutant of AGS3 with all GPR serine and threonine amino acids mutated 
to alanine showed defective ability of these proteins to induce macroautophagy 
(Groves et al 2010). Previous studies also demonstrated phosphorylation of the 
GPR motif in AGS3 inhibits GDI activity, while phosphorylation just upstream of 
the RGS14 GPR motif demonstrated increased GDI activity as measured by 
decreased GTPγS binding of Gαi subunits (Blumer et al 2003, Hollinger et al 
2003). Indeed, AGS4 is a known phospho-protein, with multiple residues 
demonstrated to be phosphorylated (Giguere et al 2012b, Rush et al 2005, van 
Bodegom et al 2012, Zarling et al 2000, Zhong et al 2012). As an initial platform 
to determine the functional consequence of AGS4 phosphorylation, we 
generated Rluc tagged AGS4 constructs with serine and tyrosine residues known 
to be phosphorylated and mutated them to aspartic acid to mimic 
phosphorylation.  Using our BRET system,  mutation of tyrosine 108 to aspartic 
acid (Y108) resulted in a dramatic decrease in G-protein binding compared to 
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wild-type AGS4  (Figure 2.7B). Interestingly, AGS4-Y108 is phosphorylated in 
response to thymic stromal lymphopoietic protein (TSLP), and this residue is a 
consensus phosphorylation site for tyrosine kinases Janus kinase 2 (JAK2) and 
Src, which are activated by TSLP (van Bodegom et al 2012, Zhong et al 2012).  
In addition, Janus kinase 2 (JAK2) and Src kinase are reported to be activated 
either by GαiGTP or directly by some GPCRs (Corre et al 1999, Ma et al 2000, 
Marrero et al 1995, Vila-Coro et al 1999). As an initial approach to determine the 
phosphorylation of AGS4 by JAK2 and Src, we used an in vitro kinase assay with 
purified, recombinant active JAK2 or Src and GST-AGS4, GST-AGS4-Y108F, or 
GST as substrates. Interestingly, both JAK2 and Src were observed to 
phosphorylate wildtype AGS4 but not AGS4-Y108F (Figure 2.7A). Taken 
together, these data suggest that the activation of JAK2 and Src results in 
phosphorylation of AGS4-Y108 resulting in a decrease of the Gαi – GPR 
interaction. The regulatory function mediated by JAK2 and Src could signify a 
positive feedback loop of the kinases in response to activation by Gαi and or 
GPCRs counteracting the GDI activity of AGS4 and possibly other GPR proteins 
(Corre et al 1999, Ma et al 2000, Marrero et al 1995, Vila-Coro et al 1999). 
Positive regulation of kinase activity may result in prolonged activation of JAK2 
and Src causing enhanced activation of downstream targets for the kinases 
including signal transducer and activator of transcription 1 and 3 (STAT1 & 
STAT3), thereby promoting gene transcription and cellular growth (Cao et al 
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Figure 2.7. AGS4 is phosphorylated on Tyr108 by JAK2 and Src in vitro, 
which profoundly inhibits the AGS4 – Gαi interaction  
(A) (Left panel) In vitro kinase assay with purified active JAK2 (Leu808-Gly1132) 
and Src kinases and recombinant purified GST-AGS4 and GST-AGS4-Y108F for 
30min at 25C.  Legend: 1) JAK2 only; 2) JAK2 + STAT5a positive control; 3) 
GST-AGS4 only (no kinase control); 4) GST-AGS4 + JAK2; 5) GST-AGS4-
Y108F only (no kinase); 6) GST-AGS4-Y108F + JAK2; 7) GST-AGS4 + Src; 8) 
GST-AGS4-Y108F + Src; 9) His-SPF45 + Src no ATP control; 10) His-SPF45 + 
Src positive control.  (Right panel) Ponceau S staining of the same nitrocellulose 
membrane used for the autoradiograph from the left panel. In vitro kinase assay 
performed with Dr. Scott Eblen 
(B) HEK293 cells were transfected with 2ng AGS4-Rluc-WT, -S56D, -Y85D or –
Y108D + 500ng Gαi2-YFP.  Forty-eight hours after transfection, BRET 
measurements were taken as described in Experimental Procedures.  Whereas 
Asp-mutations of S56 or Y85 had no effect, the placement of a negatively 
charged residue mimicking phosphorylation on Y108 reduced the AGS4 – Gαi 












BRET screening platform for small molecule modulators of the Gαi–GPR 
interaction 
The Gαi – GPR interaction appears to be a dynamic and regulated event 
in signaling pathways of immune cells where perturbation of this complex results 
in immunological pathologies; furthermore, deficiency in AGS4 recently 
demonstrated an immunoprotective phenotype inhibiting the progression of 
arthritis in mice (Branham-O'Connor et al 2014, Cao et al 2004, Giguere et al 
2013, Kamakura et al 2013, Zhao et al 2010). Therefore, using our AGS4-Rluc – 
Gαi1-YFP BRET system as a platform, we screened the 50,080 ChemBridge 
DIVERSet compound library for potential modulators of the Gαi – AGS4 
interaction. Initial results from wells containing pools of ten compounds identified 
compounds in eight wells with the highest inhibitory properties (Figure2.8A). 
These 80 compounds were then individually assessed for inhibition of Gαi 
interaction with AGS3 and AGS4 by BRET to demonstrate specificity of these 
compounds for the Gαi – GPR module. From this pool, seven molecules were 
found to retain inhibitory action against the Gαi interaction with either AGS3 or 
AGS4 (Figure 2.8B). The subsequent development of these compounds will be 
an asset to the field in the investigation of the Gαi – GPR interaction in other 
members of the Group II AGS proteins either as a reagent or possibly  in the 
development of therapeutics for pathologies linked to GPR proteins,  e.g. drug 
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addiction and craving, ischemia reperfusion injury, polycystic kidney disease, 
blood pressure control, energy expenditure and metabolism, and rheumatoid 
arthritis and inflammatory pathways (Blumer et al 2008, Bowers et al 2004, 
Branham-O'Connor et al 2014, Conley & Watts 2013, Giguere et al 2013, Kwon 















































Figure 2.8. Identification of Gαi – GPR small molecule inhibitors 
(A) Net BRET measurements from HEK cells stably expressing 
pcDNA3::Gαi1YFP transfected with 2 ng phRLucN3::AGS4. Cells were treated 
with 50,080 compounds (distributed along the x-axis) in 10 compound pools at 
1µM for 1hr at 37°C, 5% CO2 prior to fluorescence and luminescence readings as 
described in “Experimental Procedures.” Data are represented as the Gαi – 
AGS4 net BRET from drug-treated cells minus the net BRET measurement for 
vehicle only (DMSO) control (mean net BRET value 0.81 + 0.25). Data are 
expressed as means ± SEM with triplicate determinations. 
(B) Net BRET measurements from HEK cells transfected with 750 ng 
pcDNA3::Gαi1YFP and 10 ng phRLucN3::AGS3 (left panel) or 2 ng 
phRLucN3::AGS4 (right panel). Cells were treated with 80 compounds (identified 
in from the initial screening in pooled formulation to have the most pronounced 
inhibition) at 10 µM for 1hr at 37°C, 5% CO2 prior to fluorescence and 
luminescence readings as described in “Experimental Procedures.” Data are 
expressed as means ± SEM with triplicate determinations and are represented in 
percent inhibition compared to DMSO control; red dotted line depicts 15% 
inhibition of BRET signal.  
(C) Chemical names and structures of the compounds identified from the 
ChemBridge DIVERSet library to have the largest inhibition of the Gαi – GPR 
interaction (left) or inhibitory action on Gαi – AGS3 or Gαi – AGS4 interactions 




Defective Chemokine Signal Processing in Leukocytes Lacking Activator of 

















*Note: This chapter contains a portion of the paper: 
J Biol Chem. 2014 Apr 11; volume 289, issue 15, pages 10738-47. 
Defective Chemokine Signal Integration in Leukocytes Lacking Activator of 
G Protein Signaling 3 (AGS3). 
Branham-O’Connor M, Robichaux III WG, Zhang XK, Cho H, Kehrl JH, 




Integration of signals emanating from chemokine receptors represents one 
of the most commonly used mechanisms for leukocyte distribution and 
recruitment to lymphoid organs and the periphery.  Such signal integration 
involves not only the regulated expression of individual chemokine receptors and 
the stoichiometries of the core signaling triad of receptor, heterotrimeric G-protein 
and effectors but also cell-type-specific accessory proteins which modulate 
signals across this core signaling system.  Such accessory proteins bestow upon 
leukocytes and other cells the ability to tightly control signaling pathways to 
maximize signal efficiency, strength, and duration while at the same time 
providing flexibility to quickly adapt to changes in environmental stimuli (Cho & 
Kehrl 2009, Sato et al 2006a).  
Perturbations of heterotrimeric G-protein signal input or duration result in 
defective leukocyte development, trafficking, motility and overall chemokine 
responsiveness (Cho et al 2012, Han et al 2005, Hwang et al 2007, Pero et al 
2007, Rudolph et al 1995, Skokowa et al 2005, Zarbock et al 2007).  In addition, 
accessory proteins at the GPCR – G-protein interface also play key roles in 
regulating leukocyte function by modulating G-protein activity and 
responsiveness to chemokines.  Many regulators of G-protein signaling (RGS) 
proteins are expressed in leukocytes (Cho & Kehrl 2009, Moratz et al 2004a) and 
play important functions in regulating chemokine responsiveness. For example, 
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RGS1 plays an important role in modulating lymphocyte motility and trafficking 
(Han et al 2005). RGS1-/- lymphocytes move more rapidly in response to 
chemokines, suggesting that modulating the duration of Gαi activation in 
response to chemokines plays an important role in leukocyte activation and 
trafficking (Han et al 2005).  Additional mechanisms for modulation of Gαi activity 
are also likely important for spatio-temporal regulation of leukocyte 
responsiveness and for integration of signals from multiple chemokines at any 
given time. 
Another group of accessory proteins, the Activators of G-protein Signaling 
(AGS) proteins, were identified in a yeast-based functional screen for receptor-
independent activators of heterotrimeric G-proteins (Cismowski et al 1999, 
Takesono et al 1999) and can be broadly categorized into three groups based on 
their input into the G-protein activation/deactivation cycle (Blumer et al 2007).  
Group II AGS proteins are characterized by the presence of up to four G-protein 
regulatory (GPR) motifs (also referred to as LGN or GoLoco motifs (Ponting 
1999, Siderovski et al 1999)) which  bind free Gαi/o/t subunits in the GDP-bound 
conformation and act as guanine nucleotide dissociation inhibitors (GDI) (Blumer 
et al 2012, McCudden et al 2005a).   GPR motif proteins thus provide a novel 
mode of signal input to heterotrimeric G-proteins that may operate distinct from 
the super-family of G-protein coupled receptors (GPCR) and may also function 
as binding partners for Gαi subunits independent of heterotrimer formation.  
These thoughts have broad implications for signal processing and provide a 
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mechanism for unexpected functions of G-proteins as signal transducers within 
the cell. 
A member of the Group II AGS proteins, AGS3 (gene name – G-protein 
signaling modulator-1 (Gpsm1)) contains seven tetratricopeptide repeats (TPR) 
which are involved in protein-protein interactions and four G-protein regulatory 
(GPR)/GoLoco motifs, allowing AGS3 to simultaneously bind up to four GαiGDP 
subunits free of Gβγ. Previous data suggest functional roles for AGS3 in such 
diverse processes as neuronal plasticity and addiction, autophagy, membrane 
protein trafficking, polycystic kidney disease, cardiovascular regulation and 
metabolism (Blumer et al 2008, Bowers et al 2008, Bowers et al 2004, Fan et al 
2009, Groves et al 2007, Kwon et al 2012, Nadella et al 2010, Pattingre et al 
2003, Regner et al 2011, Vural et al 2010, Yao et al 2005).  As part of an 
expanded approach to more fully understand the in vivo role of AGS3 in G-
protein signal processing, we previously reported the generation of a conditional 
AGS3 null mouse strain (Gpsm1-/-), which is a valuable model to dissect 
physiological functions of AGS3 (Blumer et al 2008, Kwon et al 2012, Regner et 
al 2011). 
A second, less investigated, member of the Group II AGS proteins is 
AGS4 (gene name – G protein signaling modulator-3 (Gpsm3)).  Unlike AGS3, 
AGS4 does not possess well-defined protein interaction domains and contains 
three GPR motifs for binding GαiGDP free of Gβγ (Cao et al 2004). Although 
lacking defined protein interaction domains, the amino terminus of AGS4 is 
reported to confer GEF activity on Gαi/o (Zhao et al 2010), while another study 
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suggested that this segment could bind Gβ subunits (Giguere et al 2012c); this is 
in contrast to earlier biochemical analysis illustrating that AGS4 competes for Gαi 
binding with Gβγ (Cao et al 2004, Giguere et al 2012c, Oner et al 2010b, Zhao et 
al 2010). Although not extensively investigated, one fundamental characteristic of 
AGS4 is a restricted expression profile to immunological tissues (Cao et al 2004, 
Giguere et al 2013, Giguere et al 2014, Zhao et al 2010). Loss of AGS4 inhibited 
progression of arthritis induction (Giguere et al 2013). Additionally, cytokine 
signaling through thymic stromal lymphopoietic protein (TSLP) was found to 
phosphorylate AGS4, suggesting a possible regulatory mechanism for AGS4 in 
this immunological signaling cascade (van Bodegom et al 2012, Zhong et al 
2012). Moreover, AGS4 mRNA expression is observed to be similar or even 
more pronounced in additional immunological cell lineages including dendritic 
cells, T leukocytes, and neutrophils (www.immgen.org and www.biogps.org) and 
was demonstrated to be decreased after anti-inflammatory treatment (Schmidt et 
al 2012). In this study, we used an AGS4 null (Gpsm3-/-) mouse model as an 
initial approach to understand the functional role of AGS4 in chemokine-induced 
signal processing in leukocytes. 
Our goal in this study was to define the functional roles of AGS3 and 
AGS4 in leukocytes, beginning with their roles in chemokine receptor signal 
processing.  Our data suggest that AGS3 and AGS4 play key roles in the 
integration of signals from the receptor to the chemotactic machinery, including 
ERK1/2 phosphorylation and leukocyte motility.  Neutrophils, which demonstrate 
the highest level of AGS4 expression, require AGS4 for maximal response to 
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chemoattractants, and an in vivo model of inflammation demonstrated the 
importance of AGS4 in migration of neutrophils to sites of acute inflammation. 
These data indicate key roles for GPR proteins AGS3 and AGS4 in the 
integration of chemokine receptor signaling and expand the functional repertoire 























Materials and reagents: 
Pertussis toxin, β-actin antibody (A5441), lipopolysaccharides (LPS) from E. coli 
0111:B4 (L4391), N-Formyl-Met-Leu-Phe (fMLP) (F3506), AMD3100 (A5602), 
and Thioglycollate Broth (USP Alternative, 70157) were purchased from Sigma-
Aldrich (St. Louis, MO). Recombinant mouse GM-CSF, CXCL12 and CCL19 
were obtained from BioAbChem Inc. (Ladson, SC). AGS3-antisera generated by 
immunization of rabbits with a GST-AGS3 fusion protein encoding the GPR 
domain (Ala461–Ser650) of AGS3 was kindly provided by Dr. Dzwokai Ma 
(University of California, Santa Barbara, CA, described in (Groves et al 2010)). 
AGS4 antibody (AP5725c), anti-phospho-ERK (Tyr402), and total ERK were 
purchased from Abgent (San Diego, CA), Santa Cruz Biotechnology (Dallas, TX) 
and Abcam (Cambridge, MA), respectively. Protease inhibitor cocktail tablets 
(Complete Mini) were obtained from Roche Applied Science. ACK Lysing Buffer 
(0.15 M NH4Cl/ 0.01M KHCO3/10 µM EDTA, 10-548E) was obtained from Lonza 
(Basel, Switzerland) and Percoll™ (17-089-02) from GE Healthcare Life 
Sciences (Pittsburgh, PA). Dynabeads® Untouched™ Mouse T Cells kit 
(11413D) was purchased from Invitrogen Life Technologies (Grand Island, NY). 
Corning HTS Transwell®-96 well plates (09-761-83) as well as other materials 
and media for cell culture were obtained from Fisher Scientific (Waltham, MA). 
Conjugated antibodies FITC-CD11b (557396), isotype FITC-Rat IgG2a,κ 
(553929), PE-Ly-6G (551461), and isotype PE-Rat IgG2b,κ  (553989) were 
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purchased from BD Biosciences (San Jose, CA).Other materials were obtained 
as described elsewhere (Oner et al 2010a, Oner et al 2010b).  
Mouse models: 
Gpsm1-/- mice used in this study were generated as previously described (Blumer 
et al 2008).  Wild-type and Gpsm1-/- female littermates at 6-12 weeks of age from 
Gpsm1+/- intercrosses were used.  Gpsm1+/- breeding pairs were generated from 
backcrosses onto C57BL/6J mice for more than 12 generations.  Gpsm3-/- mice 
generated in the C57BL/6 background were obtained through the Knockout 
Mouse Project (KOMP) consortium. Wild-type and Gpsm3-/- littermates at 6-12 
weeks of age from Gpsm3+/- intercrosses were used.  Genotyping of these mice 
was performed using a three-primer polymerase chain reaction (PCR) using the 
following primer set: mgAGS4 16651 forward primer 5’-TGA CGG GTG GAC 
ACA GGA GAC TTG GGA AAG-3’; Common 3’ forward (universal RAF5 forward) 
5’-CAC ACC TCC CCC TGA ACC TGA AA-3’; CSD-Gpsm3-SR1 5’-CAG GGA 
AAG TGG GTG GTA AAT ACA G-3’. Tissues and lysates were prepared and 
processed for immunoblotting as described (Blumer et al 2002) .  
Complete Blood Count Analysis:  
Cardiac puncture was administered to euthanized WT or Gpsm3-/- mice using a 1 
ml syringe fitted with a 21G needle to harvest fresh blood from the left ventricle 
slowly to prevent cardiac collapse of the heart and subsequently collected in BD 
Microtainer tubes containing EDTA. Samples were maintained at constant 
temperature and humidity throughout processing and analysis. Complete blood 
cell counts (CBCs) were performed using a HemaVet 950 (Drew Scientific, 
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Dallas, TX) instrument to measure leukocyte, erythrocyte, and thrombocyte 
levels in each sample.  Machine calibration and performance were verified each 
day that samples were analyzed using MULTI-TROL standard solution (Dog, 
Drew Scientific, Dallas, TX). All samples were run within 2 hr of initial collection. 
Primary cells: 
Dendritic cells – Bone marrow was isolated from WT, Gpsm1-/- or Gpsm3-/- 
mouse femurs and tibiae using a 25G syringe to flush the bone marrow out with 
10 mL of DPBS (PBS, Ca++ and Mg++ free). Isolated bone marrow was then 
filtered through a 40-μm nylon cell strainer, centrifuged at 4°C 500 x g and 
decanted. Red blood cells were lysed with 5 mL of ice-cold ACK lysing buffer 
(0.17 M NH4Cl/0.17 M Tris) for 5 min at room temperature, followed by an 
additional spin at 4°C 500 x g to pellet the harvested bone-marrow cells. Isolated 
cells were then resuspended in 10 mL DC I media (RPMI-1640 supplemented 
with 10% FBS, 100 U/mL penicillin, 100 mg/mL streptomycin, and 20 ng/ml 
rmGM-CSF), and plated 4-5 x 105 cells/mL in a 10 cm tissue culture dish. On day 
four, 10 mL fresh DC I media was added to each dish.  On day eight, non-
adherent and loosely adherent cells were harvested, centrifuged 4°C 500 x g, 
decanted and re-seeded in 10 mL fresh DC II media (RPMI-1640 supplemented 
with 10% FBS, 100 U/mL penicillin, 100 mg/mL streptomycin, and 10 ng/ml 
rmGM-CSF) to generate immature dendritic cells (iDC). Day nine cells were 
treated with or without 200 ng/mL LPS for the indicated times or for 24 hours to 
generate mature dendritic cells (mDC).   
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B and T lymphocytes –  Spleens of WT, Gpsm1-/- or Gpsm3-/- mice were gently 
crushed between frosted glass slides in 10 mL serum-free RPMI. Spleen 
homogenate was centrifuged at 4°C 500 x g and decanted. Red blood cells were 
lysed with 10 mL of ice-cold ACK lysing buffer for 5 min at room temperature, 
followed by an additional spin at 4°C 500 x g to pellet the splenocytes. 
Splenocytes were then washed once and resuspended in DPBS supplemented 
with 0.1% BSA and 2 mM EDTA at 5 x 107 cells/mL or 1 x 108 cells/ml for 
subsequent B or T cell isolation, respectively. Cell isolation was performed 
according to Invitrogen Dynabeads protocol for untouched B cell isolation or 
negative T cell isolation. 
Neutrophils – Bone marrow was isolated from WT or Gpsm3-/- mouse femurs and 
tibiae using a 25G syringe to flush the bone marrow out with 10 mL of DPBS. 
Isolated bone marrow was then filtered through a 40-μm nylon cell strainer, 
centrifuged at 4°C 500 x g and decanted. Pelleted cells were resuspended in 2 
mL DPBS followed by subsequent careful layering on top a 3-layer Percoll™ 
density gradient. The density gradient was generated by diluting 100% Percoll™ 
in DPBS to required densities represented by 78%, 64%, 52% Percoll dilutions. 
Stacking of the different layers was conducted as follows, 3 mL 78% Percoll, 2 
mL 64% Percoll, and 2 mL 52% Percoll followed by subsequent 2 mL of sample. 
After centrifugation, 1500 x g for 40 min at 4°C, the 78/64% Percoll interface was 
carefully isolated and added to 9 mL of DPBS to disrupt the remaining gradient. 
Isolated cells were then centrifuged 4°C, 1500 x g for 5 min, decanted, and 
subjected to 1 mL of ice-cold ACK lysis buffer for 5 min at room temperature to 
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remove any remaining red blood cells. Cells were then resuspended in 1-2 mL 
phenol red-free RPMI supplemented with 0.1% BSA and 2mM EDTA. 
Immunoblotting: 
Single-cell suspensions from spleen and thymus were prepared by crushing 
freshly dissected tissues between frosted glass slides in 10 mL DPBS. After 
centrifugation 4°C 500 x g 5min, samples were decanted and red blood cells 
lysed with 10 mL ice-cold ACK lysis buffer for 5 min at room temperature 
followed a second round of centrifugation at 4°C 500 x g for 5 min. ACK lysis 
buffer was then decanted and pellets were resuspended in 100-300 µL 1% NP40 
lysis buffer (50 mM Tris, pH 8.0, 150 mM NaCl, 5 mM EDTA, 1% Nonidet P-40) 
with protease inhibitors. Samples were incubated on ice for 20 min followed by 
centrifugation at 10,000 x g for 30 min at 4°C. Dendritic cells were harvested 
using cell scrappers and neutrophils samples were collected after Percoll density 
centrifugation to be processed in the 1% NP-40 lysis buffer with protease 
inhibitors as described above. Protein concentration was determined by a Pierce 
BCA protein assay. Protein samples were subjected to sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE, 10-13.5%), then separated 
proteins were transferred to polyvinylidene difluoride (PVDF) membranes for 
immunoblotting as described (Blumer et al 2002). Immunoblotting with AGS4 
antibodies (Abgent, San Diego, CA) was conducted as follows: Membranes were 
then blocked with 50% Odyssey Buffer [LI-COR Biosciences] and 50% Tris-
buffered saline + 0.01% Tween (TBST) for 30 min at room temperature, 
incubated with AGS4 antibody (1:250 dilution) overnight 4°C, followed by three 
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10 min washes in TBST. Membranes were then exposed to 1:5,000 dilution of 
horseradish peroxidase-conjugated goat anti-rabbit IgG 30 min room 
temperature, followed by three 30 min washes with TBST and subsequent 
exposure with ECL. Cell pellets processed for phosphorylated proteins were 
lysed in 1% NP40 buffer with protease inhibitors and additional phosphatase 
inhibitors (50 mM NaF, 5 mM sodium pyrophosphate, 40 mM β-glycerophosphate 
and 200 μM Na3VO4) on ice for 20 min followed by centrifugation at 10,000 x g 
for 30 min at 4°C. Samples were subjected to SDS-PAGE, proteins transferred to 
PVDF membranes and immunoblotted for anti-phospho-Erk (Y402) (Santa Cruz 
Biotechnology, Dallas, TX, USA), or total Erk (Abcam, Cambridge, MA, USA) 
antibodies. Densitometric quantification of the immunoblotted bands was 
performed using ImageJ densitometry software (Version 1.49i, National Institutes 
of Health, Bethesda, MD).  Selected bands were quantified based on their 
relative intensities and normalized to total Erk. 
Chemotaxis: 
Corning Transwell 24-well inserts (6.5 mm diameter, 5.0 µm pore size) or 96-well 
inserts (5.0 µm pore size) were used for all chemotaxis assays.   For dendritic 
cell chemotaxis, 235 µL of serum-free RPMI with or without  CXCL12 (10-500 
ng/mL) or CCL19 (250 ng/mL) was added to each lower chamber and 75 µL of 
approximately 3 x 106 cells/ml were loaded in at least triplicate determinations 
into the upper chambers.  Where indicated, dendritic cells were pre-incubated 
with 100 ng/mL of pertussis toxin for 18 hr at 37°C prior to measuring 
chemotaxis. For lymphocytes, 235 µL of serum-free RPMI supplemented with 
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0.1% BSA and 2mM EDTA with or without CXCL12 (50-300 ng/ml)  or CCL19 
(50-300 ng/ml) was added to each lower chamber, and 75 µL of approximately 1 
x 107 lymphocytes/mL were added in at least triplicate determination into the 
upper chambers. In the case of neutrophils, 235 µL of serum-free RPMI 
supplemented with 0.1% BSA and 2mM EDTA with or without fMLP (0.1-5.0 µM) 
was added to each lower chamber, and 75 µL of approximately 5 x 106 cells/ml 
were added in at least triplicate determinations into the upper chambers. 
Chemotaxis chambers were incubated at 37°C, 5% CO2 for 20 hrs for dendritic 
cells, 5 hrs for lymphocytes, and 3 hrs for neutrophils. The upper chamber was 
removed and cells migrating to the bottom chamber as well as cells retained in 
the upper chamber were counted by flow cytometry. The percentage of cells 
migrated was calculated relative to the input, where the number of cells migrating 
to the bottom chamber in the absence of chemokine was subtracted. 
Thioglycollate-induced intraperitoneal inflammation: 
WT and Gpsm3-/- mice received intraperitoneal injections using an insulin syringe 
(28G) to deliver 1 mL of DPBS or 4% thioglycollate (in DPBS, sterilized, and 
aged for a minimum of 2 wks). After 2 hrs, intraperitoneal (IP) cavity lavage was 
carried out through injection of 10 mL cold DPBS and thorough subsequent 
agitation of the cavity. Blood (350 – 600 µL) was also collected by cardiac 
puncture and bone marrow was collected from femurs as described above in 
Primary Cells section. Isolated cells were centrifuged 4°C 500 x g 5 min, excess 
supernatant decanted, and red blood cells were lysed using 1 mL ice-cold ACK 
lysis buffer (5 min incubation followed by subsequent 500 x g centrifugation for 5 
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min). Blood samples required a minimum of two ACK lysis steps to remove all of 
the red blood cells. Isolated IP lavage cells were then resuspended in 50 µL of 
PBS with 1% BSA and 0.1% NaN3 (PBS-BSA), isolated cells from the blood were 
resuspended in 200 µL of PBS-BSA, and isolated bone marrow cells were 
resuspended in 1 mL of PBS-BSA. Each sample then had 50 µL subjected to 
incubation with conjugated antibodies for analysis by flow cytometry as described 
below.   
Flow cytometry and cell sorting: 
Single-cell suspensions from spleen and thymus were prepared from female 
mice (Gpsm1+/+ and Gpsm1-/- littermates) at 6 weeks of age by crushing freshly 
dissected tissues between frosted glass slides in PBS. After lysing red blood 
cells with 10 mL ACK lysis buffer (0.17 M NH4Cl/0.17 M Tris), cells were counted 
and washed with PBS with 1% BSA and 0.1% NaN3 (PBS-BSA). A total of 106 
cells were first incubated with anti-FcγIII (CD16/CD32) for 30 min at 4°C to block 
Fc receptors, then cells were incubated with primary FITC or PE-conjugated Abs 
in PBS-BSA for 30 min at 4°C (BD Pharmingen, San Diego, CA). Cells were 
washed twice in PBS-BSA, resuspended in 500 µl of PBS-BSA, and analyzed on 
a flow cytometer (BD Pharmingen). Additionally, single-cell suspensions of WT 
and Gpsm3-/- neutrophils collected from Percoll density centrifugation or from 
thioglycollate-induced inflammation experiments were prepared as described 
above. Pellets cells were washed and resuspended in 50 µL PBS supplemented 
with 1% BSA and 0.1% NaN3 (PBS-BSA). Cells were incubated with primary 
FITC-CD11b (0.3 µL, 0.15 µg) or PE-Ly-6G (2 µL, 0.4 µg) conjugated Abs or 
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isotype controls FITC-Rat IgG2a,κ (1 µL, 0.5 µg) or PE-Rat IgG2b,κ (3 µL,0.6 µg) 
in PBS-BSA for 30 min at 4°C (BD Pharmingen, San Diego, CA). Cells were 
washed thrice with 500 µL PBS-BSA with subsequent centrifugations 4°C 500 x g 
5 min, and resuspended in 250-500 µl of PBS-BSA for analysis by flow cytometer 
(BD Pharmingen). Neutrophil populations were observed as being dual positive 
(CD11b+, Ly-6G+). 
Data Analysis: 
Statistical significance for differences involving a single intervention was 
determined by one-way analysis of variance (ANOVA) followed with a post hoc 

















Results and Discussion 
Accessory proteins for G-protein signaling systems have revealed 
surprising diversity in modes of heterotrimeric G-protein signal processing, 
including but not limited to the modulation of signal strength, duration, location, 
termination and the formation of signal transduction complexes (Refer to Chapter 
2) (for review, see (Blumer et al 2012, Blumer et al 2007, McCudden et al 2005a, 
Sato et al 2006a)). In order to attain a proper response to dynamic chemotactic 
stimuli, leukocytes require highly specialized and spatially integrated G-protein 
signaling mechanisms (Cho & Kehrl 2009, Kehrl et al 2009).  Moreover, 
increasing evidence indicates that proteins containing GPR motifs play key roles 
in dynamic biological signaling systems where signal integration is required for 
appropriate and efficient responsiveness of the system (Bowers et al 2008, 
Bowers et al 2004, Branham-O'Connor et al 2014, Fan et al 2009, Giguere et al 
2012a, Kamakura et al 2013, Sanada & Tsai 2005, Yao et al 2005). As an initial 
approach to define the role of GPR proteins in such modes of signal integration, 
we studied the role of the GPR proteins AGS3 and AGS4 in chemotactic signal 
integration of immune cells.  
Functional roles for AGS3 in numerous physiological signaling systems 
have been described, including drug addiction and neuronal plasticity, ischemia 
reperfusion injury and polycystic kidney disease, blood pressure control, energy 
expenditure and metabolism, autophagy and membrane protein trafficking; 
however, the functional role(s) of AGS3 in the immune system is not defined 
(Blumer et al 2008, Bowers et al 2004, Conley & Watts 2013, Fan et al 2009, 
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Garcia-Marcos et al 2011, Groves et al 2007, Kamakura et al 2013, Kwon et al 
2012, Nadella et al 2010, Pattingre et al 2003, Regner et al 2011, Sanada & Tsai 
2005, Vural et al 2010, Yao et al 2005). Additionally, biological roles of AGS4, 
particularly in the immune system where its expression predominates, are poorly 
understood (Cao et al 2004, Giguere et al 2013, Giguere et al 2014, Schmidt et 
al 2012). Thus, the data described here begin to explore potential functions for 
AGS3 and AGS4 in the regulation of chemokine-induced signaling and response 
to inflammation in various leukocyte populations where these GPR containing 
proteins are expressed. Indeed, there are relatively few reports of GPCR signal 
modulation by GPR-containing proteins (Conley & Watts 2013, Fan et al 2009, 
Kinoshita-Kawada et al 2004, Sato et al 2004, Webb et al 2005, Wiser et al 2006, 
Yao et al 2005), underscoring the significance of the current study which makes 
use of primary cells obtained from genetic null Gpsm1-/- and  Gpsm3-/- mice.  
 
Analysis of protein expression and leukocyte populations from AGS3/Gpsm1-/- 
and AGS4/Gpsm3-/- mice    
To investigate potential functional roles for AGS3 and AGS4 in leukocytes, 
we utilized two recently generated mouse models, namely the AGS3/Gpsm1-null 
and AGS4/Gpsm3-null mouse models. The AGS3/Gpsm1-null model was 
generated by Blumer et al. and the AGS4/Gpsm3-null was obtained from the 
Knockout Mouse Project (KOMP) (Blumer et al 2008). Initial investigation of 
immune tissues of these mice compared to WT tissues determined abundant 
expression of AGS3 (Mr ~ 74,000) and AGS4 (Mr ~18,000) in WT tissues and 
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complete absence of these proteins in the null animals (Figure 3.1A, 3.1B). As 
predicted from the mRNA expression of AGS4, neutrophil expression of AGS4 
was observed to be the most abundant of the collected tissues (Figure 3.1B). 
With a documented role for Gαi and GPR proteins in asymmetric cell division and 
thus a potential impact on cell fate and differentiation, we measured leukocyte 
populations in  AGS3 and AGS4-null animals (Dalwadi et al 2003, Gonczy 2008, 
Huang et al 2003, Knoblich 2010, Rudolph et al 1995). While initial results from 
Gpsm1-/- mice indicated that differentiation of lymphocyte populations are 
unaffected by the loss of AGS3 (Branham-O'Connor et al 2014), mice deficient in 
AGS4 expression demonstrated a mild but significant neutropenia and 
lymphocytosis while other populations were unaltered (Figure 3.2). Altered levels 
of circulating populations of neutrophils and lymphocytes in Gpsm3-/- mice may 
indicate a role for AGS4 in either differentiation or proper leukocyte trafficking 
mechanisms of these cells in these mice (Figure 3.2, 3.4B, 3.4D, 3.4E). In 
addition to these findings, our initial results validate the loss of AGS3 and AGS4 
expression in immune cells and tissues in the knockout model systems, thus 
proving their utility in the investigation of the functional roles these GPR proteins 







































Figure 3.1. Expression of AGS3 and AGS4 in isolated primary leukocytes of 
WT, Gpsm1-/-, Gpsm3-/- 
(A) Thymocytes and splenocytes (top panel) were isolated from WT vs Gpsm1-/- 
mice following red blood cell lysis and filtering to remove cell and tissue 
aggregates as described in Experimental Procedures.  Harvested BMDCs from 
WT and Gpsm1-/- mice were also cultured to immature (iDC) and mature (mDC) 
dendritic cells (lower panel) as described in Experimental Procedures. Lysates 
were prepared with 1% NP-40 lysis buffer and subjected to SDS-PAGE (100 µg 
per lane) and immunoblotting with AGS3 and β-actin-specific antisera as 
described in Experimental Procedures. Immunoblots depicted are representative 
of at least 3 independent experiments. 
(B) WT and Gpsm3-/- splenocytes (top panel) were isolated following red blood 
cell lysis and filtered to remove cell and tissue aggregates as described in 
Experimental Procedures. Harvested BMDCs from WT and Gpsm3-/- mice were 
cultured to immature (iDC) and mature (mDC) dendritic cells (middle panel) or 
used to isolate neutrophils (lower panel) by Percoll gradient centrifugation as 
described in Experimental Procedures. Lysates were prepared with 1% NP-40 
lysis buffer and subjected immunoblotting (100 µg) with AGS4 and β-actin-
specific antisera as described in Experimental Procedures. Immunoblots 



























Figure 3.2. Altered circulating leukocyte populations are observed in 
Gpsm3-/- mice 
Blood was collected from WT and Gpsm3-/- (KO) mice by cardiac puncture as 
described in Experimental Procedures. Complete blood cell counts (CBCs) were 
performed within 2 hr of blood collection using a HemaVet 950 instrument to 
measure leukocyte levels in each sample. The following populations were 
measured: neutrophils (NE), lymphocytes (LY), monocytes (MO), eosinophils 
(EO), basophils (BA). Percent of leukocyte populations in relation to total number 
of white blood cells was calculated and compared between WT and Gpsm3-/- 
littermate pairs. Data are representative of 5 independent experiments in box and 
whiskers plots depicting the median with quartiles 1 to 3 contributing to the 
surrounding box, while the maximum and minimum values are depicted by the 













Leukocyte stimulation enhances AGS3 and AGS4 protein levels 
Activation of leukocytes often results in upregulation of proteins whose 
function is required for proper signal integration; thus, we postulated that AGS3 
and AGS4 expression may be upregulated in response to stimulation of 
leukocytes. Activation of primary B lymphocytes with LPS or IgM for 12h 
demonstrated upregulation of AGS3 protein, but AGS4 protein expression was 
unaltered (Figure 3.3). Interestingly, stimulation of primary T lymphocytes with 
anti-CD3 and IL-2 illustrated enhanced expression of AGS4 over time, while 
AGS3 was significantly upregulated subsequent to CD3/IL-2 treatment followed 
by a moderate decrease in this expression after the time allotted (Figure 3.3). 
The differential expression of AGS3 and AGS4 during T-lymphocyte activation 
may represent unique, unexplored modulatory functions for each protein at 
different stages of this process. Additionally, bone marrow-derived dendritic cells 
(BMDCs) were observed to have increased expression of AGS3 in response to 
stimulation by LPS (Figure 3.1A), (Branham-O'Connor et al 2014).  Moreover, 
these findings are in support of a recent report also depicting upregulation of 
AGS4 during monocyte differentiation from bone marrow by macrophage-colony 
stimulating factor over nine days, while decreased expression of AGS4 was 
observed in differentiation of macrophage-like cells using phorbol 12-myristate 
13-acetate (PMA) over three days (Giguere et al 2013). Taken together, the 
upregulation of AGS3 and AGS4 in response to leukocyte activation further 
suggests a biologically significant role for these proteins in regulating immune 
responses to stimuli; furthermore, our results are consistent with regulated 
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expression of GPR proteins responding to extracellular cues (Bowers et al 2008, 
Bowers et al 2004, Cho et al 2000, Fan et al 2009, Giguere et al 2013, Giguere 

























































































Figure 3.3. Differential upregulation of AGS3 and AGS4 protein expression 
in lymphocytes upon stimulation  
Purified B- and T-lymphocytes from C57BL/6J mice were isolated as described in 
Experimental Procedures. Purified B cells were stimulated with 20 µg/mL anti-
IgM F(ab')2 fragment or 1 mg/ml LPS for 12 h. Purified T cells were stimulated 
with 0.1 µg/ml CD3 and 20% interleukin (IL)-2 for 24 to 48 h.  After treatment, 
cells were washed and lysed in SDS sample buffer and subjected to SDS-PAGE 
and immunoblotting with AGS3, AGS4 and actin-specific antisera as described in 
Experimental Procedures. Samples were kindly provided by Dr. John H. Kehrl, 

















Defective chemotaxis in AGS3/Gpsm1-/- and AGS4/Gpsm3-/- leukocytes 
Chemokine signaling is mediated by Gαiβγ heterotrimer activation, which 
is a critical component to this signaling cascade (e.g.(Delgado-Martin et al 
2011)). Furthermore, the importance of Gαi subunits in chemokine signaling is 
commonly overshadowed by the effects imparted by the Gβγ subunit; however, 
previous reports have illustrated the importance of Gαi itself to the overall signal 
integration for chemokine receptors, as decreased chemokine-directed migration 
is observed in leukocytes isolated from Gαi-null animals (e.g. (Hwang et al 2007, 
Jin et al 2008). Thus, we investigated the functional consequence resulting from 
the absence of the Gαi binding proteins, AGS3 and AGS4, on chemokine-
mediated signal integration in leukocytes. As an initial approach to address this 
question, chemotaxis of leukocytes isolated from WT, Gpsm1-/-, and Gpsm3-/- 
mice were analyzed. Upregulation of AGS3 in activated B- and T-lymphocytes 
coincided with a nearly 50% reduction in chemotaxis towards either 
CXCL12/SDF-1 or CCL19 observed in isolated Gpsm1-/- B- and T-lymphocytes 
compared to WT lymphocytes (Figure 3.4A). Similarly, isolated T-lymphocytes, in 
which AGS4 expression is up-regulated after stimulation, from Gpsm3-/- mice 
demonstrated a ~ 25% decreases in chemokine-induced migration to CCL19, 
while chemotaxis to CXCL12 was reduced but not significantly (Figure 3.4B). The 
discrepancy in chemokine signal processing between these two Group II AGS 
proteins may signify unique regulatory functions for AGS3 and AGS4 in specific 




Similar to the chemotactic defect observed in lymphocytes from Gpsm1-/- 
and Gpsm3-/- mice, bone marrow-derived dendritic cells (BMDCs) from AGS3-
null and AGS4-null mice showed ~30% reduction and ~20% reduction, 
respectively, in migration towards the chemokine CXCL12 (Figure 3.4C and 
3.4D). This effect was completely blocked by pertussis toxin pretreatment 
regardless of genotype (Figure 3.4D).  
Significant levels of AGS4 expression in neutrophils prompted the 
investigation into chemokine-induced migration of neutrophils to fMLP (Figure 
3.4E). Coinciding with the chemotactic reduction in lymphocytes and BMDCs, 
isolated neutrophils from Gpsm3-/- mice revealed > 30% reduction in fMLP-
directed chemotaxis (Figure 3.4E).  
Further analysis of the data indicated no significant difference in random 
migration between WT leukocytes and leukocytes lacking AGS3 and AGS4, 
suggesting that the chemotactic defect in Gpsm1-/- and Gpsm3-/- cells was 
primarily directional and not due to an overall decrease in the ability of the cells 
to migrate. Additionally, to rule out that loss of chemokine receptor expression in 
these cells was contributing to the reduction in cell migration, flow cytometry 
analysis revealed that chemokine receptor levels were unaltered in the absence 
of AGS3 or AGS4 indicating that the chemotactic defect in these leukocytes was 
















































Figure 3.4.  Chemotaxis of primary leukocytes from WT, Gpsm1-/-, and 
Gpsm3-/- mice to chemokines CXCL12, CCL19, and fMLP 
(A,B)  T lymphocytes (A, left panel and B) and B lymphocytes (A, right panel) 
were separately isolated from freshly harvested splenocytes of WT, Gpsm1-/- (A) 
or Gpsm3-/- (B) mice.  Cells were loaded in transwell migration chambers with the 
bottom chamber containing serum-free RPMI supplemented with 0.1% BSA and 
2mM EDTA in the absence and presence of 300 ng/mL CXCL12 or CCL19 (A) or 
50-300 ng/mL CXCL12 (B, left panel) or CCL19 (B, right panel). After 5h at 37°C, 
cells in the bottom chamber were counted, and the percentage of cells migrated 
was calculated relative to the input, where the number of cells migrating in the 
absence of chemokine was subtracted. Data are represented as the mean +/- 
S.E. of 3 independent experiments with at least triplicate determinations. *, p < 
0.01 based on Tukey’s post hoc test following ANOVA. 
(C,D) Bone marrow cells were harvested from of WT, Gpsm1-/- (C) or Gpsm3-/- 
(D) mice and cultured as described in Experimental Procedures. After 8d, 
immature dendritic cells (iDCs) were cultured in the absence or presence of 
100ng/ml Pertussis toxin for 18hr where indicated (D). Dendritic cells were 
loaded in transwell migration chambers with the bottom chamber containing 
serum-free RPMI in the absence and presence of 250 ng/mL CXCL12 (C) or 0-
500 ng/mL CXCL12 (D).  After 20hr at 37°C, cells in the bottom chamber were 
counted, and the percentage of cells migrated was calculated relative to the 
input, where the number of cells migrating in the absence of chemokine was 
subtracted. Data are represented as the mean ± S.E. of 3 independent 
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experiments with at least triplicate determinations. *, p < 0.01 based on Tukey’s 
post hoc test following ANOVA.   
(E) Neutrophils from WT and Gpsm3-/- mice were isolated from freshly harvested 
bone marrow of WT and Gpsm3-/- mice as described in Experimental 
Procedures. Isolated neutrophils were loaded in transwell migration chambers 
with the bottom chamber containing serum-free RPMI with 0.1% BSA and 2mM 
EDTA in the absence and presence of fMLP (0.1–5 µM).  After 3h at 37°C, cells 
in the bottom chamber were counted, and the percentage of cells migrated was 
calculated relative to the input, where the number of cells migrating in the 
absence of chemokine was subtracted. Migration data are represented as the 
mean +/- S.E. of at minimum 4 independent experiments with at least triplicate 
































































Figure 3.5. Receptor expression is unaltered in Gpsm1-/- and Gpsm3-/- 
leukocytes 
(A) Splenocytes were isolated from WT and Gpsm1-/- mice following red blood 
cell lysis and filtering to remove cell and tissue aggregates as described in 
Experimental Procedures. WT and Gpsm1-/- total splenocytes (left panel) were 
stained with PE conjugated CD19 antibody and FITC conjugated CXCR4 
antibody and BMDCs (right panel) were stained with FITC conjugated CXCR4 
antibody with subsequent flow cytometric analysis. Results are representative of 
at least two independent experiments 
(B) Splenocytes were isolated from WT and Gpsm1-/- mice following red blood 
cell lysis and filtering to remove cell and tissue aggregates as described in 
Experimental Procedures. CD4+ and CD8+ T lymphocytes were isolated and 
analyzed by flow cytometry through collaborative efforts with Dr. John H. Kehrl, 













Impaired chemokine-mediated signal processing in AGS3/Gpsm1-/- and 
AGS4/Gpsm3-/- leukocytes 
Stimulation of chemokine receptors also activates downstream targets 
such as ERK1/2 kinases as part of the chemotactic process, predominately 
through Gβγ activation of PI3Kγ (Tilton et al 2000). Previous reports have 
demonstrated the importance of ERK1/2 activation subsequent to chemokine 
receptor stimulation in chemokine-mediated migration of leukocytes (Delgado-
Martin et al 2011, Sagar et al 2012). Therefore, we hypothesized that the 
deficient chemotaxis observed with loss of AGS3 and AGS4 in leukocytes 
corresponded to deficient ERK1/2 phosphorylation. As an initial approach to 
explore this affect we isolated dendritic cells and splenocytes from WT, Gpsm1-/-, 
and Gpsm3-/- bone marrow and spleens, respectively, and stimulated the 
leukocytes with CXCL12. Gpsm1-/- dendritic cells and splenocytes were unable to 
phosphorylate and sustain active ERK1/2 at similar levels to WT leukocytes 
(Figure 3.6A and 3.6C). Similarly, Gpsm3-/- leukocytes also demonstrated a 
reduction in chemokine-induced activation of ERK1/2 (Figure 3.6B and 3.6D).  
These results further demonstrate a role for AGS3 and AGS4 in chemokine-



















































Figure 3.6.  Gpsm1-/- and Gpsm3-/- dendritic cells and splenocytes exhibit 
reduced chemokine-stimulated phosphorylation of ERK1/2 
(A,B) Single cell suspensions of WT, Gpsm1-/- (A), and Gpsm1-/- (B) cultured 
dendritic cells were treated in the absence or presence of CXCL12 (200 ng/mL) 
as described in Experimental Procedures.  At the indicated times, cells were 
lysed in 1% NP40 lysis buffer containing protease and phosphatase inhibitors 
and lysates (50 µg per lane) were subjected to SDS-PAGE, transferred to PVDF 
and  immunoblotted with anti-phospho-Erk (Y204) or total Erk-specific antibodies 
as described in Experimental Procedures. Representative immunoblots are 
shown in the left panels and densitometric analysis of at least 3 independent 
experiments normalized to total Erk levels and basal phosphorylated Erk at time 
point 0 (represented as means ± S.E.) are shown in the right panels. *, p < 0.05 
based on Student’s t-test analysis. 
(C,D) Single cell suspensions of WT, Gpsm1-/- (C), and Gpsm1-/- (D) freshly 
isolated splenocytes were treated in the absence or presence of CXCL12 (200 
ng/mL) as described in Experimental Procedures. At the indicated times, cells 
were lysed in 1% NP40 lysis buffer containing protease and phosphatase 
inhibitors and lysates (50 µg per lane) were subjected to SDS-PAGE, transferred 
to PVDF and  immunoblotted with anti-phospho-Erk (Y204) or total Erk-specific 
antibodies. Representative immunoblots are shown in the left panels and 
densitometric analysis of at least 3 independent experiments normalized to total 
Erk levels and basal phosphorylated Erk at time point 0 (represented as means ± 
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AGS4/Gpsm3-/- is required for maximal infiltration of neutrophils to sites of 
inflammation  
The requirement for AGS4 in chemokine signal integration ex vivo 
prompted the question of how loss of AGS4 may affect chemokine signal 
processing in the intact animal. We hypothesized that AGS4 expression was 
required for neutrophils to efficiently migrate and to sites of inflammation in vivo.  
As an initial investigation into this biological role for AGS4, WT and Gpsm3-/- 
mice were injected with thioglycollate to induce peritonitis in the intraperitoneal 
cavity of these animals. WT mice demonstrated a significant accumulation of 
neutrophils at the initial site of inflammation (Figure 3.7A). This also coincided 
with an influx of neutrophils present in the blood (Figure 3.7B). In contrast, the 
level of neutrophils recruited to the IP cavity in Gpsm3-/- animals was drastically 
reduced by ~80% compared to WT littermates, while maintaining similar levels in 
the bone marrow during this period (Figure 3.7A and 3.7C). However, the 
presence of comparable induction of neutrophils in the blood similar to levels 
seen in WT mice (Figure 3.7B) suggests a possible deficiency in extravasation or 
a delayed response of neutrophils from the blood to the IP cavity in Gpsm3-/- 
mice after thioglycollate challenge. Interestingly, paracellular transendothelial 
migration of immune cells has been connected with signaling mechanisms 
involving Gαi2, as inhibition or loss of Gαi2 in immune cells and endothelial cells 
impairs neutrophil extravasation to sites of inflammation (Pero et al 2007, 
Warnock et al 1998, Wiege et al 2012, Zarbock et al 2007). Thus, aberrant 
transmigration of AGS4-null neutrophils from the blood to the IP cavity may 
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reflect simultaneous abnormal regulation of Gαi2 signaling in both endothelial 






































































Figure 3.7. AGS4-null neutrophils demonstrate reduced migration in 
peritonitis model  
WT and Gpsm3-/- mice received 1 mL intraperitoneal injections of sterile DPBS or 
4% thioglycollate to induce localized inflammation as described in Experimental 
Procedures. Two hours post-injection, 10 ml of cold, sterile PBS was used to 
lavage the intraperitoneal cavity (A). Blood was collected by cardiac puncture 
and femurs were processed to harvest bone marrow cells as described in 
Experimental Procedures (B and C, respectively). Red blood cells were lysed 
from collected samples and cells were stained with FITC–CD11b and PE–Ly-6G 
for analysis of neutrophil levels in each tissue by flow cytometry. Neutrophil cell 
numbers were calculated using total events collected, applying flow rate and 
percentage of dual positive cells followed by dilutions carried out during 
processing of the cells. Data are represented as the mean +/- S.E. of 4 
independent experiments. Notation of * signify p-values <0.001 based on Tukey’s 









In this report we demonstrate that chemokine-induced signal processing 
relies in part on AGS3 and AGS4, resulting in reduced chemokine-directed cell 
migration and ERK1/2 activation in the absence of either protein. An impaired 
neutrophil response to peritonitis further implicates GPR proteins in inflammatory 
signaling of leukocytes. Our results thereby expand the roles of GPR proteins, 
AGS3 and AGS4, to encompass chemokine signaling in leukocytes, where these 
proteins are predicted to modulate Gαi signal transduction of chemokine 
receptors. Various populations of AGS3-null and AGS4-null leukocytes 
demonstrate 25-40% reduction in chemotactic response, consistent with the idea 
that these are modulatory proteins that act to regulate the fundamental Gαi2 
subunit signaling previously shown to be indispensable in chemokine stimulated 
systems (Cho et al 2012, Han et al 2005, Hwang et al 2007, Jin et al 2008, Pero 
et al 2007, Rudolph et al 1995, Skokowa et al 2005, Thompson et al 2007, Wiege 
et al 2012, Zarbock et al 2007). In light of these results, three hypotheses for the 
potential role of GPR containing proteins in modulation of chemokine receptor 
signal integration are as follows: 1) the 7TM chemokine receptor effectively 
couples the Gαi-GPR module to promote nucleotide exchange in a manner 
analogous to the Gαiβγ heterotrimer; 2) the distinct Gαi-GPR signaling module 
induces formation of a signaling complex to non-canonical signal mechanisms 
that direct chemokine-induced migration independent of Gβγ; and/or 3) GPR 
motifs of AGS3 and AGS4 act to sequester Gαi subunits and decrease the rate of 
heterotrimer reassociation thus prolonging or enhancing Gβγ signaling events 
that further facilitate chemokine-directed migration of leukocytes. 
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One hypothesis of the mode of action for GPR-proteins involves the 
chemokine receptor coupling to the Gαi – GPR complex as described in Chapter 
2 (Oner et al 2010a, Oner et al 2010b) in a manner analogous to Gαiβγ 
heterotrimer to contribute to chemokine-stimulated downstream signaling. In 
heterologous systems, the Gαi – GPR module appears to directly engage with 
and is regulated by Gαi-coupled GPCRs (Oner et al 2010a, Oner et al 2010b) 
including CXCR4 (Chapter 2). Although the function of the Gαi-GPR signaling 
module is not fully elucidated for 7TMR signaling systems, reports of the 
importance of the Gαi subunit in chemokine-mediated signaling suggest that Gαi 
transduction may play a pivotal role in the systems. Gαi2 deficient immune cells 
demonstrate aberrant chemokine-directed migration and cytokine production 
(Huang et al 2003, Hwang et al 2007, Jin et al 2008, Thompson et al 2007, 
Wiege et al 2012). Additionally, maintaining low levels of intracellular cAMP was 
found to be essential to neutrophil chemotaxis (Harvath et al 1991). The active 
Gαi liberated by chemokine receptor activation can also activate the Src family of 
non-receptor tyrosine kinases leading to cascades which are implicated in cell 
migration and transmigration (Arefieva et al 2005, Fumagalli et al 2007, Ma et al 
2000, Ptasznik et al 2002). Thus, the interaction of GPR containing proteins with 
Gαi subunits may in part participate in the modulation of chemokine activated 
Gαi-mediated signaling cascades.  
The second hypothesis involves the Gαi – GPR complex formed after 
receptor activation but prior to heterotrimer reassociation, exhibiting a scaffolding 
function to recruit additional molecules to a non-canonical signaling complex. 
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This complex would then work in concert with Gβγ signaling events to promote 
efficient and appropriately directed cell motility. Indeed recent reports denote Gαi 
– AGS3 forming a large signaling complex with mammalian Inscuteable (mInsc) 
to recruit Par3-Par6-aPKC complex to leading edges of neutrophils and 
modulating directed migration (Kamakura et al 2013). These observations would 
suggest that GαiGDP bound to GPR motif(s) would either function as an active 
signaling entity (Gonczy 2008) or serve as a platform for additional signal input 
as previously proposed (Blumer et al 2012).   
As mentioned prior, signaling via chemokine receptors is generally 
understood to be primarily via Gβγ and its activation of downstream effectors 
(Arai et al 1997, Neptune & Bourne 1997, Neptune et al 1999, Peracino et al 
1998, Spangrude et al 1985, Surve et al 2014). Gβγ-mediated stimulation of 
PI3Kγ (Stephens et al 1994, Stephens et al 1997), PLCγ (Wang et al 2000), 
ERK1/2  (Crespo et al 1994, Koch et al 1994) and exchange factors for small 
GTPases Rac and Cdc42 (Ueda et al 2008, Welch et al 2002) (reviewed in (Khan 
et al 2013)) as well as other scaffolding proteins (Sun et al 2011) appears to 
underlie the requirement of Gβγ for regulating chemoattractant-directed cell 
motility. Further supporting the critical role of Gβγ in chemokine signaling, recent 
reports demonstrate small molecule inhibitors and a small molecule activator of 
Gβγ are able to effectively respectively inhibit or promote chemotaxis of 
neutrophils and breast cancer cells (Kirui et al 2010, Lehmann et al 2008, Surve 
et al 2014). Although there is a solid foundation to support Gβγ as being an 
essential component of chemokine-mediated migration, even in the presence of 
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Gβγ small molecule inhibitors such as gallein, there still exists a degree of 
directed migration to chemokine suggesting that these cells may have additional 
signaling modules for promoting chemotaxis independent of Gβγ (Branham-
O'Connor et al 2014, Lehmann et al 2008). Indeed, the use of a small molecule 
that activated Gβγ by heterotrimer dissociation recently demonstrated Gβγ 
signaling to be required for maximal neutrophil migration; but interestingly, in the 
co-treatment of both the small molecule and pertussis toxin, neutrophil 
chemotaxis was slightly reduced suggesting a minor, but observable contribution 
of Gαi to chemokine-induced migration of neutrophils (Surve et al 2014). 
However within the context that Gβγ is primarily responsible for the 
majority of effects observed in chemokine signaling, AGS3 and AGS4 may 
influence interactions between Gαi and Gβγ subunits and thus impart a positive 
modulatory effect on cellular responses to chemokines. The competitive nature of 
the GPR motif with Gβγ for GαiGDP binding (Bernard et al 2001, Ghosh et al 
2003, Oner et al 2010a, Takesono et al 1999), suggests that GPR proteins may 
“grab” free GαiGDP prior to heterotrimer reassociation to enhance or prolong Gβγ-
regulated effector activation (Blumer & Lanier 2014, Blumer et al 2012, Blumer et 
al 2007). This hypothesis is supported by investigations in the broader context of 
GPR proteins influencing Gαiβγ subunit interactions (Kinoshita-Kawada et al 
2004, Kwon et al 2012, Nadella et al 2010, Regner et al 2011, Sanada & Tsai 
2005, Sato et al 2004, Takesono et al 1999, Webb et al 2005, Wiser et al 2006). 
Therefore, the observed defects in chemotaxis resulting from the absence of 
AGS3 and AGS4 may in part be attributed to increased rates of Gαiβγ 
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heterotrimer reassociation thereby decreasing periods of Gβγ activation, 
consequent phosphorylation of ERK1/2, and subsequent cell motility (Figure 3.4, 
3.6 and 3.7).  
Taken together, the data strongly support the hypothesis of GPR proteins 
contributing a modulatory function to chemokine-mediated Gβγ signaling. The 
data may also point to potential functional redundancy between AGS3 and AGS4 
in the chemotactic migratory response. In this context multiple questions begin to 
develop.  Are the actions of AGS3 or AGS4 independent of one another, or is the 
loss of one GPR-protein compensated by the capacity of the other? Do AGS3 
and AGS4 have differential functions in subpopulations of immune cells and 
within certain periods of activation? Does absence of both GPR-containing 
proteins simultaneously lead to a potentiation of the defects observed in the 
absence of either protein alone? Generation of a dual knockout mouse for AGS3 
and AGS4 would be a valuable asset in further exploring distinct functions of 
AGS3 and AGS4 and identifying mechanisms in which the GPR-proteins are 
interchangeable (see Chapter 4: Future Directions). Aside from the potential 
functional redundancy observed between AGS3 and AGS4 demonstrated by the 
above data, other GPR proteins are also expressed in immune tissues and cells, 
including LGN/Gpsm2 (Blumer et al 2002, Branham-O'Connor et al 2014, Oliaro 
et al 2010) and RGS14 (Cho et al 2000).Thus, it is possible that any of these 
proteins may be partially masking the effects of the loss of AGS3 or AGS4 in this 
process. Defining the roles of these GPR proteins in chemokine signal integration 
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may reveal additional functional capacity of the GPR motif in this context and is a 
focus of future efforts. 








The overall goal of this dissertation is to examine the regulation of GPR 
proteins, establish possible contributors of this regulation, and demonstrate a 
functional role for GPR proteins in chemokine signal processing. My 
experimental approach is as follows: 1) establish if the Gαi – GPR module is 
regulated by chemokine receptors; 2) determine if the regulation of the Gαi – 
GPR complex involves direct modulation by 7TMRs or flux of endogenous G-
protein subunits; 3) identify alternative binding partners that may regulate 
function of AGS4; 4) a drug screen to identify potential small molecule 
modulators of the Gαi – GPR interaction; and 5) define functional roles for AGS3 
and AGS4 in chemokine signal processing using null mice. 
 
CXCR4 induces agonist-mediated regulation of the Gαi2 – GPR complex that is 
receptor proximal and Gαi2 dependent 
Cells of hematopoietic origin have to constantly adapt to a dynamic 
extracellular environment. Many of these signals are transduced through the Gαi-
coupled chemokine receptor family, which signals predominantly through the 
Gαi2βγ heterotrimer to direct leukocyte migration to secondary locales (Arai et al 
1997, Neptune & Bourne 1997, Wright et al 2002). Interestingly, two GPR-
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containing proteins, AGS3 and AGS4, which bind GαiGDP, are abundantly 
expressed in leukocytes (Chapter 3), (Branham-O'Connor et al 2014, Cao et al 
2004, Giguere et al 2013, Zhao et al 2010). Additionally, previous reports 
indicated that the interaction between GPR-containing proteins (AGS3, AGS4, 
and RGS14) and Gαi1 can be regulated by 7TMRs (Oner et al 2010a, Oner et al 
2010b, Vellano et al 2013). However, the regulation of the Gαi2 – GPR complex 
by chemokine receptors has not been investigated.  
Using a BRET system to monitor the association between AGS3 or AGS4 
with Gαi2 before and after CXCR4 receptor activation, we observed an agonist-
dependent decrease in association between AGS3 or AGS4 with Gαi2 (Chapter 
2, Figure 2.1). Similar to Gαiβγ heterotrimer, this regulation is effectively blocked 
by pre-treatment with pertussis toxin or addition of receptor antagonist. Further 
investigation into the regulation of the Gαi2 – GPR complex by chemokine 
receptors demonstrated that the interaction of AGS3 or AGS4 with the receptor 
was Gαi2-dependent and disrupted upon addition of agonist (Chapter 2, Figure 
2.2). Taken together, these findings suggest of the formation of a ternary GPCR-
Gαi2-GPR protein complex that is regulated by agonist-mediated activation of the 
CXCR4 receptor, which is analogous to agonist regulation of  canonical Gαiβγ 





Gαi – GPR complexes exhibit direct coupling to 7TMRs, where the observed 
regulation is independent of competitive displacement of tagged Gαi subunits by 
endogenous, untagged G-proteins  
Although the previous data suggests the existence of a GPCR-Gαi2-GPR 
ternary complex, the regulation observed could also be attributed to a secondary 
event, namely the cycling of endogenous, untagged G-protein α and βγ subunits 
in the microenvironment of the signaling complex. This scenario could result from 
canonical receptor activation of Gαiβγ heterotrimer resulting in the displacement 
of tagged proteins with untagged endogenous G-protein subunits to diminish the 
signal (Burt et al 1998).  
As an initial approach to delineate the regulation of the Gαi2 – GPR 
complex from an exchange of endogenous subunits with this signaling module, a 
fusion protein was generated between α2A/D-AR and Gαi2-YFP (Bahia et al 1998, 
Bertin et al 1994, Burt et al 1998, Seifert et al 1999, Wise et al 1997). This 
construct allowed for detection of Gαi2YFP– GPR-Rluc associations directly at a 
7TM receptor in the plasma membrane distinct from alternative subcellular 
compartments. Additionally, site-directed mutagenesis of the cysteine residue in 
Gαi2 that is ribosylated by pertussis toxin (C352I) effectively blocks the inhibitory 
effect of pertussis toxin on the tagged proteins. Implementing these α2A/D-AR-
Gαi2YFP fusion proteins, we demonstrated agonist regulation of the Gαi2 – GPR 
complex as previously observed for the unlinked proteins (Chapter 2, Figure 
2.3E). A key observation was that treatment with pertussis toxin to inhibit 
endogenous Gαi coupling did not inhibit agonist-mediated regulation of the PTX-
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insensitive fusion protein (α2A/D-AR-Gai2YFP) with either AGS3 or AGS4 
(Chapter 2, Figure 2.3E). These data indicated that endogenous Gαi subunits 
were not involved in the observed agonist regulation of the Gαi2 – GPR module 
by 7TMRs. In addition, we also addressed the possibility that the agonist-
mediated reduction in the Gαi2-GPR interaction may be due to competition with 
endogenous, untagged Gβγ subunits released subsequent to receptor activation.  
The expression of the Gβγ scavenger GRK2-CT or pharmacological inhibition of 
Gβγ by the small molecule inhibitor gallein had no effect on agonist-mediated 
regulation of the Gαi2 – GPR complex, indicating that endogenous, untagged 
Gβγ was not responsible for 7TM receptor regulation of the Gαi – GPR module 
(Chapter 2, Figure 2.4). Collectively, these data indicate that Gαi2 – GPR 
complexes may indeed couple to 7TMRs. Upon receptor activation, the Gαi – 
GPR module appears to sense conformational changes in the receptor 
analogous to canonical Gαiβγ heterotrimer, which disrupts Gαi2 association with 
the GPR motif presumably through nucleotide exchange and activation of the Gαi 
subunit. The implications of such a complex on the way we perceive GPCR 
signaling will be elaborated on in the following section. 
 
Affinity purification identified ARID1b and eEF1d proteins directly binding AGS4 
 Many Group II AGS proteins are comprised of at least one GPR motif and 
additional protein interaction domains that are important for subcellular 
localization and/or function of these proteins (An et al 2008, Blumer et al 2003, 
Blumer et al 2002, Du & Macara 2004, Du et al 2001, Pizzinat et al 2001, Shu et 
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al 2007). However, AGS4 does not contain defined protein interaction domains 
aside from its three GPR motifs (Cao et al 2004, Takesono et al 1999). Thus, to 
define potential interacting partners, AGS4 was fused to an amino terminal 
tandem affinity purification (TAP) tag. Pulldown of these proteins and subsequent 
LC-MS/MS analysis revealed three previously unidentified AGS4 interacting 
proteins including 14-3-3, ARID1b, and eEF1d (Chapter 2, Figure 2.6C). One of 
the protein families, 14-3-3, was subsequently demonstrated to bind AGS4 and 
modulate subcellular location (Giguere et al 2012b). Furthermore, previous 
yeast-two hybrid screens revealed the association of AGS4 with ARID2 and 
eEF2, which are closely related to ARID1b and eEF1d, which we identified in the 
TAP purification screen (Cao 2005). GST-pulldown assays with both ARID2 and 
eEF2 demonstrated interaction with AGS4, thus validating the binding of AGS4 to 
these proteins (Cao 2005). Thus, while further experiments are required to 
delineate the functional role for these novel interactions, the direct binding of 
related proteins identified in two independent screens unexpectedly positions 
AGS4 to potentially be involved in modulation of protein translation and 
transcriptional regulation.   
 
JAK2 and Src phosphorylate AGS4 on a tyrosine residue essential for maximal 
GPR capacity 
 The cytokine thymic stromal lymphopoietic protein (TSLP) was recently 
identified as initiating a signaling cascade that results in the phosphorylation of 
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AGS4 on tyrosine 108, a Janus kinase 2 (JAK2) and Src kinase consensus 
sequence (van Bodegom et al 2012, Zhong et al 2012). While phosphorylation of 
other GPR-containing proteins have demonstrated functional responses to this 
post-translational modification, the effect of phosphorylation on AGS4, remains 
largely unexplored (Blumer et al 2003, Groves et al 2010, Hollinger et al 2003, 
Johnston et al 2009, Rush et al 2005, Zarling et al 2000). In addition, AGS4 is the 
only GPR protein known to undergo tyrosine phosphorylation, which represents < 
2% of total phosphorylation sites in cells (Hunter & Sefton 1980, Olsen et al 
2006).  Mutation of serine and tyrosine residues in AGS4 identified a critical 
tyrosine residue, Y108, which when replaced with a negatively charged aspartic 
acid residue to mimic phosphorylation, results in a dramatic reduction in Gαi 
binding (Chapter 2, Figure 2.7B). Furthermore, in vitro kinase assays revealed 
that the kinases JAK2 and Src effectively phosphorylate AGS4 on this critical 
Y108 residue (Chapter 2, Figure 2.7A). Regulation of AGS4 - Gαi interactions by 
phosphorylation reveals an additional, uninvestigated layer of regulation of AGS4 
and further supports a connection between G-protein signaling to growth factor 
regulated kinases (Corre et al 1999, Della Rocca et al 1999, Luttrell et al 1997, 
Ma et al 2000, Marrero et al 1995, Maudsley et al 2000, Vila-Coro et al 1999).  
 
Identification of small molecules that modulate Gαi – GPR interaction 
Previous studies have linked the presence of GPR proteins to several 
disease pathologies including drug addiction and craving, learning and memory, 
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ischemia reperfusion injury, polycystic kidney disease, blood pressure control, 
energy expenditure and metabolism, and rheumatoid arthritis and inflammatory 
pathways (Blumer et al 2008, Bowers et al 2004, Branham-O'Connor et al 2014, 
Conley & Watts 2013, Giguere et al 2013, Kwon et al 2012, Lee et al 2010, 
Nadella et al 2010, Regner et al 2011, Yao et al 2005). Recently, studies have 
focused on the importance of GPR proteins in chemokine receptor signal 
processing where AGS3 was implicated in a non-canonical signaling complex 
directing migration of neutrophils and loss of AGS3 decreased chemotaxis and 
chemokine receptor processing of various leukocyte populations (Branham-
O'Connor et al 2014, Kamakura et al 2013). Additionally, immunoprotective 
phenotypes for a model of rheumatoid arthritis were observed in the absence of 
AGS4, which has restricted expression to immunological tissues (Cao et al 2004, 
Giguere et al 2013, Zhao et al 2010). Thus, the Gαi – GPR complex may be a 
favorable target for development of therapeutics. A screening platform was 
developed to identify modulators of this interaction by observing alterations in the 
BRET signal between Gαi subunits and GPR proteins, using AGS4 as a model 
GPR protein. Primary and secondary screening identified seven potential hits 
that decreased the BRET signal between Gαi and AGS4 as well as AGS3 
(Chapter 2, Figure 2.8). Further development of these compounds will be 
advantageous to future investigations of the Gαi – GPR interaction in other 
Group II AGS proteins as a reagent for blocking this association or development 




AGS3 exhibits a functional role in chemokine signal processing of leukocytes 
Although the biological role of AGS3 in numerous physiological processes 
has been described, a functional role for AGS3 in the regulation of chemokine 
receptor signaling of hematopoietic cells was unknown (Blumer et al 2008, 
Bowers et al 2008, Bowers et al 2004, Fan et al 2009, Groves et al 2007, Kwon 
et al 2012, Nadella et al 2010, Pattingre et al 2003, Regner et al 2011, Sanada & 
Tsai 2005, Vural et al 2010, Yao et al 2005). Leukocytes incorporate dynamic 
signaling events through highly specialized, spatially integrated, G-protein 
signaling mechanisms to function properly (Cho & Kehrl 2009, Kehrl et al 2009). 
Similarly AGS3 is implicated in dynamic signaling processes of the central 
nervous system where adaptation of G-protein signaling is required for 
appropriate responses of the system (Bowers et al 2008, Bowers et al 2004, Fan 
et al 2009, Sanada & Tsai 2005, Yao et al 2005).  
In recognition of these investigations, activation of primary AGS3-null 
leukocytes exhibited enhanced expression of AGS3 demonstrating that levels of 
AGS3 are influenced by changing extracellular environmental signals and 
suggesting a significant purpose for AGS3 in chemokine signal processing of 
these cells. Loss of AGS3 in leukocytes resulted in significantly decreased 
chemokine-directed migration that was not contributed to decreased receptor 
expression or decrease in chemokinesis as compared to WT leukocytes (Chapter 
3, Figures 3.4A, 3.4C and 3.5A). Chemokine stimulated activation of ERK1/2, 
primarily contributed to Gβγ mediators, was also decreased demonstrating 
additional components of chemokine receptor processing are affected by loss of 
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AGS3 (Chapter 3, Figures 3.6A and 3.6C). These data suggest that a role for 
AGS3 in hematopoietic cells through positive modulation of Gβγ signaling events, 
whereas loss of this protein results in decreased periods of Gβγ activity. 
 
A biological function for AGS4 in leukocyte chemokine signal processing was 
determined  
Unlike AGS3, the biological function of AGS4 is less well understood. The 
expression of AGS4 is known to be restricted to tissues of immune origin, but 
only recently has AGS4 been found to be involved in pathways corroborating with 
its expression profile (Cao et al 2004, Giguere et al 2013, Giguere et al 2014, 
Schmidt et al 2012, van Bodegom et al 2012, Zhao et al 2010, Zhong et al 2012). 
Thus AGS4-null mice were used to define a functional role for AGS4 in primary 
leukocytes. Circulating populations of neutrophils and lymphocytes were altered 
in the absence of AGS4, possibly resulting from a defective trafficking 
mechanism (Chapter 3, Figure 3.2). Chemokine-directed migration of T 
lymphocytes, dendritic cells, and neutrophils was investigated and revealed a 
requirement for AGS4 in maximal chemotaxis in these cells (Chapter 3, Figures 
3.4B, 3.4D, 3.4E). As seen with AGS3-null mice, levels of chemokine receptors 
and random migration were unaltered in the leukocytes from AGS4-null mice 
(Chapter 3, Figure 3.5B). Chemokine-mediated activation of ERK1/2, another 
mechanism in chemokine signal processing, was significantly reduced in the 
absence of AGS4. Furthermore, we demonstrated that the reduction in ex vivo 
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chemokine-directed migration of neutrophils translated to a deficiency of 
neutrophil recruitment to a site of induced-inflammation in vivo. The implications 
of defective chemokine signal processing upon loss of GPR-containing proteins 

















Perspective/Context in the Field  
This dissertation expands on previous observations that suggested Gαi1 – 
GPR complexes were regulated by 7TMRs in a reversible manner (Oner et al 
2010a, Oner et al 2010b, Vellano et al 2013). Developing this notion in the 
context of immunological systems, Gαi2 – GPR complexes were found to be 
regulated by agonist-dependent activation in close proximity to the chemokine 
receptor CXCR4. Further investigation into the direct coupling of this complex to 
the receptor demonstrated the observed regulation was proximal to the integral 
membrane protein α2A/D-AR and not resulting from subunit flux between 
endogenous and tagged proteins. My research further validated the direct 
coupling of 7TMRs to a GαiGPR complex, ostensibly promoting nucleotide 
exchange in a manner that may be similar to 7TM receptor engagement of Gαβγ 
heterotrimer. Several interesting conceptual thoughts emanate from this aspect 
of my research. Considering the simultaneous docking of up to 3-4 Gαi subunits 
on AGS4 and AGS3, my research provides further support to an interesting 
potential for these proteins to scaffold receptors and Gα subunits within a larger 
signaling complex (Adhikari & Sprang 2003, Bernard et al 2001, Blumer & Lanier 
2014, Jahangeer & Rodbell 1993, Jia et al 2012, Kimple et al 2004). Also, 
previous reports and my research demonstrate the regulation of the GαiGPR 
complex is sensitive to pertussis toxin in a manner similar to that observed for 
canonical Gαiβγ heterotrimer, suggesting that functional effects imparted by 
pertussis toxin may in part be attributed to 7TMR regulation of GαiGPR 
complexes (Oner et al 2010a, Oner et al 2010b). Finally, differential regulation by 
167 
 
hormones, neurotransmitters, and small molecules may represent ligand bias of 
7TMRs to couple GαGPR or canonical heterotrimer complexes thus modulating 
signal transmission. Therefore, characterization of the regulation of the novel 
GαGPR signaling complex positions 7TM receptors to potentially couple to one of 
three known (and possibly more) signaling complexes including Gαβγ, GαGPR 
and/or arrestin in a ligand-dependent, conformationally-selective manner to 
potentially generate alternate signaling pathways and allow flexibility of signal 
processing for these receptors (Azzi et al 2003, Barlic et al 2000, Lambright et al 
1996, Lefkowitz & Shenoy 2005, Luttrell & Lefkowitz 2002, Rasmussen et al 
2011, Wall et al 1995).  
 The regulation of subcellular distribution and function of GPR-containing 
proteins is typically attributed to the binding of interacting proteins or post-
translational modifications (An et al 2008, Blumer et al 2003, Blumer et al 2002, 
Du & Macara 2004, Du et al 2001, Pizzinat et al 2001, Shu et al 2007). My 
research further builds upon these studies by identifying potential binding 
partners ARID1b, eEF1d and 14-3-3 proteins for AGS4, which, aside from Gαi, 
lacks defined interacting proteins. Interactions of AGS4 with these alternative 
binding proteins may reveal unexpected and potential modulatory functions for 
AGS4 in protein synthesis and transcriptional modulation. Potential binding of 
AGS4 to the site coinciding with diphtheria toxin inactivation of eEF2 suggests an 
interesting concept that binding of AGS4 to eEF2 may cause decreased protein 
synthesis (Van Ness et al 1980). The binding of ARID family members with 
AGS4 was quite unexpected, but this interaction may position AGS4 to bind 
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ARID proteins excluding them from the nucleus, thus potentially regulating 
transcription. These potential regulatory roles of AGS4 in protein synthesis and 
gene transcription were unanticipated, but require further studies to delineate the 
true nature of their biological functions. Additionally, tyrosine phosphorylation of 
AGS4 by the cytokine TSLP was recently described (van Bodegom et al 2012, 
Zhong et al 2012). Our data demonstrate that JAK2 and Src phosphorylate a 
critical tyrosine residue (Y108).  Mutation of AGS4-Y108, which is positioned 
within the second GPR motif in AGS4, to Asp, reduced Gαi binding to AGS4 by 
nearly 70%, suggesting that Y108 phosphorylation may be a key (and novel) 
mechanism for cells to regulate the AGS4 – Gαi interaction. Interestingly, 
activation of JAK2 and Src is also linked to GαiGTP and 7TMRs by multiple studies 
(Corre et al 1999, Luttrell et al 1997, Ma et al 2000, Marrero et al 1995, Vila-Coro 
et al 1999). The phosphorylation of AGS4 by JAK2 and Src may therefore 
represent a positive modulatory loop of the kinases. Reduction of AGS4 
sequestration of Gαi subunits would enhance 7TMR activation of Gαi further 
prolonging activation of the kinases and downstream transcription factors 
including STAT1 and STAT3 (Cao et al 1996, Darnell et al 1994). 
Reports have recently begun to implicate GPR proteins in immunological 
signaling pathways, which is supported by my findings of the significance of 
AGS3 and AGS4 expression in leukocytes (Branham-O'Connor et al 2014, Cao 
et al 2004, Cho et al 2000, Giguere et al 2013, Giguere et al 2014, Schmidt et al 
2012, van Bodegom et al 2012, Zhao et al 2010, Zhong et al 2012). My research 
has defined signaling mechanisms that require AGS3 and AGS4 for maximal 
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signal integration including chemokine-induced chemotaxis and activation of 
ERK1/2. Interestingly, LGN expression (sharing structural domains and over 60% 
sequence homology with AGS3) is unaffected by AGS3 knockout and there 
appears to be no compensatory mechanism observed in these animals or 
animals that have both AGS3 and AGS4 absent (Figure 3.4, 3.6 and 4.4). These 
results suggest potentially divergent signaling pathways where chemokine signal 
processing may be more structured to AGS3 signaling while LGN is not a 
participant. However, the functions of AGS3 and AGS4 in chemokine signal 
processing that were observed could suggest a potential positive modulatory role 
for Gβγ signaling in this context. The restrictive expression of AGS4 to 
immunological tissues has led to recent investigations into its role as an 
inflammatory mediator in arthritis models (Giguere et al 2013, Schmidt et al 
2012). This immunoprotective phenotype resulting from decreased 
proinflammatory signaling observed in the absence of AGS4 is supported by my 
research that defines the importance of AGS4 to chemokine signal processing 
including chemokine-directed migration of leukocytes to sites of inflammation. 
The use of ex vivo (primary cells) and in vivo animal models in my work has 
revealed novel functional roles for GPR proteins in integrating chemokine signals 
in the immune system. Furthermore, targeting of the GPR proteins may offer an 
alternative approach for development of therapeutics to pathologies that utilize 
chemokine receptor signaling (i.e. inflammatory diseases and certain cancers) 
(Branham-O'Connor et al 2014, Cunningham et al 2010, Giguere et al 2013, 
Koelink et al 2012, Singh et al 2010). 
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 Moreover, investigation of the regulatory elements modulating the Gαi – 
GPR complex and identification of a biological role for AGS3 and AGS4 in 
chemokine signal processing suggests the Gαi – GPR module could provide a 
novel platform for the identification of pathway-targeted drugs. First steps into the 
initial exploration for potential modulators of the Gαi – GPR are described in this 
dissertation. Further development of these compounds will provide unique 
reagents to probe the functionality of the Gαi – GPR module and provide a 
starting platform for potential therapeutic manipulation. Therapeutics against the 
Gαi – GPR module may be advantageous in several disease pathologies 
connected with GPR containing proteins including drug addiction and craving, 
learning disability and memory, ischemia reperfusion injury, polycystic kidney 
disease, blood pressure control, energy expenditure and metabolism, and 
rheumatoid arthritis and inflammatory pathways (Blumer et al 2008, Bowers et al 
2004, Branham-O'Connor et al 2014, Conley & Watts 2013, Giguere et al 2013, 
Kwon et al 2012, Lee et al 2010, Nadella et al 2010, Regner et al 2011, Yao et al 
2005). 
Emerging from the results demonstrated in this dissertation, three working 
hypotheses for the action of GPR proteins in leukocyte migratory response are 
supported (Figure 4.1). One hypothesis is that chemokine receptors directly 
couple to the Gαi – GPR complex sensing conformational changes in the 
receptor, analogous to Gαiβγ heterotrimer, resulting in guanine nucleotide 
exchange and subsequent release of the Gαi subunit to modulate chemotactic 
response (Figure 4.1). This hypothesis has support from previous reports 
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suggesting the existence of a Gαi – GPR signaling module and selective Gαi 
responses in chemokine signaling (Huang et al 2003, Hwang et al 2007, 
Kamakura et al 2013, Oner et al 2010a, Oner et al 2010b, Vellano et al 2011a, 
Wiege et al 2012). Thus, in this hypothesis, chemokine signaling would have a 
Gαi-mediated component in addition to the classically accepted Gβγ signaling 
mechanisms, where the Gαi – GPR module may be operational. A second 
possibility is that binding of Gαi by GPR proteins prior to reformation of the Gαiβγ 
heterotrimer could prolong or enhance Gβγ signaling through slowing 
heterotrimer reassociation and thereby facilitating directed migration (Figure 4.1). 
This hypothesis has support from previous studies that conclude chemokine 
receptor activation and subsequent directed migration occur predominantly 
through Gβγ mediated activation of PI3Kγ and PLCβ2/3 and the downstream 
mediators (Arai et al 1997, Hirsch et al 2000, Li et al 2000, Neptune & Bourne 
1997, Neptune et al 1999, Peracino et al 1998, Sotsios et al 1999, Stephens et al 
1994, Stephens et al 1997, Wang et al 2014). Small molecule inhibitors and 
activators of Gβγ have further demonstrated the necessity of Gβγ signaling in 
chemokine response of leukocytes (Kirui et al 2010, Lehmann et al 2008, Surve 
et al 2014). The final working hypothesis would implicate the Gαi-GPR module, 
generated subsequent to receptor activation and prior to heterotrimer 
reassociation, functioning independently to initiate the formation of an alternative, 
non-canonical signaling complex distinct from Gβγ that modulates chemokine-
directed signaling events (Figure 4.1). A recent report supports this hypothesis by 
demonstrating that the Gαi – AGS3 complex managed to assemble a Par3 – 
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aPKC complex through interaction with mInsc which was required for directional 
migration of neutrophils (Kamakura et al 2013). In this manner, the Gαi – GPR 
module could function as an independent active signaling entity or a platform for 
further diverse signal inputs (Blumer & Lanier 2014, Blumer et al 2012, Gonczy 
2008). It is also possible that any combination of these hypotheses may be at 
work concurrently in migrating cells to provide the proper signaling responses to 
chemoattractants and may be the underlying factor that contributed to the 
observed deficiency of AGS4-KO neutrophils to respond to inflammatory stimulus 
in vivo. Further research is needed to make direct conclusions as to which of 
these hypotheses best describes the regulated interaction between Gαi and 
proteins expressing multiple GPR motifs; however, the work presented in this 
dissertation further depicts a diverse signaling mechanism for this dynamic 
















Figure 4.1 Schematic illustration of working hypotheses for the influence of 
GPR containing proteins on G-protein signal integration  
The GαGPR complex may present as direct targets for 7TMR activation. In this 
scenario, the GPR protein would function analogous to Gβγ in the canonical 
Gαβγ heterotrimer. Agonist-mediated receptor activation catalyzes nucleotide 
exchange on GαGPR module to release active GαiGTP (red outline). Gαi subunits 
undergo GTP hydrolysis through intrinsic GTPase activity of the Gαi subunit or 
acceleration of GTPase activity by RGS proteins inactivating the subunit. GαiGDP 
can then reassociate with GPR motifs (1). GPR proteins may also influence 
subunit interactions subsequent to receptor activation of Gαiβγ heterotrimer. In 
this scenario, agonist-bound receptor catalyzes nucleotide exchange on Gαiβγ 
heterotrimer to release active GαiGTP and Gβγ subunits to mediate secondary 
signals (red outline). GTP hydrolysis of the Gαi subunits inactivates the subunit 
which can then reassociate with Gβγ or GPR motifs (2). GαiGDPGPR complexes 
formed during receptor-mediated cycling of G-protein may act to prolong or 
enhance Gβγ signaling (2). This GαiGDPGPR may also form non-canonical 
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signaling complexes distinct from Gβγ mediated signaling (e.g., those involved in 














Demonstrate the 7TMR – Gαi – GPR interaction results in the formation of a 
functional ternary complex  
 My research determined the regulation of Gαi tethered to a 7TMR with 
GPR proteins to be functionally active in the absence of endogenous G-protein 
subunits, but further validation of the formation and regulation of this complex is 
required. One possibility is to track the Gαi – GPR module before and after 
receptor activation. Using a membrane fractionation assay with the receptor – 
Gαi2 fusion protein linked with BRET or immunoblotting, one could demonstrate 
the displacement of AGS3 or AGS4 from the membrane after receptor activation 
further suggesting the disruption of a Gαi – GPR module by the 7TMR activation 
similarly demonstrated for untethered Gαi1-YFP untethered constructs (Oner et 
al 2010a, Oner et al 2013b). Tracking of AGS3 and AGS4 during agonist 
treatment could be accomplished through fluorescent labeling and real-time 
microscopy of the GPR-containing proteins. Furthermore, direct physical 
association of the three components (GPR protein, Gαi, and 7TMR) would further 
demonstrate Ga-GPR coupling to a 7TMR. Following previously described 
methodologies, co-immunoprecipitation could be used to isolate all three 
components simultaneously in the presence or absence of agonist to 
demonstrate ternary complex formation and regulation by 7TMRs (McCoy et al 
2010). To fully determine direct coupling of the Gαi – GPR module to the 
receptor, a biochemical approach could be used to demonstrate receptor-
stimulated nucleotide exchange on Gαi within this complex. A reconstituted 
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system consisting of purified 7TMR and Gαi subunits pre-assembled with either 
GPR-containing proteins or Gβγ would be incubated with GTPγ35S in the 
absence or presence of agonist. Agonist-induced GTPγ35S binding to Gαi-GPR 
would confirm direct coupling of the Gαi-GPR module to 7TMRs as a substrate 
for receptor-catalyzed nucleotide exchange in a manner analogous to Gαβγ 
heterotrimer.  
 Define intrinsic differences between AGS3 and AGS4 in the differential 
regulation of the Gαi-GPR interaction by 7TMRs  
 My research as well as previous reports have consistently observed that 
agonist-induced changes in the Gαi – AGS3 interaction are much greater than 
that seen for Gαi – AGS4 (Chapter 2, Figures 2.1-5) (Oner et al 2010a, Oner et al 
2010b), An obvious distinction between AGS3 and AGS4 is the presence of TPR 
domains. These domains have been implicated in regulatory functions for AGS3 
and LGN (Adhikari & Sprang 2003, An et al 2008, Bernard et al 2001, Blumer et 
al 2003, Oner et al 2010a, Oner et al 2013c, Pan et al 2013, Vural et al 2010); 
therefore, I initially hypothesized that the presence of these domains may be 
responsible for the discrepancies observed between AGS3 and AGS4 in the 
context of 7TMR regulation. Initial experiments using the α2A/DAR – Gαi fusion 
protein BRET platform to compare the regulation of Rluc tagged AGS3-sh and 
AGS4-sh proteins (which both exhibit truncation of the amino terminus and 
express three GPR motifs), demonstrated that the interaction of AGS3-sh with 
Gαi and subsequent regulation was still similar to that observed for AGS3, while 
AGS4-sh was similar to the full-length AGS4 as well (Chapter 2, Figure 2.5D). 
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These data would suggest properties intrinsic to the GPR motifs of AGS3 or 
AGS4 are responsible for imparting their distinct agonist-mediated regulation 
profiles.  Alternatively, intervening residues between the GPR motifs in each 
protein may also impart a regulatory role on the Gαi interaction with AGS3 versus 
AGS4.  In support of these findings, a single amino acid alteration within the GPR 
II motif of AGS4 was previously reported to affect Gαi binding (Kimple et al 
2004). Additionally, intrinsic differences between Gαi binding to single GPR 
motifs of AGS3 have demonstrated the importance of the interlinking sequences 
to specific domains (Adhikari & Sprang 2003). Thus, taking these observations 
into account, the differential regulation may be due to intrinsic differences 
between the GPR motifs and/or intervening residues between these domains 
specific to AGS3 or AGS4. This question could be initially addressed by 
generating chimeric proteins between AGS3-sh and AGS4 GPR domains. The 
regulation of such constructs by 7TMRs could shed light on amino acids involved 
in the distinct regulation of AGS3 versus AGS4 in our BRET experiments.  
The diversity of regulation of AGS3 and AGS4 may coincide with distinct 
functional roles for these proteins. Similar regulation of these complexes by 
7TMRs would illustrate a redundant mechanism, while differences suggest a 
more dynamic signaling process. One could envision AGS proteins functioning 
as dynamic repositories for Gαi subunits. Under physiological conditions, Gαiβγ 
heterotrimers are responsible for a large majority of G-protein signaling; however 
when stressed or under abnormal conditions, the cell could potentially “tap” into 
these sources of surplus Gαi subunits to maintain effective G-protein signaling. In 
178 
 
this context differential regulation of the Gαi – GPR complex could represent 
distinct repositories of Gαi where AGS3 has more readily available Gαi subunits 
for use in the cells while AGS4 has more stringent retention of Gαi subunits for 
cells to potentially harness during periods of high activity or stress. These 
dynamically regulated repositories could represent an unexplored mechanism 
utilized by cells where variations in regulation of the Gαi – AGS3 and Gαi – 
AGS4 interactions would be advantageous. 
Determine if multi GPR-containing proteins can effectively scaffold larger 
signaling complexes to promote signaling  
As previously discussed, proteins containing multiple GPR motifs can 
effectively dock 2-4 subunits of Gαi simultaneously (Adhikari & Sprang 2003, 
Bernard et al 2001, Blumer & Lanier 2014, Jahangeer & Rodbell 1993, Kimple et 
al 2004). Thus, these proteins could potentially scaffold larger receptor 
complexes each bound to a single Gα subunit. As an initial approach to 
determine the effect of multi GPR-containing proteins on the formation of larger 
signaling complexes, I generated a α2A/D-AR – Gαi-Rluc fusion protein to be used 
in concert with the α2A/D-AR – Gαi-YFP construct. Increasing levels of AGS3 and 
AGS4 were able to effectively congregate differentially tagged receptors as 
determined by BRET measurements, while Q/A mutants that are unable to bind 
Gαi demonstrated no such effect (Figure 4.2). As an initial follow-up to this 
experiment, the effect of agonist on the GPR-dependent assembly of these 
receptor complexes could be determined. Moreover, to further validate the 
formation of these higher order complexes on the cell surface versus intracellular 
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domains, time-resolved fluorescence resonance energy transfer (TR-FRET) 
linked with snap-tag technology can be used. This technique would specifically 
label the α2A/D-AR expressed on the cell surface with FRET capable fluorophores 
followed by TR-FRET analysis to determine association of the receptors in the 
presence of increasing levels of GPR proteins as previously used to determine 
dimerization of other GPCRs (Maurel et al 2008). Although the scaffolding of 
larger receptor complexes is an interesting potential role for multi-GPR proteins, 























Figure 4.2. GPR-containing proteins scaffold larger receptor signaling 
complexes 
(Left panel) Net BRET signals were obtained from HEK293 cells transfected with 
α2A/D-AR–Gαi1YFP (500 ng) and α2A/D-AR–Gαi1Rluc (500 ng) with increasing 
levels of AGS3-WT or AGS3-Q/A (0-500 ng). (Right panel) Net BRET signals 
were obtained from HEK293 cells transfected with α2A/D-AR–Gαi1YFP (500 ng) 
and α2A/D-AR–Gαi1Rluc (500 ng) with increasing levels of AGS4-WT or AGS4-
Q/A (0-500 ng). Fluorescence and luminescence readings were measured as 
described in “Chapter 2: Experimental Procedures.” All data are expressed as 





Validate binding regions and functional significance of ARID1b and eEF1d 
binding AGS4 
 Identification of binding partners for AGS4 demonstrates potential 
modulatory functions for AGS4 in alternative signaling pathways. Moving forward, 
the alternative binding partners of AGS4, ARID1b and eEF1d, require validation. 
Corroboration of these interactions could be accomplished through generation of 
GST fusions for ARID1b and eEF1d followed by subsequent co-precipitation 
studies with lysates of cells expressing AGS4. Even after validation, the region of 
binding of AGS4 to ARID1b and eEF1d and vice versa would require further 
exploration. Truncation of AGS4, eEF2, and ARID2 (Figure 4.3) followed by co-
immunoprecipitation experiments could determine the regions in which these 
proteins bind one another.  Additionally, BRET experiments could be conducted 
to further validate these interactions by measuring BRET signals between AGS4 
and candidate interacting proteins as well as their effect on the AGS4 – Gαi 
interaction. Furthermore, screening lysates from immune tissues or cell lines 
could potentially determine any unique binding partners to AGS4 in the context of 
leukocytes. With the related protein eEF2 found to bind AGS4 at the carboxy 
terminal domain where diphtheria toxin is known to inactivate the protein, it would 
be interesting to determine the effect of AGS4 binding on protein translation (Cao 
2005, Van Ness et al 1980). 35S-methionine incorporation into proteins over a 
period of time in the presence of increasing AGS4 and AGS4-Q/A could 
demonstrate the effect of AGS4 on protein synthesis. As for the unique 
interaction of AGS4 with ARID1b, investigation into a potential role of AGS4 in 
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modulating the endogenous role of ARID1b in transcriptional regulation could 
exhibit interesting findings. A luciferase reporter assay was recently described to 
determine the direct effect of inducible ARID1b on c-myc and p21 promoter 
activity demonstrating both repressive and stimulatory actions of transcription, 
respectively (Inoue et al 2011). Co-expression of increasing levels of AGS4 or 
AGS4-Q/A could be monitored for alterations in luciferase activity in this model to 
determine if the ARID1b component of the SWI/SNF complex can be modulated 
in part by AGS4 binding. These studies would allow for conclusions to be drawn 

























Figure 4.3. Truncation of potential AGS4 interacting proteins 
Depicted are schematic representations of AGS4 and potential alternative 
binding partners of AGS4 identified in my affinity purification screen. Major 
domains for each protein are identified: 1) GPR domains - G-protein regulatory 
domains; 2) LXXLL – Nuclear receptor recognition sequence; 3) ARID – AT-rich 
interaction domain; 4) EF1_beta_acid – Central acidic region related to eEF1b 
domain; 5) EF1-GNE – Guanine nucleotide exchange domain. Arrows shown are 







Establish a role for AGS4 phosphorylation in TSLP signal transduction 
Earlier reports define post-translational modifications within or proximal to 
GPR motifs to affect interaction of Gαi subunits with GPR motifs (Adhikari & 
Sprang 2003, Blumer et al 2003, Hollinger et al 2003, Kimple et al 2004). 
Building on this notion my dissertation demonstrated that phosphorylation of one 
(Y108) of the two tyrosine residues expressed by AGS4 effectively decreases the 
binding of Gαi to the GPR domain. Also recent evidence depicted Y108 being 
phosphorylated subsequent to TSLP signaling, which my research determined 
could be potentially mediated by JAK2 and Src kinases activated downstream of 
TSLP activation (Zhong et al 2012). This is important since TSLP signaling has 
been shown to be a critical mediator in regulating the immune response in 
pathologies involving allergies and hypersensitivity, such as asthma and atopical 
dermatitis (He et al 2008, Liu et al 2007, Redhu et al 2013, Roan et al 2012, 
Wilson et al 2013, Ziegler 2012, Ziegler et al 2013). Thus, the finding that JAK2 
and Src kinases phosphorylate AGS4, potentially through TSLP-mediated 
activation, begs the question of the regulatory role AGS4 plays on this signaling 
cascade. To address this possible modulatory function, Jurkat and JAWSII cell 
lines (representing T-lymphocytes and dendritic/monocyte cells), could be 
activated by TSLP in the presence of increased levels of AGS4, AGS4Y108F, 
AGS4Y108D, or AGS4-Q/A to determine the effect of AGS4 phosphorylation on 
the downstream phosphorylation and subsequent activation of STAT molecules 
(STAT1, STAT3, and STAT5). 
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Development of small molecules found to modulate the Gαi – GPR 
interaction 
 The role of GPR proteins in various biological systems is intensely 
investigated through the use of knockout animals (Blumer et al 2008, Branham-
O'Connor et al 2014, Giguere et al 2013, Giguere et al 2014, Kwon et al 2012, 
Lee et al 2010, Regner et al 2011). Development of compounds that block Gαi – 
GPR would therefore be of great utility in further exploration of the functional role 
of these proteins. My dissertation represents a step forward in the identification of 
such compounds, but much more research is required to validate and develop 
the small molecules presented by this work. Initially, independent validation of 
the efficacy of these compounds using purified Gαi and AGS3 and AGS4 
proteins would be conducted, coupled with immunoblotting or BRET analysis as 
subsequent readout for disruption of the Gαi – GPR interaction. Furthermore, 
determination of efficacious concentrations for these potential small molecule 
modulators would be determined by administering dose responses of the small 
molecules in our BRET system and in GTPγS binding experiments. Obtaining 
IC50 and EC50 values for each compound would assist in the determination of 
proper dosing to be used on primary cells and potentially in animal models. 
Secondary screening in primary WT leukocytes would then be conducted to 
observe if similar defects in chemokine signal integration are recapitulated as 
were seen in the AGS3-null and AGS4-null animals upon treatment with the 
small molecule modulators. As a final testament to the potential of these 
compounds to be developed into therapeutics, I would administer them into mice 
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subjected to collagen antibody-induced arthritis (CAIA) to simulate rheumatoid 
arthritis as described previously (Giguere et al 2013, Khachigian 2006). 
Importantly, GPR proteins are also involved in cells that utilize chemokine 
receptors CXCR4 and CCR7 for non-canonical measures, such as secondary 
metastasis in certain malignancies (Cunningham et al 2010, Singh et al 2010). 
Thus, it would be interesting to determine if administration of these compounds in 
a xenograft mouse model of inflammatory breast cancer could reduce secondary 
metastasis (Singh et al 2010). 
Determine if AGS3 and AGS4 have functionally redundant roles in 
leukocytes  
 Published results from this dissertation and recent studies have connected 
chemokine signal integration with proteins containing GPR motifs (Branham-
O'Connor et al 2014, Cho et al 2000, Giguere et al 2013, Giguere et al 2014, 
Schmidt et al 2012, van Bodegom et al 2012, Zhong et al 2012). Interestingly, 
compared to mice lacking Gαi2, the deficiencies seen in this dissertation appear 
modulatory in nature (Cho et al 2012, Han et al 2005, Hwang et al 2007, Pero et 
al 2007, Rudolph et al 1995, Skokowa et al 2005, Zarbock et al 2007). 
Furthermore, it is possible that the effect of loss of AGS3 or AGS4 is masked by 
the presence of the opposing protein in leukocytes as well as other GPR-
containing proteins including LGN/Gpsm2 and RGS14 (Blumer et al 2002, Cho et 
al 2012, Oliaro et al 2010). Thus, generation of a model deficient in both AGS3 
and AGS4 would be of high importance to determine if there is a redundant effect 
in chemokine-mediated signaling with the simultaneous deletion of both these 
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proteins. Recently, I have generated these mice through cross breeding of 
heterozygous mice from Gpsm1+/- and Gpsm3+/- backgrounds (DKO). Initial 
experiments are promising and demonstrate a potentially synergistic effect of the 
loss of both AGS and AGS4 as revealed in a dramatic decrease in ex vivo 
neutrophil chemotaxis (Figure 4.4A). Additionally, circulating populations in DKO 
animals illustrate similar neutropenia and lymphocytosis as seen in AGS4-null 
mice (Figure 4.4B). Similar experiments to those portrayed in this dissertation 
may determine that the loss of multiple GPR proteins further exacerbates the 
phenotypes that were observed with the loss of either AGS3 or AGS4. These 
animals represent an important tool in the determination of Gαi – GPR function in 
immunological tissues. Furthermore, the deficiency in chemokine-directed 
migration observed in AGS3-null, AGS4-null, and DKO animals suggests a 
fundamental issue with directed motility in these leukocytes. Live cell microscopy 
of these cells in real time could be used to track the overall speed, velocity, and 
directionality to chemokine stimuli to determine where the deficiency lies 
(Kamakura et al 2013). In order to investigate if the functional defects seen in  ex 
vivo experiments translates to an in vivo phenotype, intravital imaging could be 












Figure 4.4. Gpsm1-/-/Gpsm3-/- demonstrate altered leukocyte populations 
and substantial reduction in neutrophil chemotaxis 
(A) Blood was collected from WT, Gpsm3-/-, and Gpsm1-/-/Gpsm3-/- mice by 
cardiac puncture as described in Experimental Procedures (Chapter 3). 
Complete blood cell counts (CBCs) were performed within 2 hr of blood collection 
using a HemaVet 950 instrument to measure leukocyte levels in each sample. 
Percent of leukocyte populations in relation to total number of white blood cells 
was calculated.  
(B) Neutrophils from WT, Gpsm3-/-, and Gpsm1-/-/Gpsm3-/- mice were isolated 
from freshly harvested bone marrow as described in Experimental Procedures 
(Chapter 3). Isolated neutrophils were loaded in transwell migration chambers 
with the bottom chamber containing serum-free RPMI with 0.1% BSA and 2mM 
EDTA in the absence and presence of fMLP (0.1–5 µM).  After 3h at 37°C, cells 
in the bottom chamber were counted, and the percentage of cells migrated was 
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calculated relative to the input, where the number of cells migrating in the 
absence of chemokine was subtracted.  
Data are represented as the mean +/- S.E. of at minimum 3 independent 
experiments with at least triplicate determinations (* denotes p < 0.05 as 















Determine if the defective inflammatory response observed for AGS4-null 
mice is due to a synchronous or independent function of neutrophils and 
endothelial cells. 
This dissertation also demonstrated a possible functional defect in 
extravasation of neutrophils to a site of inflammation. Indeed, impaired 
transmigration of other leukocytes has been linked to Gαi2 signaling both in the 
immunological cells as well as endothelial cells involved in trafficking the 
leukocytes through to the inflamed tissue (Pero et al 2007, Warnock et al 1998, 
Wiege et al 2012, Zarbock et al 2007). Thus to investigate the extravasation 
ability of AGS4-null neutrophils to inflamed tissues, intravital two-photon imaging 
could be utilized as described in recent reports (Kreisel et al 2010, Li et al 2012). 
The other interesting possibility is that the deficiency could be in the endothelial 
cells of AGS4-null mice. Determination of the cell responsible for the defective 
phenotype observed could be delineated by lethal irradiation of AGS4-null or WT 
mice (Figure 4.5). After reconstitution with bone marrow from the opposing 
genotype and subsequent recovery for hematopoietic repopulation, induced 
peritonitis could demonstrate if the AGS4-null neutrophils or AGS4-null 
endothelial cells are the source of the defective transmigration (Figure 4.5) 
(Frasca et al 2000, Jakus et al 2009, von Vietinghoff et al 2010). An alternative 
explanation to this defective infiltration of neutrophils could be represented by a 
delayed response to immunological challenge. Therefore, inducing peritonitis and 
harvesting the inflamed tissues at later time points could determine if the AGS4-
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null neutrophils eventually migrate to the IP cavity depicting a latent innate 

























































Figure 4.5. Experimental design to determine if neutrophils or endothelial 
cells are responsible for defective neutrophil infiltration in Gpsm3-/- mice 
(A) Gpsm3-/- bone marrow will be isolated as described in Experimental 
Procedures (Chapter 3). WT mice will be lethally irradiated to abolish the 
endogenous immune system followed by subsequent transplant of the isolated 
Gpsm3-/- bone marrow as described (Frasca et al 2000, Jakus et al 2009, von 
Vietinghoff et al 2010). After a sufficient recovery period, mice will have peritonitis 
induced using 4% thioglycollate. Two hours post-injection, 10 ml of cold, sterile 
PBS will be used to lavage the intraperitoneal cavity, blood collected by cardiac 
puncture and femurs processed to harvest bone marrow cells. Samples will have 
red blood cells lysed and be stained for neutrophil markers, FITC–CD11b and 
PE–Ly-6G, for flow cytometry analysis. 
(B) WT bone marrow will be isolated as described in Experimental Procedures 
(Chapter 3). Gpsm3-/- mice will be lethally irradiated to abolish the endogenous 
immune system followed by subsequent transplant of the isolated WT bone 
marrow as described (Frasca et al 2000, Jakus et al 2009, von Vietinghoff et al 
2010). After a sufficient recovery period, mice will have peritonitis induced using 
4% thioglycollate. Two hours post-injection, 10 ml of cold, sterile PBS will be 
used to lavage the intraperitoneal cavity, blood collected by cardiac puncture and 
femurs processed to harvest bone marrow cells. Samples will have red blood 
cells lysed and be stained for neutrophil markers, FITC–CD11b and PE–Ly-6G, 
for flow cytometry analysis. 
194 
 
Determine if AGS4 is required for proper clearance of acute infections  
Mice of the C57BL/6 background are known to be one of the most highly 
resistant strains to Staphylococcus aureus infections; however,  when the innate 
immune system of the animal is comprised the mice succumb to the infection 
much more rapidly (Cho et al 2012, McIntyre et al 1989, Verdrengh & Tarkowski 
1997, Wiege et al 2013). As a means to determine the extent of the 
immunodeficiency in AGS4-null mice, S. aureus infections would be administered 
to WT and AGS4-null mice followed by mortality monitoring. Given my 
encouraging data presented in this dissertation which suggests GPR proteins are 
important to chemokine signal integration, the future experiments presented 
above should lay the groundwork for further dissecting the functional roles for 
GPR proteins in the immune system. 
 
As the culmination of my research, this dissertation demonstrates a 
diverse array of regulatory mechanisms for the Gαi – GPR module by chemokine 
receptor regulation and direct coupling of 7TMRs in a manner similar to Gαiβγ 
heterotrimer. Additionally, my research identified unexpected alternative 
interacting proteins for AGS4 and phosphorylation of a critical tyrosine residue 
that may represent unique modulatory functions for this Group II AGS protein. I 
also defined a biological function for AGS3 and AGS4 in the context of 
chemokine signal integration in leukocytes of the immune system; furthermore, I 
determined that AGS4 was required for inflammatory response of neutrophils in 
intact animals. My dissertation depicts an initial approach to identify compounds 
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to specifically target the Gαi – AGS4 interaction through a small molecule 
screening. These small molecule modulators could conceivably be highly 
valuable as reagents to further investigate the functionality of the Gαi – GPR 
module or to provide an initial platform for development of potential pathway 
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